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Burn injuries, chronic wounds (venous, pressure and leg ulcers), excision of skin and 
tumors are the main forms of skin damage. The full-thickness skin loss caused by these 
damages is not adequately addressed by current methods of wound coverage. 
Split-thickness skin autografts still represent the “gold standard” treatment to resurface 
the deep wounds. However, in patients with very large total body surface area wounds, 
insufficient donor sites for autografting complicate wound closure, which can 
compromise recovery, increase the risk of invasive wound infection and mortality. Tissue 
engineering has emerged as a new and promising field for the treatment of skin lesions, 
combining scaffolds, cells and biomolecular signals, such as growth factors. The tissue 
engineered skin grafts are being applied to overcome the problem of insufficient 
autografts. However, a critical issue of tissue engineered scaffold is the ex vivo cell 
expansion which is required to obtain sufficient numbers of the needed cells, while 
preserving the cells' normal phenotype and functionality within a short time. Interestingly, 
light and electrical stimulations were found to promote cell proliferation. In this project, 
it is hypothesized that tissue-engineered skin grafts composed of cost-effective and 
biodegradable nanofibrous scaffolds (NFS) enriched with growth factor, photosensitive 
polymer and adipose-derived stem cells (ASCs) can promote wound healing and skin 
regeneration in acute full-thickness skin wounds. 
 
Composite gelatin/poly( L -lactic acid)–co-poly(ε-caprolactone) (Gel/PLLCL) nanofibers 
with four different weight ratios of gelatin:PLLCL (w/w) of 80:20 [Gel/PLLCL(80)], 
70:30 [Gel/PLLCL(70)], 60:40 [Gel/PLLCL(60)] and 50:50 [Gel/PLLCL(50)] were 
successfully fabricated with electrospinning technique. It demonstrated that the 
Gel/PLLCL(60) naonfibers which had small pore size, proper mechanical properties both 
in wet and dry conditions and higher cell proliferation was the optimized nanofibrous 
scaffold for skin tissue engineering. The wound healing performance of Gel/PLLCL(60) 
was further evaluated in vivo. A faster wound healing and better reepithelialization were 
achieved by using the cost-effective Gel/PLLCL(60) NFS.  
 
 XI 
A few major epidermal induction factors (EIF) were successfully incorporated into 
polymeric core-shell nanofibers and the results of the release studies demonstrated that 
the core-shell nanofibers achieved sustained release without burst release. The 
differentiation potential of ASCs into epidermal lineage on core-shell NFS was 
confirmed and the expression of early and intermediate epidermal differentiation markers 
was observed. With sustained release of EIF from core-shell nanofibers, the percentage of 
epidermally differentiated ASCs on core-shell nanofibers (62%) was significantly higher 
than that on EIF blended nanofibers (43%).  
 
The optimized photosensitive poly(3-hexylthiophene) (P3HT) containing 
poly(ε-caprolactone) (PCL) nanofibrous scaffolds were fabricated by electrospinning. 
Photocurent generation in electrospun PCL/P3HT nanofibers was confirmed. Fibroblast 
proliferation on PCL/P3HT and PCL nanofibrous scaffolds under light stimulation was 
studied and the results suggestted that fibroblasts cultured on PCL/P3HT after light 
stimulation had better proliferation and morphology than fibroblasts cultured on 
electrospun PCL nanofibers. Electrospun PCL/P3HT nanofibrous scaffold was capable of 
supporting cell proliferation and favoring cell ECM secretion.  
 
Epidermal growth factor (EGF) and photosensitive polymer P3HT were encapsulated into 
electrospun core-shell NFS. Fibroblast proliferation was significantly improved on EGF 
encapsulated nanofibers and photosensitive P3HT in the core-shell nanofibers can further 
promoted fibroblast proliferation under light stimulation. Keratinocyte-like ASCs were 
only found on the light stimulated EGF and P3HT encapsulated core-shell nanofibers. 
The expression of early epidermal differentiation markers was observed. Moreover, this 
core-shell nanofibrous scaffold was found to accelerate in vitro wound healing. Therefore, 
the biomimetic and photosensitive core-shell nanofibers could be a novel scaffold applied 
in photocurrent therapy for wound healing and skin construction. Our study sheds light 
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Gel/PLLCL/P3GF(cs) (NS) and Gel/PLLCL/GF(cs) (NS) at p ≤ 0.05. #Significant against 
cell proliferation on Gel/PLLCL/P3GF(cs) (NS) at p ≤ 0.05.
◆
Significant against cell 
proliferation on Gel/PLLCL/GF(cs) (S) at p ≤ 0.05. 
 
Fig. 6.4 In vitro wound healing on stimulated and non-stimulated Gel/PLLCL/P3GF(cs) 
nanofibrous scaffold for 9 days. 
 
Fig. 6.5 Dual immunocytochemical analysis for the expression of Ker 10, CD 105 and 
merged image showing the dual expression of both CD 105 and Ker 10 on stimulated 
Gel/PLLCL/P3GF(cs), Gel/PLLCL/GF(cs) nanofibers and non-stimulated 
Gel/PLLCL/P3GF(cs), Gel/PLLCL/GF(cs) nanofibers at 20 × magnification. 
 
Fig. 7.1 Photograph of a scaffold of radially aligned nanofibers directly deposited on the 
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Skin is the largest organ of the body, serving primarily as a protective barrier against the 
environment [1, 2]. It also helps to prevent body dehydration and constitutes a physical 
barrier, limiting the penetration of potentially harmful agents to internal organs. The skin 
has a three-layer structure composed of epidermis, dermis and hypodermis [3, 4]. The 
epidermis, the superficial layer, is mainly composed of keratinocytes [5, 6], providing a 
barrier against infection and moisture loss. The dermal layer, situated below the 
epidermis, is responsible for the elasticity and mechanical integrity of the skin. It contains 
vascularized extracellular matrix (ECM) rich in collagen, elastin and glycosaminoglycans 
[4, 6]. The hypodermis, located below the dermis, is mainly composed of adipose tissue 
and collagen, and mainly acts as an energy source [3, 5, 6]. However, when the skin is 
damaged, it will lose its integrity and barrier function. According to WHO, 300,000 
deaths are annually attributed to burn injuries, while 6 million patients worldwide suffer 
from burns every year. Additionally, more than 6 million individuals suffer from chronic 
skin ulcers. In the USA alone, more than 3 million patients suffer from chronic wounds 
[3, 7]. In Singapore, average annual burn admissions from 1997 to 2003 were 288 with a 
range from 188 to 348. This represents a incidence rate of 0.07 per 1000 population (on 
average) for burn injury in the city of Singapore [8]. Acute large full-thickness skin 
wounds not only cause an immediate loss of wound coverage, but also initiate 
physiological instability and give rise to various complications. Insufficient autologous 
grafts greatly impede wound closure in patients with large area wounds, and then lead to 
infection and low mortality [9]. As a result, the development of tissue engineered skin 
replacements is greatly motivated by the need for permanent wound closure in 




Tissue-engineered skin graft is an attractive alternative substitute for clinicians to use for 
the healing of full-thickness skin wounds because they can overcome certain 
disadvantages of using autografts like insufficient donor supply and size mismatches. The 
application of biomimetic scaffolds and culturing skin cells (keratinocytes, hair follicle 
cells and fibroblasts etc.) in the scaffold is the current approach in designing skin tissue 
engineered substitutes. Many commercialized tissue-engineered skin grafts are available 
on market (Table 2.2). They offer advantages of resurfacing large wound area, supporting 
host fibroblast infiltration (Permacol
TM
, OrCel®, Integra®) and improving granulation 
tissue deposition (Apligraf®) etc. However, a critical issue of tissue engineered scaffold 
is the ex vivo cell expansion that is required to obtain sufficient numbers of the needed 
cells, while preserving the cells' normal phenotype and functionality within a short time. 
What’s more, the high cost and short shelf time limit the application of the current tissue 
engineered skin grafts. All of these deficiencies in current treatments for full-thickness 
skin wounds lead to an urgent necessity for the development of a novel tissue-engineered 
skin graft incorporating a bioactive molecular and abundant safe cell source in 
combination with a cost-effective, biodegradable and functional scaffold with appropriate 
mechanical properties.  
1.2 Motivation 
 
The composition of the native extracellular matrix (ECM) is a complex mixture of 
structural and functional proteins, glycosaminoglycans, glycoproteins and bioactive 
factors arranged in a unique, tissue specific three-dimensional architecture [11]. The 
native ECM contains fibrils ranged from tens of nanometers to micrometers in scale. The 
organized structure of these matrix fibrils guides tissue morphogenesis and remodeling. 
In addition, matrix fibrils serve as “depots” for the storage of bioactive factors for the 
regulation of cell migration, proliferation, and differentiation [12]. 
 
Research on the construction of synthetic mimics of ECM has profound implications in 
the field of regenerative medicine and tissue engineering [13]. Advances in tissue 
engineering techniques have sparked interests in making scaffolds with biocompatible 
and/or biodegradable polymer nanofibers. The non-woven polymeric architecture of 
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nanofibrous scaffolds (NFS) mimics the nano-scale protein fiber meshwork in native 
ECM. The large surface area-to-volume ratio of NFS favors cell adhesion, proliferation, 
migration and differentiation [14]. For skin graft application, the high porosity of NFS 
provides more structural space for accommodation of migrating and proliferating cells 
and enables efficient nutrient delivery, gas exchange and waste excretion, while the small 
pore size of NFS can protect the wound from bacterial penetration [15]. Additionally, 
polymeric NFS are usually strong in tensile strength, so they can retain structural 
integrity and prevent wound contraction when surgeon handles and implants it into the 
defect site of the host [16]. The most efficient and easy way to fabricate NFS at a large 
scale is electrospinning due to its easy setup and operation. Moreover, electrospun NFS 
has interconnected pores and large surface area to volume ratio [17]. The main 
component of native skin ECM, collagen I has been successfully electrospun into NFS 
and this collagen NFS was shown to have great biocompatibility both in vitro and in vivo 
[18-20]. However, the poor mechanical properties and high cost limit the application of 
collagen in wound healing. Compared with collagen, gelatin, which is derived from 
collagen by controlled hydrolysis, is cheaper and does not show antigenicity under 
physiological conditions [21, 22]. Moreover, gelatin is biodegradable, biocompatible and 
displays many integrin binding sites for cell adhesion, migration, proliferation and 
differentiation due to the abundant Arg–Gly–Asp (RGD) sequences in its amino acid 
chain [16, 23].  
 
In addition to mimic the component of native ECM with cost-effective proteins, 
core-shell nanofibers incorporated with bioactive factors of ECM could be a better 
biomimetic scaffold for wound healing. The controlled release of bioactive factors can be 
realized via core-shell nanofibers and core-shell nanofibers can also protect the biological 
agents from the harsh environments [24]. Incorporation of such growth factors and 
bioreagents in biocompatible and biodegradable nanofibers can be a potential alternative 
to regulate cell proliferation, migration and differentiation, thus enhancing skin tissue 




Researches in phototherapy and electrotherapy have inspired the studies in making 
scaffolds with functional polymer nanofibers for wound healing. Phototherapy, using low 
intensity radiation in the visible or near-infrared region, whether from a laser or a light 
emitting diode (LED), can be beneficial in a number of clinical situations, from pain 
remission to wound healing. Phototherapy is gaining recognition for the immediate relief 
of acute and chronic pain, for treating inflammatory conditions, and for the promotion of 
wound healing. At the inflammatory phase, a cellular modulation occurs with a decrease 
in cell inflammation [25] and an increase in the release of growth factors [26], initiating 
the proliferative phase. In the second phase, neovascularization is enhanced by 
photo-stimulation of endothelial cells [27]; increased proliferation of fibroblasts and 
collagen deposit [28, 29] also contribute towards granulated tissue formation and the 
ensuing closing of the wound. In addition, weak electrical current stimulation was found 
to promote wound healing by 20% per week [30]. Meanwhile, electrical stimulation (ES) 
can improve the survival of skin flaps in vivo [31] and significantly shorten the time of 
wound closure [32], epithelialization [33] fibroblast proliferation [34]. As phototherapy 
and electrotherapy have shown positive results in wound healing, the combination of 
these two therapies (photocurrent therapy) could be more helpful in skin regeneration. 
The photovoltaic polymer poly (3-hexylthiophene) (P3HT) is the most promising 
candidate for photocurrent therapy. When light irradiates on photosensitive polymer 
P3HT containing fibers, electrons are generated in the photosensitive polymer molecules 
and when the electrons flow in the fibers, an electrical current is formed. This 
photocurrent generated in the P3HT containing fibers could be a new way for treatment 
of skin wounds 
 
Besides working on developing biomimetic and functional scaffolds for tissue 
engineering, researchers also combine the assist of stem cells to realize tissue 
regeneration. ASCs display immunosuppressive properties, allogeneic cell treatment can 
be foreseen to overcome unsatisfactory results with autologous cell therapy for 
regenerative medicine [35, 36]. Therefore, adipose tissue represents an abundant, 
practical, and appealing source of donor tissue for autologous and allogeneic cell 
replacement [37, 38]. Moreover, due to the capability of multipotential differentiation and 
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secretion of growth factors, ASCs will have a great contribution in wound healing. ASCs 
can be easily obtained from liposuction of human adipose tissue; can be cultured on a 
large scale [39-41]. The ability of ASCs to promote angiogenesis, to secrete growth 
factors and to differentiate into multiple cell types, could create a viable skin substitute. 
ASCs are known to significantly reduce the wound size and accelerate the 
re-epithelialization process via promoting the proliferation of human dermal fibroblasts 
(HDF) [42]. 
 
In this project, we utilized electrospinning technique to fabricate cost-effective core-shell 
structured nanofibrous scaffolds which encapsulated bioactive factor and photosensitive 
polymer and we further studied the feasibility of the resultant nanofibers/stem cell 
composites as skin grafts to promote wound healing and skin regeneration.  




Electrospun cost-effective core-shell structured nanofibrous scaffolds which 
encapsulate bioactive factor and photosensitive polymer, promote wound healing 
and skin regeneration in full-thickness skin wounds. 
 
a) Cost-effective natural polymer like gelatin can be electrospun into nano-scale 
architectures in tissue-engineered skin grafts with appropriate mechanical stability 
to resemble the natural ECM structure and accelerate in vivo wound healing.  
 
b) Sustained release of multiple epidermal induction factors (EIF) from core-shell 
structured nanofibrous scaffold can be achieved. ASCs will differentiate into 
epidermal lineage on this multiple EIF encapsulated core-shell NFS.  
 
c) Biodegradable synthetic polymer and photosensitive polymer like P3HT can be 
blended for co-electrospinning to provide the photosensitive skin grafts with the 




d) Epidermal growth factor (EGF) and P3HT encapsulated core-shell nanofibers can 
promote cell proliferation, meanwhile assist ASC epidermal differentiation and 




 Electrospin cost-effective NFS as skin grafts, find out the optimized NFS and 
apply this scaffold to realize fast wound healing in vivo. 
 
 Confirm the epidermal differentiation potential of ASCs by inducing ASCs into 
epidermal lineage in vitro through manipulating the biochemical, environmental 
and physical conditions on an EIF encapsulated core-shell nanofiberous scaffold.  
 
 Utilize electrospinning technique to fabricate photosensitive polymer P3HT 
blended nanofibrous scaffold and irradiate the cell-scaffold composite by 
light-emitting diode to achieve an efficient proliferation of human dermal 
fibroblasts.  
 
 Demonstrate the feasible application of EGF and P3HT encapsulated 
photosensitive core-shell NFS as skin grafts to promote fibroblast proliferation, 
wound healing and skin regeneration.  
1.4 Research rationale and strategy  
 
A cost-effective NFS were fabricated by electrospining technique using PLLCL blended 
with natural polymer gelatin. The NFS were demonstrated a faster wound closure in vivo 
in a mouse model compared with control groups. The cost-effective NFS were further 
improved by encapsulating EGF and photosensitive polymer (P3HT), using coaxial 
electrospinning. Fibroblast proliferation was significantly improved on EGF and P3HT 
encapsulated core-shell NFS under light stimulation. Keratinocyte-like ASCs were only 
found on the light stimulated EGF and P3HT encapsulated core-shell nanofibers. We 
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confirmed that the biomimetic and photosensitive core-shell nanofibers could be a novel 
scaffold applied in photocurrent therapy for wound healing and skin construction. To the 
best of our knowledge, we are the first to apply photosensitive scaffold combained with 
light stimulation in skin tissue engineering and evaluate their capability in promoting skin 
reconstruction and regeneration. Thus, our study will inspire more research opportunities 
to explore the mechanism beneath the promising outcomes. 
 
The Rationale of using EGF and P3HT encapsulated core-shell nanofibrous 
scaffold/ASCs composites as skin graft for the treatment of full-thickness skin wounds in 
this study are: 
 
 ASCs have the potential to improve skin regeneration by differentiating into the 
phenotypes of damaged skin cells and/or enhancing repair by creating 
microenvironment that promotes the regeneration of local cells (such as HDF).  
 
 The sustained release of EGF from core-shell NFS will promote cell proliferation 
and guide ASCs epidermal differentiation 
 
 Photo and electrical stimulation can promote wound healing. The photocurrent 
generated in photosensitive P3HT containing core-shell NFS will promote cell 
proliferation under light stimulation.  
 
 The non-woven polymeric architecture of NFS mimics the nano-scale protein 
fiber meshwork in native ECM. Its high surface area-to-volume ratio is efficient 
for cell adhesion, proliferation, migration and differentiation.  
 
 The NFS has a high porosity for efficient nutrient delivery, gas exchange and 
waste excretion after transplantation into wounded skin.  
 




 NFS gradual biodegradation profile allows the new skin tissue to regenerate and 
reduces immunological responses.  
1.5 Work scope 
 
In this dissertation, a detailed literature review is presented in Chapter 2 that includes the 
wound healing process, current treatments for full-thickness skin wounds, properties and 
potentials of electrospun photosensitive NFS for wound healing and skin regeneration. 
Table 1.1 summarizes the project scopes from chapter 3 to chapter 6. Conclusions for this 
thesis and recommendations for future work are described in Chapter 7.  
  
Table 1.1 Overview of project scope. 
Hypothesis Objective Descriptions Thesis 
(1) Biodegradable synthetic 
polymer and cost-effective 
natural protein like gelatin 
can be blended for 
co-electrospinning to 
provide the skin grafts with 
appropriate mechanical 
stability and biomolecular 
cell recognition signals for 
cell-scaffold interactions.  
 
Find out the 
optimized gelatin 
containing NFS 
and confirm the 
promoting wound 
healing ability of 
the NFS in vivo.  
(1) The solutions with 
different content of 
gelatin: PLLCL in 
blend (80:20, 70:30, 
60:40 and 50:50 wt%) 
were electrospun into 
NFS and the NFS were 
further characterized 





(2) The mechanical 
properties of these NFS 
were studied both in 
dry and wet conditions. 
The comparative 




these NFS was 
evaluated by cell 
proliferation assay. 
(3) The wound healing 
capability of the 
optimized gelatin and 
PLLCL blended NFS 
was evaluated studied 
in vivo. 
(1) Coaxial electrospinning 
can be used to fabricate 
nano-scale architectures in 
tissue-engineered skin grafts 
to encapsulate multiple 
bioactive factors to resemble 
the natural ECM. 
(2) The burst release can be 
restrained or eliminated by 
using core-shell structured 
NFS.  
(3) ASCs will differentiate 
into epidermal lineage under 
the guidance of the 
sustained release of EIF 

















potential of ASCs 
on EIF 
encapsulated 
core-shell NFS.  
(1) PLLCL blended 
with gelatin core-shell 
NFS were electrospun 
to encapsulate EIF and 
the NFS were further 






(2) The release of EGF 
from the core-shell 
NFS was studied for 15 
days.  
(3) ASCs were induced 
into keratinocyte-like 
cells with expression of 
epidermal 
differentiation markers 






polymer and photovoltaic 
polymer like P3HT can be 
blended for 
co-electrospinning to 
provide the photosensitive 
skin grafts with appropriate 
mechanical stability for 















(1) The solutions with 
different content of 
PCL: P3HT in blend 
(150 : 2, 150 : 10 and 
150 : 20 wt%) were 
electrospun into NFS 
and the NFS were 
further characterized 
for its morphology, 
diameter and chemical 
composition properties 
etc. 
(2) The photosensitive 
property and 
photocurrent generation 
of these NFS were 
studied.  
(3) The comparative 
proliferation of HDF on 
these NFS with or 
without light 
stimulation was 
evaluated by cell 
proliferation assay. 
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(1) Core-shell NFS 
encapsulated both EGF and 
P3HT can be fabricated by 
coaxial electrospinning.  
(2) Higher proliferation of 
HDFs on this photosensitive 
core-shell NFS under light 
(1) Demonstrate 




skin grafts to 
promote cell 
(1) The core-shell NFS 
were electrospun to 
encapsulate EGF and 
P3HT. The 
photosensitive 





stimulation will be 
achieved.  
(3) ASCs will differentiate 
into epidermal lineage under 
the guidance of sustained 
release of EGF from the 
core-shell NFS and light 
stimulation.  
(4) The photosensitive 
core-shell NFS will promote 







(2) Study the 
mechanism of 
light stimulation 
in promoting cell 
proliferation. 
(3) Achieve faster 
in vitro wound 











(2) The comparative 
proliferation of HDF on 
these NFS with or 
without light 
stimulation was 
evaluated by cell 
proliferation assay. 
(3) ASCs epidermal 
differentiation on the 
photosensitive 
core-shell NFS were 
studied.  
(4) The in vitro wound 
healing has been done 
to show the capacity of 
the photosensitive 
core-shell NFS as skin 











2.1.1 Skin composition and functions  
 
Skin, the largest human organ, covers between 1.5 and 2 m
2
 of the total surface area of 
human body [43]. It acts as an anatomical barrier from pathogens and damage between 
the internal and external environment in bodily defense and it protects the body against 
excessive water loss [44, 45]. The skin has two layers, the epidermis and the dermis (Fig. 
2.1).  
 
Fig. 2.1 Structure of skin [46] 
 
The epidermis is defined as a stratified aquamous epithelium which is about 0.1 mm thick, 
although the thickness is greater (0.8 – 1.4 mm) on the palm and sole. The prime function 
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of epidermis is to act as a protective barrier. The main cell of the epidermis is the 
keratinocyte [47]. Keratinocytes, produced by cell division in the deepest layer of the 
epidermis (basal layer), are carried towards the skin surface where they are shed. The 
four layers of epidermis (Fig. 2.2) represent the stages of maturation of keratin by 
keratinocytes.  
 
The basal cell layer (stratum basale), which is 1-3 cells thick, is comprised mostly of 
keratinocytes which are either dividing or nondividing. Melanocytes make up 5-10% of 
the basal cell population. Melanocytes contain cytoplasmic organelles called 
melanosomes, in which melanin pigment is synthesized from tyrosine. The melanosomes 
migrate along the dendrites of the melanocytes, and are transferred to the keratinocytes in 
the prickle cell layer. The main stimulus to melanin production is ultraviolet (UV) 
radiation. Melanin protects the cell nuclei in the epidermis from the harmful effects of 
UV radiation. Skin neoplasia is extremely uncommon in dark-skinned races because their 
skin is protected from UV damage by the large amounts of melanin it contains [48]. 
Above the basal layer is the prickle cell layer (stratum spinosum). Scattered throughout 
the prickle cell layer are Langerhans. Langerhans cells are dendritic cells and primarily 
located in stratum spinosum. Upon infection, these cells will take up and process 
microbial antigens to become fully-functional antigen-presenting cells [49]. Above the 
prickle cell layer is the granulaer layer (stratum granulosum). Cells become flattened and 
lose their nuclei in the granular cell layer. The flattened cells contain the darkly staining 
keratohyalin granules. These lamellar granules contain lipids and enzymes, and they 
discharge their contents into the intercellular spaces between the cells of the granular 
layer and stratum corneum-providing the equivalent of ‘mortar’ between the cellular 
‘bricks’, and contributing to the barrier function of the epidermis [48]. The end results of 
keratinocyte maturation can be found in the horny layer (stratum corneum), which is 
comprised of sheets of overlapping polyhedral cornfield cells with no nuclei. These 
adjacent cells form a very effective barrier. The thickness of the stratum corneum is 




The main cellular elements of the dermis are fibroblasts, mast cells and macrophages. 
Fibroblasts synthesize the connective tissue matrix of the dermis, and are usually found in 
close proximity to collagen and elastin fibres. Mast cells are specialized secretory cells 
present thought out the derims, but they are more numerous around blood vessels and 
appendages. They contain granules whose contents include mediators such as histamine 
and prostaglandins etc. Macrophages are phagocytic cells that originate in the bone 
marrow, and they act as scavengers of cell debris and extracellular material [48].  
2.1.1.1 Keratinocyte maturation 
 
Keratinocyte is the principal cell type of epidermis and it is produced by cell division in 
the deepest layer of the epidermis (basal layer). As interfollicular epidermal stem cells in 
this basal layer expand due to division, some of these stem cells detach from the 
basement membrane and begin to migrate towards the epidermal surface, changing shape 
until they enter the outermost cell layer of stratum corneum as flattened cornified cells 
(see Fig. 2.2) [50]. As keratinocytes pass towards the skin surface, they undergo a 
complex series of morphological and biochemical changes known as terminal 
differentiation (keratinization) to produce the surface layer of tightly packed dead cells 
(stratum corneum or horny layer). The intermediate filaments (IF), present in the 
cytoplasm of epithelial cells, are a major component of the cytoskeleton. They contain a 
group of fibrous proteins knowns as keratins. Pairs of keratins are characteristic of certain 
cell types and tissues, and K5/K14 are characteristic of stratified aquamous epithelia. 
Epidermal basal cells express K5 and K14, but K10 is also expressed during 
differentiation in the suprebasal layers. After production of all materials is completed, the 
cells cease transcriptional and metabolic activity and undergo a programmed cell death. 
The inner cells keep moving outwards to continually replace the cell remnants [51]. 
Many proteins including keratins and non-keratins are expressed specifically during the 
process of epidermal differentiation and stratification according to the type of the 
epithelium, the stage of differentiation and the location of the keratinocytes within the 
epidermis. Table 2.1 is an overview of the common protein markers used for 
characterization of different epithelial types and disease detection [52]. The underlined 
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groups are used for the immunological analysis in this research to characterize the stage 
of skin development. 
 
 




Cytokeratins (CKs) are intermediate filament keratins found in the intracytoplasmic 
cytoskeleton of epithelial tissue. There are two types of CKs: the low weight (40-65 kDa), 
acidic (pI 4.5-6.0) type I CKs and the high weight (50-70kDa), basic or neutral (pI 
6.5-8.5) type II CKs. CKs are usually found in pairs comprising a type I CK and a type II 
CK. The type II CKs comprise subtypes CK1-CK8. The type I CKs comprise subtypes 






Table 2.1 Keratin markers expressed in different human epithelial types (summarized 
from [52]). 
Keratins Type Location Disease associated 
with gene mutation 
Keratin 1 Type II Spinous and granular layers paired 




erythroderma in which 
the palms and soles of 
the feet are affected. 
Keratin 2 Type II Upper spinous layer Bullous congenital 
ichthyosiform 
erythroderma. 




Keratin 4 Type II Differentiated layers of the mucosal 
and esophageal epithelia paired with 
keratin 13 
White Sponge Nevus, 
characterized by oral, 
anal and esophageal 
leukoplakia 
Keratin 5 Type II Basal layer as a heterotetramer with 
two keratin 14 molecules 
Epidermolysis bullosa 
Simplex 
Keratin 6 Type II Paired with keratin 16 and/or keratin 
17 in the filiform papillae of the 
tongue, the stratified epithelial lining 
of oral mucosa and esophagus, the 
outer root sheath of hair follicles and 
the glandular epithelia 
Pachyonychia 
congenita 
Keratin 7 Type II Most glandular and transitional 





Keratin 8 Type II Single layer epithelial tissues paired 




Keratin 9 Type I Terminally differentiated 




Keratin 10 Type I Suprabasal layers (Spinous and 
granular layers) of the epidermis 
paired with keratin 1, a marker for 




which the palms and 
soles of the feet are 
unaffected. 




Keratin 13 Type I Suprabasal layers of non-cornified 





Keratin 14 Type I Basal layer and appendages as a 




Keratin 15 Type I Some progenitor basal cells within 
complex epithelia, in the bulge and 
the bulb of follicle 
Undefined 
Keratin 16 Type I Paired with keratin 6 in 
hyperproliferative (including tissue 
culture), traumatized and 
wound-healing epidermis; Buccal 
stratified squamous epithelia  








Keratin 17 Type I Nail beds, hair follicles, sebaceous 









Keratin 18 Type I Single layer epithelial tissues paired 
with keratin 8 
Cryptogenic cirrhosis 
Keratin 19 Type I Periderm, the transiently superficial 
layer that envelopes the developing 
epidermis; follicle bulge stem cell 
marker for epidermal stem cells in 
outer root sheet, basal epidermis and 
deep rete ridges 
Undefined 
Keratin 20 Type I Mature enterocytes and goblet cells 
in the gastric and intestinal mucosa 
Gastrointestinal, 





Involucrin is a component of the keratinocyte cornified envelope and found in the 
cytoplasm and crosslinked to membrane proteins by transglutaminase. It is a marker of 
keratinocyte terminal differentiation and is expressed only in the granular and cornified 
layers of stratified squamous epithelium [54]. Filaggrin is a basic histidine-rich protein in 
epithelia and it is widely believed to promote the lateral aggregation of keratin filaments. 
It is one of the markers for intermediate keratinocyte differentiation [55]. Collagen IV 
and VII are expressed by the basal keratinocytes and form the basal layer of the stratum 
basale. β-integrin is highly expressed in outer root sheath of epidermal stem cells, follicle 
bulge and basal epidermis. α6-integrin is expressed in outer root sheath, follicle bulge and 
basal epidermis. Integrin β1 and α6 are epidermal stem cell marker (non-specific) due to 
their high expression within epidermal stem cells [56]. 
2.1.2 Wound healing in vivo 
 
Wound healing consists four precisely programmed phases, which are continuous and 
overlapping. In healthy adults, wound healing contains six events: rapid hemostasis; 
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inflammation; differentiation, proliferation, and migration of mesenchymal cells to the 
wound site; re-epithelialization; and remolding [57, 58]. Hemostasis, the first stage of 
wound repair, occurs instantly after tissue damage. It involves vascular constriction and 
fibrin clot formation. Inflammatory phase involve the migration of inflammatory cells 
into the wound; more specifically the sequential infiltration of neutrophiles, macrophages, 
and lymphocytes [58-60]. Neutrophiles can clean up the initial rush of contaminating 
bacteria, and serve as a source of pro-inflammatory cytokines, which may provide signals 
to active local fibroblasts and keratinocytes [61]. The next phase is the new tissue 
formation phase, which is characterized re-epithelialization, the epithelial proliferation 
and migration over the provisional matrix within the wound. Keratinocytes will migrate 
over injured dermis. Following the migration of keratinocytes, granulation tissue 
formation characterized with capillary proliferation is in progress and the newly formed 
granulation tissue acts as a new substrate for keratinocyte migration. In the late part of 
this stage, under the stimulation of macrophages, some of the fibroblasts either from the 
wound edge or from bone marrow are differentiated into myofibroblasts [62]. 
Myofibroblasts are contractile cells that can gradually bring the edges of a wound 
together. Remodeling is the final stage of wound repair, which begins 2-3 weeks after the 
injury and lasts for usually one year or more.  
 
In summary, the normal healing process starts with an well-organized process of 
hemostasis and fibrin deposition, which results result in formation of an inflammatory 
cell cascade, characterized by neutrophils, macrophages and lymphocytes [63]. The 
subsequent processes include attraction and proliferation of fibroblasts, collagen 
deposition, and finally the remodeling by collagen cross-linking and scar maturation. If 
any of part of the healing cascade is altered, the pathologic responses may lead to fibrosis 
or chronic ulcers [64]. 
2.2 Full-thickness skin wounds  
 
Rapid, extensive, deep wounds could be caused by burns and scalds and they can lead to 
death due to the difficulty in treatments with common techniques [65]. 6.5 million 
patients are affected by chronic wounds in the United States and the treatment of chronic 
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wounds will cost more than US$25 billion annually. The market share of the wound care 
products will reach $15.3 billion by 2010 [66]. In Singapore, average annual burn 
admission from 1997 to 2003 was 288 with a range from 188 to 348. This represents a 
incidence rate of 0.07 per 1000 population (on average) for burn injury in the city of 
Singapore [8]. On a worldwide scale, 27 million burns that occur require professional 
treatment and of these, 7 million suffer large and deep burns that require hospitalization 
[15]. Acute large full-thickness skin wounds not only cause an immediate loss of wound 
coverage, but also initiate physiological instability and give rise to various complications. 
Without a protective barrier from injured skin, patients are easily susceptible to infections, 
especially the nosocomial infections from Pseudomonas. [67]. Therefore, normal process 
of natural repair is lost and the wounds are locked into a state of chronic inflammation 
characterized by abundant neutrophil infiltration with associated reactive oxygen species 
and destructive enzymes. The chronic inflammation is mainly caused by the 
over-abundant neutrophil. A large number of enzymes such as collagenase, which can 
destroy the connective tissue matrix, are released by the neutrophils. [68, 69]. In addition, 
elastase, an enzyme released bythe neutrophils, can destroy healing factors such as PDGF 
and TGF-ß [70]. Current high tech materials and topical cytokines such as PDGF will not 
cure these wounds, unless the wound bed is received proper care from specialists [71, 72]. 
However, due to the loss of epidermal and dermal tissue to their full depth in 
full-thickness skin wounds, the epidermal stem cells in hair follicles for epidermal 
renewal, the basement membrane for cell migration and the blood vessels in dermis are 
all destroyed, which creates great difficulties for skin regeneration. Scar tissue is 
preferable to no healing. However, they are not fully functional, cross-linked with only 
80% of the tensile strength of the tissue it replaces and aesthetically disfiguring. 
Therefore, there is a great need for the development of synthetic skin, which can facilitate 
skin regeneration and minimize scar formation.  
2.2.1 Current treatments for full-thickness skin wounds 
 
Based on the depth of the injury, wounds can be indetified into epidermal, superficial 
partial-thickness, deep partial-thickness and full-thickness wounds [73]. Specific surgical 
treatment is not required for epidermal injuries which are characterized by erythema and 
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minor pain [65]. The epidermis and superficial parts of the dermis are injured in the 
superficial partial-thickness wounds with characterizations of epidermal blistering and 
severe pain accompanying. In deep partial-thickness injuries, most of the dermis is lost 
with only fewer skin appendages remaining and therefore they take longer to heal [65]. 
The most severe injury is the full-thickness wounds that are characterized by the 
complete lose of epithelial-regenerative elements. In the process of contraction, cells 
around the edge of the wound will migrate into the wound center to cover the injury area, 
leading to cosmetic and functional defects. Skin grafting is needed for all full-thickness 
skin wounds, which are more than 1 cm in diameter due to the lost self-healing ability. 
Moreover, the full-thickness skin wounds may lead to extensive scarring, resulting in 
limitations in joint mobility and severe cosmetic deformities [73]. 
2.2.1.1 Autografts, allografts and xenografts  
 
Untill now, the autologous skin grafting is still the ‘gold standard’ in full-thickness 
injuries treatment [2, 4, 74]. The composite skin (epidermis with a superficial part of the 
dermis) is obtained from an undamaged skin donor site and applied to the full-thickness 
wound [65]. In the donor site, keratinocyte will migrate from hair follicles, sweat glands 
and edges of the wound to heal the wound. It will take around one week to cure the donor 
site. The healed donor site can be used for further split skin graft (SSG) re-harvesting. 
Usually, the thicker SSG will be more capable in promoting wound healing at the site of 
application with less contraction compared to the thin SSG. However, it will take longer 
time to heal the donor site [74].  
 
Many factors such as the physiological condition of the patient, could affect the 
availability of SSG. Meanwhile, due to the issues of graft rejection and the possibility of 
disease transfer, allografts and xenografts can only be used as temporary wound coverage 
[75]. All of these faults give rise to the clinical need for the development of 
tissue-engineered alternatives. 




To address the limitations of traditional therapies, tissue engineering is intensively 
applied to treat tissue loss or organ failure. The number of journal publications in tissue 
engineering keeps increasing year by year (Fig. 2.3). The limitation of split-thickness 
skin autografts drives the demand of efficient wound healing substitute - tissue 
engineered skin substitutes. 
 
 
Fig. 2.3 Number of journal publications in tissue engineering 
 
Three major requirements are needed to be satisfied for all tissue-engineered skin 
substitute bio-constructs. First, the tissue engineered skin substititues must be safe for the 
patient. Second, they should be clinically effective. Third, they are supposed to be 
convenient in handling and application. In general, such biomaterials must avoid toxicity, 
immune rejection and should not cause excessive inflammation and transmissible disease 
risk.  
 
The prime approach of tissue engineering is utilizing scaffolds to support the proliferation 
and differentiation of specific autologous cells to form an artificial tissue. Then the 
cultured tissue will be transplanted into the defective site of patients to promote tissue 
regeneration. Obviously, scaffold, cells and their interactions will be the three key factors 
to affect the performance of the tissue-engineered grafts. Among them, cells play a 
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dominant role for the success of tissue-engineered scaffolds.  The cell types applied in 
skin tissue engineering are fibroblasts, keratinocytes and hair follicle cells etc. Progenitor 
cells which are from hair follicles, interfollicular epidermis and sebaceous glands, are 
also used in skin tissue engineering [76]. Moreover, stem cells from the peripheral blood 
or bone marrow system are also studied in skin tissue engineering due to their ability of 
multipotential differentiation and growth factors secretion. 
2.2.1.2.1 Commercialized tissue-engineered skin grafts  
 
Tissue-engineered skin grafts have been intensively developed and the currently available 
products are summarized in Table 2.2 and organized according to anatomical structure 
classification (dermal, epidermal and composite).  
2.2.1.2.1.1 Dermo-Epidermal (Composite) skin substitutes  
 
In order to mimic the structure of normal skin, composite skin substitutes have both 
epidermal and dermal layers. Compared with epidermal and dermal substitutes, 
composite skin substitutes are the most advanced and sophisticated products. However, 
they are also the most expensive tissue-engineered biological constructs for tissue repair 
[4]. Apligraf® is one of the composite skin substitutes and it was approved by FDA in 
1998 for the treatment of venous leg ulcers [77]. The matrix of Apligraf® is made of 
bovine type I collagen cultured with allogeneic fibroblasts and keratinocytes to mimic the 
normal structure of human skin. Although without immune rejection, the short survive 
time (one to two months) for the allogeneic cells, limits its performance as a skin graft 
[78, 79]. It is now believed that Apligraf® works by delivering growth factors and ECM 
to the wound bed [80]. The drawbacks of this graft include short time shelf life (only 5 
days), difficulty in handling and risk of disease transfer from its allogeneic cells. In a 
large multicenter trial, it showed signs of wound infection in 29% of patients receiving 
Apligraf® versus 14% of patients receiving standard medical care [81]. Orcel® is another 
composite skin graft and it includes allogeneic keratinocytes and fibroblasts. An array of 
bioacters such as FGF-1, KGF-1, PDGF, VEGF and TGF-α are producted in this 
bilayered product and these bioactors are all favourable for host cell migration and 
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wound healing. However, due to the presence of allogeneic cells, Orcel® can only act as 
a temporary coverage and it will be resorbed within 7-14 days [65].  
 
Several other composite skin substitutes combining dermal and epidermal elements have 
been developed. One of them is PolyActive, which is a Polyactive matrix cultured with 
autologous keratinocytes and fibroblasts. A soft polyethylene oxide terephthalate is the 
main component of the porous Polyactive matrix and a hard polybutylene terephthalate is 
further applied to prevent contraction of this polymer [82, 83]. Autologous cells are 
cultured in this matrix and therefore cross-contamination by infective agents or immune 
rejections are greatly reduced. However, it will take longer time for autologous cells 
expension and this may limit its immediate availability and increase its costs compared 
with competitive allogeneic-based products. Moreover, the non-biodegradable synthetic 
dermal component makes this tissue engineered graft only as a temporary skin substitute 
[65]. 
2.2.1.2.1.2 Dermal skin substitutes  
 
Integra®, which consists of porous bovine type I collagen matrix and a silicone 
pseudo-epidermis to prevent contraction, is a representative dermal skin substitute [84]. 
After being applied onto the wounded site, the type I collagen sponge recruited host 
dermal fibroblasts and degraded during cell invasion and the pseudo-epidermal 
component protects wounds from bacterial contamination and vapour loss. Integra® has 
received the approval of the US Food and Drug Administration (FDA) in 1996 for the 
treatment of deep-dermal and full-thickness wounds [77]. The product is widely adopted 
because of its great performances in handling, storage, with less immune rejection and 
disease transmission, good cosmetic outcomes with reduced rates of contraction and 
scarring [85]. However, meticulous surgical preparation, long time for vascularization 
(10-14 days) and requirement of a second operative procedure to replace the silicone 
layer consist the disadvantages of Integra®. TransCyte consists of a pseudo-epidermal 
semipermeable silicon film bonded to nylon fabric with incorporated porcine collagen 
and neonatal allogeneic fibroblasts are cultured in this scaffold. This bioengineered 
construct provides growth factors, matrix proteins and cytokines necessary for wound 
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healing improvement; it is effective for pain relief and vapour loss control. However, the 
silicon film is non-degradable and it has to be removed after 7-14 days. Extra treatments 
(applying an extra temporary wound cover etc.) are need after removing silicon film. The 
biomaterial applied in Dermagraft is polyglactin mesh; further fibroblasts are seeded in 
the scaffold. The cultured fibroblast can proiduce growth factors and ECM components 
to mediate wound healing. The will degrade by hydrolysis in 20-30 [86]. However, no 
significant difference is found in clinical trials comparing the application of meshed skin 
graft to the application of meshed skin graft combined with Dermagraft [87], and its 
performances were found to be similar to allograft [88]. Multiple applications, higher cost 
and safety issues are the main limitations of this skin bio-construct [86].  
2.2.1.2.1.3 Epidermal skin substitutes  
 
Isolation of keratinocytes and its ex vivo expension are the key challenges in the 
designing and production of epidermal substitutes. Epicel® is an epidermal skin 
substitute and it is produced using an autologous keratinocyte sheet cultured for 15 days. 
The unavoidable drawbacks of this approach are long culture time; difficulties in 
handling and application. Furthermore, the poor long-term results, poor mechanical 
properties, high cost and a short (24 h) shelf-time limit its application [89]. MySkin®, 
which uses a specially surface coated silicone to support autologous keratinocytes, 
greatly improve the difficult handling issue of Epicel® and decrease the time for culture 
[90].  
2.2.1.2.2 Drawbacks of current commercialized skin grafts  
 
Although increased healing rates of burn and/or chronic wounds can be observed with 
current engineered constructs, several intrinsic shortcomings limit their use [91]: (a) 
epidermal grafts are fragile and therefore difficult to handle; (b) cell-populated matrices 
used in ‘skin substitutes’ are not readily scalable for manufacturing and are difficult to 
store and transport; (c) use of autologous skin cells require creation of fresh wounds; (d) 
it takes about 2 to 3 weeks for autologous skin cells to expand in vitro before reaching 
sufficient numbers for grafting. This time interval cannot satisfy patients with urgent 
clinical requirements [76]; (e) use of allogeneic keratinocytes or fibroblasts may induce 
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immune rejection; (f) allogeneic or xenogeneic skin substitutes may carry infectious 
agents including prions [92]. Moreover, disadvantages include cost, short shelf life limit 
the applications of tissue engnineered skin grafts. It has been recommended that informed 
consent must be obtained from all patients before the implantation of such biological 
material [93]. Further improvements are needed to address these limitations and the ideal 
tissue-engineered skin grafts should be cost-effective, user-friendly and safe to use 
(minimal risk of infection). 
 
Table 2.2 Examples of current commercialized tissue-engineered skin substitutes with 
associated advantages and disadvantages 
 Product 
Name 








cover and pain relief 
during the first few 
weeks 
Immune rejection 












foreskin fibroblasts  
Improves 
granulation tissue 
deposition and have 
good healing results 
for venous leg ulcer 
and diabetic foot 
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Can not be used as 
a permanent skin 
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secreted by cells. 
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Because of using 
autologous cells, no 
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Limited ‘off the 
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show effective 
results in plantar 
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rapidly proliferate to 
produce GAGs, 
collagen and growth 
factors to aid wound 
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Graft rejection and 
disease transfer; 






polymer on a 
Encourages cell 
















needs to be 
replaced with an 
epidermal autograft 
after 14 to 21 days 
Transcyte 
 
A thin silicone 
layer on a 
collagen-coated 









collagen, GAGs and 
growth factors to aid 
wound healing 
Graft rejection and 
disease transfer; 
nylon mesh not 
biodegradable; 
























Large area of 
permanent wound 
coverage with little 
risk of rejection 










Reduced cell culture 
time 
It is limited to 
partial-thickness 






A less fragile system 
for keratinocytes; 


















capacity; success in 
chronic ulcer 
treatment  
6 weeks for cell 









Improvement in cell 
attachment and 
proliferation; a more 
stable cell delivery 
system; cells can be 
thawed for repeated 
application 
Long time (2 
weeks) for cell 
expansion; repeated 
application required 
for good clinical 
outcome 
 




Phototherapy (low intensity radiation from a laser or LED) is reported to have beneficial 
results in many clinical situations, from pain remission to wound healing. Phototherapy is 
gaining recognition for the immediate relief of acute and chronic pain, for treating 
inflammatory conditions, and for the promotion of wound healing. At the inflammatory 
phase, a cellular modulation occurs with a decrease in cell inflammation [25] and an 
increase in the release of growth factors [26], initiating the proliferative phase. In the 
second phase, neovascularization is enhanced by photo-stimulation of endothelial cells 
[27]; increased proliferation of fibroblasts and collagen deposit [28, 29] also contribute 
towards granulated tissue formation and the ensuing closing of the wound. In the last 
phase, tissue remodeling occurs where low level laser therapy (LLLT) has induced 
intense neovascularization and collagen deposit with elevated collagen orientation and 
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maturation [29, 94]. Several studies have reported enhanced healing following LLLT [25, 
95-99]. LLLT affects the cellular components of wound healing by modulating the 
proliferation of macrophages [100], lymphocytes [101], fibroblasts [102], and 
keratinocytes [103]. It also influences microcirculation [104], cellular respiration and 
ATP synthesis [105, 106], the release of granulocyte-monocyte colony-stimulating factor 
and other cytokines [107], transformation of fibroblasts into myofibroblasts, and collagen 
synthesis [108, 109]. These studies indicate that LLLT speeds up healing by modulating 
the inflammatory response, fibroblast proliferation, angiogenesis, collagen deposition, 
and re-epithelialization. In the aspect of growth stimulation, the same wavelength lights 
generated from laser or lamp show similar performance, no significant difference was 
found [110] and the main light sources of phototherapy for wound healing are LED and 
lasers. Continuous diode laser was used by Damante et al. to irradiate human gingival 
fibroblasts twice (6 h interval) to study the relation of laser phototherapy on the release of 
growth factors by fibroblasts [111]. They found that basic fibroblast growth factor (bFGF) 
was 1.49 times greater in groups treated with infra-red laser than groups without laser 
phototherapy and bFGF accelerated granulation tissue formation and induced 
re-epithelialization [112]. Sousa and colleagues evaluated the effect of light stimulation 
on fibroblast proliferation in vivo. Red (700 ± 20 nm), green (530 ± 20 nm) and blue (460 
± 20 nm) LEDs are applied and the output power for these LEDs is 10J/cm
2
. They found 
that red LED and green LED showed a significant increase in fibroblast numbers (p < 
0.01) when compared with the control group (without light irradiation) [113]. Table 2.3 
summarizes the applications of phototherapy in wound healing. 
 







Energy Result Refs. 




 LED produced in vitro increases of cell growth 
of 140–200% over untreated controls in 
mouse-derived fibroblasts 
[26] 




 Right circularly polarized light and linearly 




healing by increasing the proliferation of 
fibroblasts 




 Mice exposed to 670-nm red light showed 
significantly faster healing than control mice 
[115] 






Keratin-10 mRNA level elevated in light 
treated group compared to control group in rat 
model 
[116] 






Green LED yielded a significantly higher 
number of cells, than red (p < 0.001) and 
infrared LED light (p < 0.001) and than the 








 Red LED and green LED showed a significant 









 The effect of LED therapy in oval 
full-thickness wound-healing in the diabetic 
model with the use of 5 J/cm 
2





The generation of endogenous electric fields around the wound sites is confirmed by 
many studies and these generated electric fields are important in wound healing [119, 
120]. Electric fields couple to directed cell migration through phosphatidylinositol-3-OH 
kinase-g (PI(3)Kg) and phosphatase and tensin homolog (PTEN) signaling [121]. This 
study gives us a promising and novel perspective to cure skin wound by electrical 
stimulation (ES) via manipulation of the endogenous electric fields generated by skin 
lesion. [122]. The effects of noninvasive electro-magnetic field (EMF) on keratinocytes 
and fibroblasts proliferation were assessed by Huo and colleagues in an incisional wound 
model. The cDNA microarray and RT-PCR were applied to study the gene expression in 
the EMF treated keratinocytes. They found that EMFS can accelerate keratinocyte 
migration. cDNA micro-array and RT-PCR performed revealed increased expression of 
CDC2-related protein kinase 7 and Homeobox C8 genes in treated keratinocytes. HOXC8 
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has been shown to be involved in gene regulation and CRK7 which has been implicated 
in promoting cell migration [122]. 
 
Chronic wounds such as diabetic and venous ulcer remain a serious healthcare problem 
into the 21st century. Unlike conventional foot ulcers, the chronic foot ulcer is unique in 
that, owing to poor circulation and damage to sensory nerve endings, many chronic ulcers 
remain unable to heal [123]. ES has been intensively studied in curing chronic ulcers. The 
ability of electrical stimulation in enhancing chronic wound healing was proved by both 
preclinical [124, 125] and clinical [126-128] studies [129]. Morris and colleagues 
developed the Ahn/Mustoe lapine wound model for systematic investigation of the 
effects of ES on ischemic wound therapy [130]. In their study, transcutaneous blood gas 
levels, histology, total RNA content were measured and a2 (I) collagen (COL-I), type IV 
collagen (COL-IV), a1 (V) collagen (COL-V), and vascular endothelial growth factor 
(VEGF) expressions were measured. All markers for stimulated wounds showed 
increased activity relative to nonstimulated control wounds. Both COL-I and COL-V 
showed significantly increased activity between day 7 and day 14 for longer duration of 
electrical pulse treatment, potentially indicating a continued effect on matrix remodeling. 
In a more recently study, Goudarzi and colleagues used extremely low frequency pulsed 
EMFs to treat skin wounds in diabetic rats. They found that low frequency pulsed EMFs 
significantly promote wound healing compared with the control group (without EMF 
stimulation) [131]. These results were supported by a clinical study performed by Young 
and colleagues, who evaluated the effect of low-intensity pulsed current on chronic 
wound healing for a period of 10 days. The reduction of oedema levels in chronic wounds 
was achieved by applying the pulsed current stimulation [180]. Meanwhile, Baker and 
colleagues found that square-wave pulse electrical stimulation could enhance the healing 
of diabetes ulcers of patients by nearly 60% over the control rate of healing [132].  
 
The skin is the outer covering of the body. In human, it is the largest organ of the 
integumentary system, made up of multiple layers of ectodermal tissue, and it guards the 
underlying muscles, bones, ligaments and internal organs. As skin gets exposed to 
sun-light directly, it provides opportunities to use photocurrent in skin regeneration. The 
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mechanism of photocurrent therapy is probably the combination of electrotherapy and 
phototherapy. 
2.2.2.3 Photocurrent therapy 
 
Bart Vanhaesebroeck evaluated Zhao and colleagues’ work as “Charging the batteries to 
heal wounds” [133] and we believed that photocurrent therapy will play a promising role 
in wound healing. Photocurrent is the current that flows through a photosensitive device 
such as a photodiode, after exposure to radiant power. When visible light irradiates 
matter (metals and non-metallic solids, liquids or gases), electrons are emitted from the 
matter as a consequence of their absorption of energy from visible light. As 
electrotherapy and phototherapy have shown positive results in wound healing, the 
combination of these two therapies could be more helpful in skin regeneration. When 
light irradiate on photosensitive fibers, electrons are generated in the photosensitive 
polymer molecules and when the electrons flow in the same direction, an electrical 
current is formed. Mean while, an electromagnetic field gets created and when the cells in 
the electromagnetic field get stimulated, Ca
2+
 ion translocates through the cell-membrane 
voltage-gated calcium channels. Ca
2+
 ion translocates through voltage-gated calcium 
channels leading to an increase in cystolic Ca
2+
 and this increase in cystolic Ca
2+
 leads to 
an increase in activated calmodulin. Activated calmodulin is known to promote 
nucleotide synthesis and cellular proliferation. Light stimulation also has a similar effect 
on cell proliferation. Porphyrin absorbs the energy of photons on light irradiation and be- 
comes photo excited porphyrin (referred to as porphyrin*). The photo excited porphyrin 
can increase the proton-motive force (pmf) by transfering molecules of oxygen in the 
ground state O2(
3Σ) into singlet oxygen 1O2 ,(
1Δg ) which is a potent oxidizer. Thus more 
calcium is released into the cytoplasm from the mitochondria.  
 
Fig. 2.4 shows the schematic illustration of photocurrent stimulation in regenerative 
medicine. All these reactions in the cell will lead to an increase is cell proliferation and 
the healing time gets decreased greatly. Based on this theory, phototherapy is described 
as the combination of electrotherapy and phototherapy. This conclusion corresponds to 
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the in vitro and in vivo studies which are described earlier in this review in skin, nerve 
and bone regeneration therapies. 
 
 
Fig. 2.4 Schematic illustration of photocurrent stimulation in regenerative medicine [134]  
 
2.2.3 Potential of human adipose-derived stem cells (ASCs) for skin regeneration  
 
Aiming to recovery or replace the defective or lost tissue, regenerative medicine is 
developing rapidly. The dominant approach in regenerative medicine is stem cell therapy. 
Stem cells have the ability of shelf-renew and the capacity to differentiate into 
specialized cell types. Therefore, stem cells play a significant role in regenerative 
medicine [135, 136]. Among stem cells, embryonic stem cells can differentiate into any 
cell types derived from all three embryonic germ layers, including skin cells [137]. 
However, the use of embryonic stem cells carries a great risk of tumorigenesis and 
provokes ethical controversy [138]. Epidermal stem cells are essential to epidermal, 
however, they are destroyed in full-thickness skin wounds and difficult to isolate from 
healthy sites. In recent years, the therapeutic application of adipose-derived stem cells 
(ASCs) is gaining more and more interests due to their availability in greater quantities.  
It was found that ASCs possesse higher stem cell proliferation rate than BM-MSCs [139]. 




 2.2.3.1 Characteristics of human ASCs  
 
Rodbell and colleagues are the pioneers to isolate stem cells from minced rat fat pads 
[140, 141]. They incubated the fat tissue together with collagenase and then centrifuged 
the digest. After centrifuge, the pelleted stromal vascular fraction (SVF) will be at the 
bottom of the centrifuge tube. However, many cells types (circulating blood cells, 
fibroblasts, pericytes and endothelial cells) are in the SVF [140, 141]. Therefore, they 
performed the final isolation to selecte the plastic adherent population within the SVF 
cells. Subsequently, this procedure was further developed to isolate stem cells from 
human adipose tissue specimens [142-145]. The surface immunophenotype of ASCs 
isolated from human and other species [146-149]. Direct comparisons between human 
ASC and MSC immunophenotypes are > 90% identical [147]. Nevertheless, differences 
in surface protein expression have been noted between ASCs and MSCs. For example, 
the glycoprotein CD34 is present on human ASCs early in passage but has not been 
found on MSCs [150, 151]. ASCs express various surface markers including CD9, CD29, 
CD44, CD49, CD54, CD71, CD105, CD166 et al. and are negative for CD11b, CD16, 
CD18, CD31, CD45, CD50, CD56, CD62 and CD104. A more extensive phenotypic 
profile of MSCs can be found in Table 2.4 [152]. 
 
Table 2.4 Immunophenotype of passaged human ASCs [152] 
Antigen category Surface-positive Antigens Surface-negative Antigens 
Adhesion molecules CD9 (tetraspan), CD29 (β1 
integrin), CD49 days (α4 
integrin), CD54 (ICAM-1), 
CD105 (endoglin), CD166 
(ALCAM) 
CD11b (αb integrin), CD18 
(β2 integrin), CD50 
(ICAM-3), CD56 (NCAM), 
CD62 (E-selectin), CD104 
(α4 integrin) 
Receptor molecules CD44 (hyaluronate), CD71 
(transferrin) 
CD16 (Fc receptor) 











CD90 (Thy1); CD146 
(Muc18); collagen types I and 





Hematopoietic  CD14, CD31, CD45 
Complement cascade CD55 (decay-accelerating 





Stem cell CD34, ABCG2  




ASCs display multipotency and they are guided to differentiate into several cell types 
including adipose [144], bone [153, 154], cartilage [155, 156], endothelial cells [157] and 
epithelial cells [158, 159] (Fig. 2.5 [160]). The multipotency of these cells makes them as 




Fig. 2.5 Multilineage differentiation potential for adipose-derived stem cells [160] 
2.2.3.2 Contributions of human ASCs in wound healing and skin regeneration  
 
ASCs could promote wound healing by differentiation into various cell lineages and 
secretion of angiogenic growth factors. ASCs can be easily obtained from liposuction of 
human adipose tissue, can be cultured on a large scale [39-41]. The ability of ASCs to 
promote angiogenesis, to secrete growth factors and to differentiate into multiple cell 
types, could create a viable skin substitute. ASCs are known to significantly reduce the 
wound size and accelerate the re-epithelialization process via promoting the proliferation 
of human dermal fibroblasts (HDF), not only by cell-to-cell direct contact, but also by 
paracrine activation through secretory factors [42]. Ebrahimian and colleagues also 
demonstrated that ASCs promote wound healing, have the potential to differentiate into 
keratinocytes, and to produce KGF as well as vascular endothelial growth factor (VEGF) 
[158]. Furthermore, it was also demonstrated that ASCs can differentiate into epithelial 
lineage [159]. Meruane and colleagues combined adipose-derived stem cells and Integra 
(Integra LifeSciences, Plainsboro, N.J.) for treating full-thickness tissue injury on 
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Sprague-Dawley rats. Adipose-derived stem cells were isolated from the inguinal region 
of eight Sprague-Dawley adult rats, seeded onto a piece of dermal substitute for 48 hours, 
and then implanted into the same rat, followed by comparison of the evolution with a 
contralateral implant without adipose-derived stem cells. After 1, 2, and 3 weeks of 
regeneration in vivo, implants were removed for histologic evaluation. The histologic 
evaluation showed that adipose-derived stem cells significantly increased microvascular 
density (7.7 ± 0.6 percent versus 5.3. ± 0.5 percent, as assessed by immunohistochemical 
staining of factor VIII) and the synthesis of collagen type I (24 ± 3 percent versus 16 ± 2 
percent, as assessed by Sirius red staining) [161]. ASCs are demonstrated to accelerate 
chronic wound healings. Davis et al. demonstrated that purified ASCs delivered in a 
trans-glutaminase gel significantly accelerated wound closure in chronically irradiated 
animals compared to the controls (gel alone without cells) [162]. Meanwhile, Nambu and 
colleagues demonstrated that scaffold cultured with autologous ASCs significantly 
accelerated wound healing in diabetic mice [163]. 
2.2.4 Potential of electrospun nanofibrous scaffolds (NFS) as tissue-engineered skin 
grafts  
 
2.2.4.1 NFS as tissue-engineered scaffolds  
 
It is agreed that cells play a significant role in tissue engineering. In addition, the design 
and fabrication of scaffolds also contribute an important part for the success of tissue 
engineering. The scaffold fabricated from synthetic and natural polymers can support the 
survival, proliferation, differentiation and migration of different cell types for the 
regeneration of tissues and organs. The design of tissue-engineering scaffold should 
mimic the structure and biological function of native extracellular matrix (ECM) as much 
as possible, both in terms of chemical composition and physical structure. 
 
Micro- or naon- scaled collagen fibrils form a three-dimensional fiber network in native 
ECM of huma skin [164]. Polymeric nanofiber, which is on the same scale with fibrils in 
natural ECM, is among the most promising biomaterials for native ECM analogs. 
Phase-separation, self-assembly and electrospinning are the currently applied 
technologies to fabricate nanofibrous scaffolds to mimic natural ECM. The 
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phase-separation technique is based on thermodynamic demixing of a homogeneous 
polymer-solvent solution into a polymer-rich phase and a polymer-poor phase, usually by 
either exposure of the solution to another immiscible solvent or cooling the solution 
below a bimodal solubility curve. Polymeric foam will be obtained after removing 
solvent by freeze-drying. However, only certain polymers could be effectively processed 
by phase-separation and it is strictly a laboratory scale technique [165]. Self-assembly 
can also fabricate nanofibers and it involves the spontaneous organization of individual 
components into an ordered and stable structure with preprogrammed non-covalent bonds 
[166]. However, due to its complexity and low productivity, the application of 
self-assembly is limited [167].  
 
Electrospinning is a simple and effective way to fabricate nano- and micro- scale fibers 
from organic polymer solutions or polymer melts. The polymers can be functionalized 
with chemical or biomolecular components via electrospinning to improve cell adhesion 
and proliferation on the electrospun scaffolds [168]. The set-up of electrospinning 
consists four components: a high voltage supplier, a syringe pump, a capillary tube 
attached with a small diameter needle, and a collector. The high voltage between the need 
tip and collector, provides an electrical force to extrude fibers from constantly flowed 
polymer solutions. The extruded fibers will become solidified before reaching collector. 
Uniform fibrous membrane with interconnected pores will be collected on the collector 
[169, 170].  
 
Amongst all the techniques mentioned above, electrospinning is the most versatile, 
simple, cost-effective and scalable method to fabricate nanofibers. Electrospinning can 
produce scaffolds with most of the structural features (fibrous structure and porosity etc.) 
required for cell growth and subsequent tissue organization. It also offers many 
advantages over conventional scaffold methodologies. For example, it can produce 
ultra-fine fibers with spatial orientation and a high surface-to-volume ratio, have control 
over fiber diameter and also give flexibility for surface modification [171].  




This technique of electrospinning was first introduced by Zelency in 1914 [172]. Now, 
electrospinning has attracted increasingly worldwide attention in both the academic 
community and industrial world [17]. The fabrication process involves an electrostatic 
field of the order of 5-30 kV between a collector and the spinneret (usually in the form of 
a needle) (Fig. 2.6). The polymer melt or solution is pumped out of the spinneret at a 
controlled rate. When a stretching force provided by the sufficiently high electric field 
overcomes the surface tension of the polymer solution, a thin jet of the liquid flies 
towards the collector plate. The jet is only stable near the tip of the spinneret, after which 
it undergoes bending instability. As the charged jet accelerates toward regions of lower 
potential, the entanglements of the polymer chain will prevent the jet from breaking up, 
while the solvent evaporates resulting in the formation of randomly oriented nanofibers 
that can be collected on a grounded collector [14, 16]. 
 
 
Fig. 2.6 The scheme of electrospinning system [14]. 
 
The diameters of the electrospun fibers are at least one order of magnitude smaller than 
those made by conventional extrusion techniques. Several parameters can affect the 
electrospinning process and fiber morphology (Table 2.5). We can therefore change 




Table 2.5 Effect of changing electrospinning process parameters on the resultant fiber 
morphology [171]. 
Process Parameter Effect on fiber morphology 
Viscosity/concentration  Low concentrations/viscosities yielded defects in the form of 
beads and junction; increasing concentration/viscosity 
reduced the defects; 




 Increasing the conductivity aided in the production of 
uniform bead-free fibers; 
 Higher conductivities yielded smaller fibers in general, 
except poly(acrylic acid) and polyamide-6. 




 Increasing molecular weight reduced the number of beads 
and droplets. 
Dipole moment and 
dielectric constant 
 Successful spinning occurred in solvents with a high 
dielectric constant. 
Flow rate  Lower flow rates yielded fibers with smaller diameters; 
 High flow rates produced fibers that were not dry upon 
reaching the collector. 
Field strength/voltage  At too high voltage, beading was observed; 
 Correlation between voltage and fiber diameter was 
ambiguous. 
Distance between tip 
and collector 
 A minimum distance was required to obtain dried fibers; 
 At distance either too close or too far, beading was observed. 
Needle tip design  Using a co-axial, two-capillary spinneret, hollow fibers were 
produced. 
Collector composition  Smooth fibers resulted from metal collectors;  
 Aligned fibers were obtained using a conductive frame, 
rotating drum, or a wheel-like bobbin collector; 
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 Yarns and braided fibers were also obtained. 
Ambient parameters  Increased temperature caused a decrease in solution 
viscosity, resulting in smaller fibers; 
 Increasing humidity may result in the appearance of circular 
pores on the fibers. 
 
  2.2.3.3 Electrospun NFS as tissue-engineered skin grafts  
 
Electrosupn Nanofibers, which mimic the collagen fibrils in the native skin ECM and 
have high porosity, suitable mechanical properties and large surface-to-volume ratio, can 
be an ideal substitute for wound healing and burn wound care. Natural polymers such as 
chitosan, gelatin, collagen, fibrinogen, silk, hemoglobin, myoglobin and synthetic 
polymers such as polyesters and polyphosphazenes, poly( L -lactic 
acid)–co-poly(3-caprolactone) (PLLCL) and poly (D,L)-lactic-co-glycolic acid (PLGA) 
have been electrospun to micro- and nano- fibers for their use as scaffolds for skin 
regeneration [173-180].  
 
Synthetic materials including both nonbiodegradable and biodegradable polymers have 
also been used to manufacture NFS for promoting wound healing. Medical grade 
biostable polyurethane (PU) is a notable example of nonbiodegradable polymer for 
wound care. It has been shown that PU nanofiber dressings promoted faster healing 
compared with commercialized permeable PU (TegadermTM). Electrospun PU NFS was 
found to effectively control evaporative water loss, allow oxygen permeability and 
enhance drainage of wound exudates due to nanofiber porosity [181]. However, due to its 
long-term biostable properties, medical grade PU, either in nanofiber or commericialized 
form, can only be used as a temporary dressing in vivo and required to take off after 
completion of its functions. For the skin graft application, the hydrolyzates from the 
degraded scaffolds should not be toxic and cause any immune rejections. 
 
Other biodegradable synthetic polymers include polyesters, polyanhydride, 
polyorthoester, polycarbonate, and polyfumarate [182]. Hydrolytical and enzymatically 
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hydrolysis are the two ways for polymeric materials degradation. Accordingly, polymers 
are classified into hydrolytically degradable polymers and enzymatically degradable 
polymers [183]. Hydrolytically degradable polymers such as such as poly(lactic acid) 
(PLA), polycaprolactone (PCL) and their copolymers are most commonly used for tissue 
engineering [184-186]. PLA undergoes hydrolytic scission to its monomeric form, lactic 
acid, which is eliminated from the body by incorporation into the tricarboxylic acid cycle. 
The principal elimination path for lactic acid is respiration, and it is primarily excreted by 
lungs as carbon dioxide. PCL undergoes hydrolytic degradation due to the presence of 
hydrolytically labile aliphatic ester linkages [187]. FDA has approved the use of above 
mentioned polymers for certain human clinical use, such as surgical sutures and some 
implantable devices. All of these biodegradable polymers have been used to construct 
NFS for tissue-engineered scaffolds because of their favorable mechanical and 
biodegradation properties to promote the ingrowth of new tissue [182]. PLLCL is a 
synthetic, biodegradable and non-toxic co-polymer of poly-L-lactic acid (PLLA) and 
PCL, investigated as a biomaterial for surgery and drug delivery systems. Unlike PLA or 
PCL, the biodegradation rate of PLLCL can be adjusted by changing the molar ratio of 
lactic acid and caprolactone in the co-polymer [188, 189]. Thus, PLLCL is more capable 
to meet the requirement of different degradation rates in biomedical applications, 
compared to PLA and PCL.  
 
However, the major disadvantage of synthetic materials is the lack of cell-recognition 
signals. Therefore, manufacturing process of electrospun NFS which incorporates both 
biodegradable synthetic and natural materials was explored, such as electrospun 
PCL/Collagen NFS [190], PCL/gelatin NFS [191], 
poly(L-lactide-co-ε-caprolactone)/gelatin NFS [192] for wound healing and skin 
reconstitution.  
 
Collagen type I is a particular good candidate for constructing NFS skin grafts because it 
is the most abundant ECM substance in human skin tissue [193]. Rho and colleagues 
produced a cross-linked nanofibrous matrix of type I collagen via electrospinning to 
develop biodegradable and biomimetic scaffolds. They also examined the effect of 
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collagen nanofibers on open wound healing in rats. They found that collagen nanofibrous 
matrices promoted cell adhesion and they were very effective as wound-healing 
accelerators in early-stage wound healing [194]. However, the application of collagen is 
limited due to its high price and poor mechanical properties. Gelatin, which is a natural 
biopolymer derived from collagen has many advantages (biological origin, 
biodegradability, biocompatibility) and most importantly, it can be available at relatively 
low cost. These merits credit the wide applications of gelatin in the pharmaceutical and 
medical fields [195]. Chong and colleagues developed a cost-effective composite 
consisting of a nanofibrous scaffold directly electrospun PCL/gelatin nanofiber onto a 
polyurethane dressing (Tegaderm
TM
, 3M Medical) for dermal wound healing. Their 
results suggest that PCL/gelatin nanofibrous scaffold achieved significant cell adhesion, 
growth and proliferation [191]. Kim and colleague choosed polyurethane instead of PCL 
to electrospin gelatin/polyurethane nanofibers for wound healing applications. They 
found that as the total amount of gelatin increased, the cell proliferation increased with 
the same amount of culture time [196]. Other natural polymers such as chitosan and silk 
are also electrospun into nanofibers for wound healing. Kang and colleagues studied the 
wound healing ability of chitosan coated poly(vinyl alcohol) (PVA) nanofiber in vivo. 
They found that The chitosan coated PVA nanofibrous matrices showed faster wound 
healing than the control without coating [197]. Meanwihle, Schneider and colleagues 
fabricated silk nanofibrous scaffold for wound healing via electrospinning. They tested 
the scaffold on top of a wounded human skin-equivalent in order to measure the wound 
healing rate in tissues that accurately mimic the human wound response. The use of 
EGF-charged silk mats increased the rate of wound closure by more than 3.5-fold when 
compared to the silk dressing without EGF [198]. 
 
The nano or micro size fibrils in native skin ECM maintain the integrity of skin tissue and   
guide tissue remodeling. In addition, these fibrils also act as reservoirs to store bioactive 
factors for the regulation of cell migration, proliferation, and differentiation [12]. 
Core-shell incorporated with bioactive factors of ECM could be a promising scaffold for 
wound healing. The controlled release of bioactive factors can be realized via core-shell 
nanofibers, meanwhile, it can also protect the biological agents from the harsh 
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environments [24]. Choi and colleagues used amine-functionalized block copolymers 
composed of PCL and PEG to electrospin coaxial nanofibrous scaffolds which 
encapsulate bFGF in the core. Then EGF was further conjugated onto the surface of the 
nanofibrous meshes. The wound healing capability of the two growth factors loaded 
nanofibrous scaffolds were evaluated in vivo. Accumulation of collagen and keratin was 
found for cells cultured on the core-shell nanofibrous meshes and then they conclude that 
this nanofibrous matrix could play an promising role in wound healing rates while 
reducing scar [199]. Unlike these researchers, Zhao and his colleagues studied wound 
healing in a different way where they used electrical signals to regulate wound 
re-epithelialization. They found that with percolation of an electric field with a polarity 
that along the default healing direction, the cells will move following the direction of the 
electric signal and the wound got closed [121]. Meanwhile, Tada and colleague 
confirmed that LED irradiation promoted the process of wound healing by increasing the 
proliferation of fibroblasts. All the facts make us believe that it is time to “Charge the 
batteries to heal wounds”. Poly(3-hexylthiophene) would be one of the most promising 
photosensitive materials for regenerative medicine and wound healing due to its low 
thermal conductivity, non-toxicity and low cost properties [200] . 
 
Poly(3-hexylthiophene) or P3HT, has been the focus of great interest in organic solar 
cells [201] because of its optical and conductive properties. It has been used as an 
electron donating polymer in bulk heterojunction (BHJ) solar cells [202]. P3HT can be 
synthesized by the chemical polymerization of 3-hexylthiophene monomer by using 
iron(III) chloride as a catalyst [203] and it is known for its high mobility, good solubility 
and good film forming properties [204]. When light irradiates on P3HT, it will absorb the 
energy of photons with a certain wave length and if the energy of photons is greater than 
the electron binding energy of P3HT polymer, P3HT molecules will release electrons and 
this is the general mechanism of photosensitivity of P3HT. The biocompatibility of 
PCL/P3HT nanofibers was studied in our group and results showed that cells can attach 
on containing P3HT molecules on its surface. Being biocompatible together with its 
photosensitive properties, Electrospun core-shell nanofiber incorporating with P3HT and 
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bioactive factors could be a suitable substrate for cell attachment and could be utilized for 
enhanced skin tissue regeneration. 
2.3 Summary 
 
To promote wound healing, current research focuses mainly on the creation and 
development of an ideal skin graft that will most probably encompass several strategies 
such as the use of functional cellular components, different biodegradable materials and 
scaffolds with analogous ECM structures and components, which have been described in 
this chapter. Electric signal was found to contribute in wound healing via promoting cell 
migration towards the wound area. Meanwhile, LED irradiation promoted the process of 
wound healing by increasing the proliferation of fibroblasts. In the present study, a 
biomimetic and photosensitive nanofibrous skin graft will be designed and developed by 
combining the functionality and flexibility of electrospun NFS with the promising 
photosensitive property of P3HT. Biodegradable PLLCL and Gelatin will be blended for 
fabrication of the electrospun core-shell NFS encapsulating EGF and P3HT. The 
feasibility of resultant biomimetic and photosensitive NFS/ASCs composites as skin 
grafts will be evaluated under light stimulation. The strategy aims to provide a new aspect 
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Fabrication and optimization of cost-effective nanofibrous 




Wound injuries could be caused by acute trauma, genetic disorders, surgical interventions 
and disease leading to skin necrosis. One of the most common causes for major skin 
injury is thermal trauma [1]. According to WHO, 6 million patients worldwide suffer 
from burns every year and 300,000 deaths are annually attributed to burn injuries [3]. 
Moreover, in patients with extensive burns, limited availability of autografts complicate 
wound closure and the delayed wound healing can compromise recovery, increase the 
risk of invasive wound infection and mortality [9]. The need for permanent wound 
closure in burn patients has driven the development of tissue engineered skin 
replacements [10]. In tissue engineering, scaffold plays an important role, since it can 
maintain and promote the growth of the cells or tissue [205]. Electrospun nanofibrous 
matrices show morphological similarities to the natural ECM, characterized by ultrafine 
continuous fibers, high surface-to-volume ratio, high porosity and variable pore-size 
distribution similar to the dimensions of basement membranes. Due to the interconnected 
highly porous structures, electrospun nanofibrous matrices could be applied as tissue 
engineered scaffolds to facilitate cellular migration and transport of nutrients, and 
metabolic wastes to allow the formation of new tissue [206]. Furthermore, natural 
proteins such as collagen, gelatin, fibronectin and chitosan were incorporated into 
electrospun nanofibers to improve its biocompatibility [19, 178, 195, 207]. Because of 
their abundance in skin and their recognition by cell surface receptors, these natural 
materials display low toxicity and low chronic inflammatory response [208]. Electrospun 
collagen based nanofibrous scaffolds were observed to induce fast wound healing and 
tissue regeneration both in vitro and in vivo [209-211]. Collagen makes up approximately 
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70% of the dry weight of skin [212] and in order to provide an environment as similar as 
the native ECM of human skin, previously we fabricated collagen/poly( L -lactic 
acid)–co-poly(ε-caprolactone) (Coll/PLLCL) nanofibrous scaffolds with a 
collagen:PLLCL ratio of 70:30 (wt.%) by electrospinning and studied the epidermal 
differentiation of bone marrow derived mesenchymal stem cells (BM-MSC) on this 
scaffold. We found that the stem cells on Coll/PLLCL nanofibers had higher percentage 
of differentiated cells (66.2%) than those on PLLCL nanofibers (33.3%) without regional 
differentiation [176]. However, the poor mechanical properties and high cost limit the 
application of collagen in wound healing. Compared with collagen, gelatin, which is 
derived from collagen by controlled hydrolysis, is cheaper and does not show antigenicity 
under physiological conditions [21, 22]. Moreover, gelatin is biodegradable, 
biocompatible and displays many integrin binding sites for cell adhesion, migration, 
proliferation and differentiation due to the abundant Arg–Gly–Asp (RGD) sequences in 
its amino acid chain [16, 23]. Chong and colleagues electrospun 
poly(ε-caprolactone)/gelatin (PCL/gelatin) nanofibers from a gelatin and PCL blended 
solution at a ratio of 50:50 (v:v) to developed a cost-effective composite for dermal 
wound healing. Their results suggest that PCL/gelatin nanofibers achieved significant cell 
adhesion, growth and proliferation [191]. Lately, Heo and colleagues found that the 
electrospun gelatin/polyurethane nanofibers could promote the regeneration of 
burn-wounds [213]. For clinical applications, a proper scaffolding system must be 
inexpensive and retain structural integrity and stability during implantation in vivo, and 
after surgery, must provide sufficient mechanical support during the process of tissue 
regeneration [214, 215]. Jeong et al. electrospun naonfibers from blends of gelatin and 
PLLCL (blending ratio: 0, 30, 70 and 100 wt% gelatin to PLLCL) solutions to prepare 
non-woven fibers for the development of mechanically functional engineered skin grafts. 
They found that pure gelatin and 70% gelatin containing naonfibers are the ideal 
scaffolds for cell attachment and proliferation. Meantime, PLLCL and 30% gelatin 
containing nanofibers had better mechanical properties and they are stable for long-term 
mechanical stimulation [192]. However, they failed to find out the optimized amount of 
gelatin containing nanofiber which has suitable mechanical properties meanwhile favors 
cell proliferation. In order to find a cost-effective and the optimized electrospun NFS for 
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wound healing, we blended gelatin with PLLCL and electrospun to obtain composite 
gelatin/PLLCL nanofibers with four different weight ratios of gelatin:PLLCL (w/w) of 
80:20 [Gelatin/PLLCL(80)], 70:30 [Gelatin/PLLCL(70)], 60:40 [Gelatin/PLLCL(60)] 
and 50:50 [Gelatin/PLLCL(50)]. The mechanical properties of the scaffolds were 
evaluated in both dry and wet conditions. The comparative proliferation of human dermal 
fibroblasts (HDF) on these electrospun nanofibers was studied by cell proliferation assay. 
Based on our results, we confirmed that Gel/PLLCL(60) is the optimized skin graft and 
its capability in wound healing was further confirmed in vivo in a mouse model.  




Human dermal fibroblasts (HDFs) were purchased from American Type Culture 
Collection, USA. Dulbecco’s modified Eagle’s medium/nutrient mixture F12 
(DMEM/F12), fetal bovine serum (FBS), penicillin-streptomycinsolution, 
4,6-diamidino-2-phenylindole, dihydrochloride (DAPI), were all purchased from 
Invitrogen (Carlsbad, CA). Hematoxylin and eosin (H&E), gelatin, and 
1,1,1,3,3,3-hexafluor-2-propanol (HFP) were all purchased from Sigma-Aldrich 
(Singapore). Actin Cytoskeleton/Focal Adhesion Staining Kit was purchased from Merck 
Millipore. Poly(L-lactic acid)-co-poly-(ε-caprolactone) (PLLCL) (70:30,molecular 
weight 150 kDa) was purchased from Boehringer Ingelheim Pharma GmbH (Ingelheim, 
Germany). 
 
Male Kunming white mice (weight, 30-40 g) were obtained from center for animal 
resources and housed in the animal holding unit of Second Affiliated Hospital of Harbin 
Medical, China. Mice consumed both sterile water and standard mouse chow ad libitum.  
3.2.2 Electrospinning of nanofibers 
 
PLLCL was dissolved in HFP to obtain an 8% (w/v) solution. Gelatin and PLLCL were 
dissolved in HFP at a ratio of 80:20, 70:30, 60:40 and 50:50 (wt.%), respectively, to 
obtain 10% (w/v) solution and stirred overnight. A 3 ml standard syringe attached with a 
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27G blunted stainless steel needle was used to contain the polymer solutions separately 
and the solutions were pumped by pump a syringe pump (KDS 100, KD Scientific, 
Holliston, MA) at a flow rate of 1.0 ml h
-1
. 15 kV high was applied when the polymer 
solution was drawn into fibers and collected on an aluminum foil wrapped collector at a 
distance of 12 cm from the needle tip. Nanofibers collected on 15 mm coverslips and the 
aluminum foil were dried overnight under vacuum and used for the characterization and 
cell culture experiments.  
3.2.3 Morphology and characterization of electrospun nanofibers 
 
Field Emission Scanning Electron Microscope (FESEM) (FEI-QUANTA 200F, 
Netherlands) was used to study the morphology of the electrospun nanofibers at an 
accelerating voltage of 10 kV, after sputter coating with gold (JEOL JFC-1200 fine coater, 
Japan). The obtained SEM images were applied to obtain the diameters of the electrospun 
fibers using image analysis software (Image J, National Institutes of Health, USA). VCA 
Optima Surface Analysis system (AST products, Billerica, MA) was applied to measure 
the hydrophilic/hydrophobic properties of the electrospun nanofibrous scaffolds. A 
CFP-1200-A capillary flow porometer (PMI, New York, NY) was used in this study to 
measure the pore size. Calwick with a defined surface tension of 15.9 dynes/cm (PMI, 
New York, NY) was used as the wetting agent for porometry measurements. Nanofibers 
were cut into 3 cm × 3 cm squares for porometry measurement. Nanofibers with similar 
thickness were obtained and each sample was tested individually. Functional groups of 
the electrospun nanofibrous scaffolds were evaluated by attenuated total reflectance 
fourier transform infrared (ATR-FTIR) spectroscopic analysis in a Nicolet Avatar 380 
spectrometer (Thermo Nicolet, Waltham, MA) over the range 600-3800 cm
-1 
at a 
resolution of 4 cm
-1
. A tabletop tensile tester (Instron x345, Canton, MA) was applied to 
determine the tensile properties of the electrospun nanofibrous scaffolds at a load cell 
capacity of 10 N. The mechanical properties of the electrospun NFS were examined under 
both dry (D) and wet (W) conditions. The dry specimens were cut into approximately 20 
mm × 10 mm (length × width) in order to be loaded into the uniaxial testing machine. 
Specimens were measured with a 10 N load cell under a cross-head speed of 10 mm min
-1
 
(n = 5). For the measurement of the NFS in the wet condition, specimens were immersed 
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in distilled water at room temperature for 24 h. The measurement method was the same 
as that in the dry condition. The tensile stress strain values obtained from the instrument 
were plotted using an Excel sheet. 
3.2.4 Culture of HDFs 
 
HDFs were cultured in DMEM supplemented with 10% FBS and 1% antibiotic and 
antimycotic solutions (termed as normal growth media) in a 75 cm
2 
cell culture flask. 
Cells were incubated at 37 °C in a humidified atmosphere containing 5% CO2 and the 
culture media was changed once in every 3 days. The 15-mm cover slips with electrospun 
nanofibers were placed in 24-well plate and pressed with a stainless steel ring to ensure 
complete contact of the scaffolds with the wells. The specimens were sterilized under UV 
light, washed thrice with phosphate buffered saline (PBS) and subsequently incubated in 
DMEM overnight before cell seeding. HDFs were grown to confluency, detached by 
trypsin, counted by trypan blue assay using a hemocytometer and seeded on the scaffolds 
at a density of 10,000 cells/well.  
3.2.5 Cell proliferation  
 
The comparative proliferation of HDFs on electrospun NFS was determined using the 
colorimetric MTS assay (CellTiter 96 AQueous One solution, Promega, Madison, WI). 
After culturing the cells for a period of 3, 6 and 9 days, cells were rinsed with PBS to 
remove any unattached cells and incubated with 20% MTS reagent in serum free medium 
for a period of 3 hrs at 37 °C. Absorbance of the obtained dye was measured at 490 nm 
using a spectrophotometric plate reader (FLUOstar OPTIMA, BMG lab Technologies). 
The amount of formazan crystals formed is directly proportional to the number of live 
cells, which was also directly proportional to the absorbance values obtained. 
3.2.6 F-actin staining 
 
F-actin staining was performed to study cell morphology on different substrates after 9 
days culture. 5 % paraformaldehyde was added to fix the cells at room temperature for 15 
min, and then the cell substrate composites were washed with PBS and further incubated 
with 2 % BSA to block any unspecific binding. After that, phalloidin was used to stain the 
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cytoskeleton (F-actin) for 2 h at room temperature. Further, DAPI (1:5000) was added to 
staing the nuclear of cells for 30 min at room temperature. Final washing of the 
constructs was done with PBS before mounting on a glass slide and visualized under laser 
scanning confocal microscopy (LSCM). 
3.2.7 Expression of collagen  
 
The presence of collagen in the cell matrix was studied by Sirius Red staining. Sirius Red 
is a strong anionic dye whose sulfonic acid groups interact with the basic groups of 
collagen producing red stains. The intensity of red stains was used to determine the 
secretion of the collagen-containing ECM by fibroblasts. Sirius red stain consisting of 0.1% 
Sirius red F3B in a saturated aqueous solution of picric acid was used to stain the cell 
substrate composites which were first fixed with 2.5% formaldehyde for 1 h. Then, mild 
acidified water was used to wash the composites, followed by 100% ethanol and viewed 
under a Leica BM IRB microscope. Collagen is stained red on a yellow background in 
the nanofibrous scaffolds. 
3.2.8 Surgical procedures 
 
Twenty four male Kunming white mice were anesthetized by isoflurane inhalation, and 
their back were shaved and swabbed with povidine–iodine followed by 70% ethanol for 
three times. Then a sterile template measuring 8 × 8 mm was placed on the skin and the 
outline was traced using a sterile fine felt-tipped pen. Full thickness skin wound (FTSW) 
of 8 × 8 mm were made by excising the skin within the confines of the square down to 
the level of subcutaneous panniculus carnosus. FTSW (n = 12 for each group) were then 
subjected to two different kinds of treatments: (1) receiving no nanofibers (control); (2) 
receiving Gel/PLLCL(60) nanofibers. After the surgery, each animal was placed in one 
cage. Postsurgery care included analgesic and antibiotic injections. Checking of any 
postsurgery pain, distress, or complications was done 24 h after surgery and daily 
afterward. Then, on postoperative days 5 and 10, four mice in each group were 
euthanized and the reconstituted skin was harvested for the following evaluations. The 
left four mice in each group were not euthanized until complete wound closure. 
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3.2.9 Histological and immunological analyses 
 
The reconstituted skin was cut to the control depth determined as the layer of panniculus 
carnosus, and fixed in 4% paraformaldehyde, dehydrated, and then paraffin-embedded. 
Serial 10 mm paraffin sections were cut with a rotating microtome (MICROM) and 
stained with H&E according to routine histology protocol.  
3.2.10 Statistical analysis 
 
All the data presented are expressed as mean ± standard deviation (SD) of the mean. Each 
experiment was repeated three times. Statistical differences were determined by Student’s 
two-sample t test. Differences were considered statistically significant at p ≤ 0.05.  
3.3 Results and discussions 
 
Collagen is the dominant protein in the native ECM of human skin and around 70% of 
the dry weight of the ECM from skin is represented by collagen [212]. It has been 
incorporated to tissue engineered skin grafts to modulate cell behavior and augment the 
in vivo performance [177]. However, due to the high cost and poor mechanical properties 
of collagen, the application of collagen in tissue engineered scaffolds is limited. On the 
contrary, gelatin derived from the hydrolysis of collagen has been widely utilized in the 
pharmaceutical and medical fields in a variety of applications, including tissue 
engineering, wound dressing, drug delivery and gene therapy for its biocompatibility, 
biodegradability and most important cost efficiency [216]. For these reasons, gelatin 
could be an ideal candidate for fabricating cost-effective tissue engineered skin grafts. 
Besides mimicking the component of native ECM, the physical structure, mechanical 
properties and biocompatibility of the scaffold are also important for the success of tissue 
engineered scaffold. In the current study, we electrospun nanofibers from the solutions 
with different content of gelatin in blend (80, 70, 60 and 50 wt%) and examine the 
mechanical properties of these nanofibers in both dry and wet conditions. Cell 
proliferation assay was applied to study the biocompatible properties of these gelatin 
containing nanofibers. Finally, the optimized NFS was further evaluated in vivo in a 
mouse model.  
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3.3.1 Morphology and characterization 
 
Nanofibers of Gel/PLLCL(80), Gel/PLLCL(70), Gel/PLLCL(60), Gel/PLLCL(50) and 
PLLCL were fabricated by electrospinning and the fiber morphology was examined 
under scanning electron microscope (SEM). SEM micrographs of electrospun NFS 
revealed uniform beadless fibrous structures under the optimized spinning conditions 
utilized during this study (Fig. 3.1a). Uniform nanofibers of Gel/PLLCL(80), 
Gel/PLLCL(70), Gel/PLLCL(60), Gel/PLLCL(50) and PLLCL with fiber diameters of 
537.5 ± 121.9, 487.4 ± 152.8, 354.8 ± 70.1, 970.6 ± 81.8 and 613.3 ± 92.4 nm, 
respectively, were obtained. Applied with low pressure, capillary flow porometry 
provides a simple and non-destructive technique for rapid and accurate measurement of 
pore size [217]. Therefore, capillary flow porometry can provide reproducible pore size 
measurements with ignorable distortion errors [218]. The pore size as determined by 
capillary flow porometer, for the Gel/PLLCL(80), Gel/PLLCL(70), Gel/PLLCL(60), 
Gel/PLLCL(50) and PLLCL was 1.48, 1.31, 1.01, 1.74 and 1.53 µm, respectively. The 
mean pore sizes obtained for the nanofibers were found inversely proportional to the 
diameter of the fibers and our results were also in agreement with the results reported by 
Li et al [218]. For use as a wound dressing, scaffolds need to have an ideal structure that 
gives high porosity and small pore size yet serves as a good barrier. Among the 
electrospun NFS, Gel/PLLCL(60) has the smallest fiber diameter and pore size and this 
makes Gel/PLLCL(60) a more suitable skin graft than other electrospun NFS.  
 
PLLCL was found to be highly hydrophobic with a contact angle of 131 ± 2 °C (Fig. 
3.1b). However, with the incorporation of gelatin, the Gel/PLLCL(80), Gel/PLLCL(70), 
Gel/PLLCL(60) and Gel/PLLCL(50) nanofibers became more hydrophilic, with a contact 
angle of 39 ± 7
0
, 44 ± 8
0
, 30 ± 1
0
 and 45 ± 6
0
, respectively. Fig. 3.1c shows the 
ATR-FTIR spectra of electrospun nanofibers. The characteristic ester absorption peak of 
PLLCL was observed at 1760 cm
-1
, and C-O-C stretching vibrations were observed at 
1097, 1133 and 1187 cm
-1
. The Gel/PLLCL(80), Gel/PLLCL(70), Gel/PLLCL(60) and 
Gel/PLLCL(50) showed the characteristic amide I and amide II peaks of gelatin at 1650 
cm
-1
 and 1550 cm
-1





Fig. 3.1 Characterizations of electrospun nanofibers. a. SEM morphology of 
Gel/PLLCL/(80), Gel/PLLCL/(70), Gel/PLLCL/(60), Gel/PLLCL/(50) and PLLCL 
nanofibers. b. Water contact angle for electrospun nanofibers. c. FTIR spectra of 
Gel/PLLCL/(80), Gel/PLLCL/(70), Gel/PLLCL/(60), Gel/PLLCL/(50) and PLLCL 
nanofibers. d. Morphological changes of Gel/PLLCL/(80), Gel/PLLCL/(70), 
Gel/PLLCL/(60) and Gel/PLLCL/(50) nanofibers after degradation in PBS for 5, 10 and 
15 days.  
 
Fig. 3.1d exhibits the morphological changes in electrospun NFS during in vitro 
degradation at three different time points (day 5, 10 and 15). After 5 days of degradation, 
the gelatin containing nanofibers appeared to have swollen and lost their initial surface 
smoothness (Fig. 3.1d). Moreover, Gel/PLLCL(80) had significant morphological 
changes duo to the massive loss of gelatin in the surface layers. After 10 days of 
degradation in PBS, Gel/PLLCL(70) had apparently swelled (Fig. 3.1d). This can be 
explained by the dissolution of gelatin in the buffer. However, the fiber structure still can 
be found in Gel/PLLCL(60) and Gel/PLLCL(50). No further morphological changes 
were observed after 15 days of degradation.  
 
In addition to physically integrating into the skin wound, scaffold materials must be able 
to withstand the load of the tissue and provide mechanical strength [219]. The ideal tissue 
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engineered scaffold should be easily handled and retain certain mechanical strength after 
implantation to provides it with good resilience and compliance to movement as a skin 
graft. The mechanical behavior in the wet state is extremely important in predicting the 
mechanical properties of the membrane in vivo. Therefore, it is necessary to examine the 
mechanical properties of the electrospun NFS in both dry and wet conditions. Fig. 3.2 
shows the stress-strain curves of different electrospun nanofibers under tensile loading.  
 
 
Fig. 3.2 Typical stress-strain curves of random Gel/PLLCL/(80), Gel/PLLCL/(70), 
Gel/PLLCL/(60), Gel/PLLCL/(50) and PLLCL nanofibrous scaffolds in dry and wet 
conditions.  
 
Comparing the stress-strain curves of gelatin containing NFS with those of the 
stress-strain curve of PLLCL in the dry condition, we found that the incorporation of 
higher amounts of gelatin to PLLCL led to a significant increase in elastic modulus and 
decrease in ultimate strain of the electrospun composite scaffolds (p ≤ 0.05). Mechanical 
evaluations of the Gel/PLLCL(80) and Gel/PLLCL(70) naonfibers in dry conditions 
show a linear segment up to the proportionality limit, followed by a brittle fracture. 
Gelatin was found mainly contributes to the crystallinity of the electrospun membrane 
[220] and 80% or 70% gelatin makes Gel/PLLCL(80) and Gel/PLLCL(70) become 
extremely crystalline. The crystalline morphology of electrospun nanofibrous scaffold 
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can strongly influence its mechanical properties [221, 222]. Lim and colleagues found 
that the fibers with smaller diameter have higher degree of crystallinity and molecular 
orientation in the form of oriented fibrillar structure. The fibrillar structure would result 
in higher resistance to axial tensile force due to the higher degree of molecular orientation 
in the direction of applied stress [222]. Thus, Gel/PLLCL(80) and Gel/PLLCL(70) with 
higher crystallinity have higher elastic modulus with low or non ductility. Instead of 
showing a brittle fracture after liner segment, Gel/PLLCL(60), Gel/PLLCL(50) and 
PLLCL show a non-linear curve, which was characterized by considerable elongation 
without a corresponding increase in loading stress. This feature is mainly attributed to 
fiber arrangement in the mat. The fiber arrangement in the mat is expected to change 
during the stress–strain measurement. It was demonstrated that fibers tend to align in the 
direction of applied force before getting thinner and finally the breaking occurs [186, 
223]. However, in the wet condition, only Gel/PLLCL(60), Gel/PLLCL(50) and PLLCL 
showed the similar tensile behaviors as in the dry condition. The hydrated Gel/PLLCL(80) 
and Gel/PLLCL(70) nanofibers are barely retain their mechanical properties. The tensile 
properties of nanofibrous substrates are summarized in Table 3.1. 
 
Table 3.1 Tensile properties of the electrospun nanofibers in both dry and wet conditions 
Property Tensile Modulus (MPa) Tensile Stress (MPa) Strain at break (%) 
Dry Wet Dry Wet Dry Wet 
Gel/PLLCL/(80) 82.44 ± 1.72 0.16 ± 0.04 2.52 ± 0.03 0.28 ± 0.03 6.29 ± 0.98 86.05 ± 3.02 
Gel/PLLCL/(70) 87.42 ± 1.01 0.17 ± 0.03 2.29 ± 0.03 0.44 ± 0.01 3.64 ± 1.04 237.25 ± 5.90 
Gel/PLLCL/(60) 74.92 ± 6.19 3.05 ± 0.24 2.68 ± 0.02 1.16 ± 0.03 79.65 ± 4.46 246.13 ± 5.44 
Gel/PLLCL/(50) 73.43 ± 4.45 5.93 ± 0.40 2.76 ± 0.03 1.55 ± 0.15 93.25 ± 6.73 179.43 ± 2.13 
PLLCL 7.72 ± 0.51 6.33 ± 0.23 4.10 ± 0.06 2.95 ± 0.16 252.78 ± 9.82 198.11 ± 6.49 
 
The Young’s modulus of Gel/PLLCL(80), Gel/PLLCL(70), Gel/PLLCL(60), 
Gel/PLLCL(50) and PLLCL nanofibers in dry condition was 82.44 ± 1.72, 87.42 ± 1.01, 
74.92 ± 6.19, 73.43 ± 4.45 and 7.72 ± 0.51 MPa, respectively. In the wet condition, the 
Young’s modulus and tensile strength at break of gelatin containing nanofibers decreased 
significantly. However, the Young’s modulus of Gel/PLLCL(60), Gel/PLLCL(50) and 
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PLLCL nanofibers still can be calculated as was 3.05 ± 0.24, 5.93 ± 0.40 and 6.33 ± 0.23 
MPa, respectively. The decrease in elastic modulus for the gelatin containing nanofibers 
can be attributed to hydration of considerable amounts of uncrosslinked hydrophilic 
gelatin in the surface layers [224]. The hydrated gelatin without enough crystallinity leads 
to the decrease of mechanical properties for gelatin containing nanofibers. Compared to 
Gel/PLLCL(80) and Gel/PLLCL(70) in the wet condition, the hydrated Gel/PLLCL(60) 
and Gel/PLLCL(50) still maintain the mechanical integrity of the membrane.  
3.3.2 HDF proliferation on electrospun nanofibers 
 
The capacity for NFS to support HDFs proliferation was evaluated using cell 
proliferation assay as shown in Fig. 3.3. 
 
 
Fig. 3.3 HDFs proliferation on electrospun Gel/PLLCL/(80), Gel/PLLCL/(70), 
Gel/PLLCL/(60), Gel/PLLCL/(50) and PLLCL nanofibers. 
*
Significant against cell 
proliferation on PLLCL at p ≤ 0.05; Significant against cell proliferation on 
Gel/PLLCL/(80), Gel/PLLCL/(70) and Gel/PLLCL/(50) nanofibers. 
 
It was observed that the optical density of HDFs on all the electrospun substrates 
increased during the 9 days of cell culture. In the first three days, the attachment of HDFs 
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on naonfibrous scaffolds was proportional to the amount of gelatin included in the 
nanofibers. The reason is that gelatin displays many integrin binding sites for cell 
adhesion, migration, proliferation and differentiation due to the abundant Arg–Gly–Asp 
(RGD) sequences in its amino acid [16]. The more amount of gelatin presented in the 
nanofibers, the more integrin binding sites which lead to more cell attachments. However, 
after 6 days, the rate of proliferation on Gel/PLLCL(60) scaffold was significantly higher 
(p ≤ 0.05) than on Gel/PLLCL(80) and Gel/PLLCL(70) nanofibers. This is due to the 
degradation and morphology changes of Gel/PLLCL(80) and Gel/PLLCL(70) nanofibers 
in wet condition. Both Gel/PLLCL(80) and Gel/PLLCL(70) nanofibers loss their 
nanofibrous morphology faster than Gel/PLLCL(60) and they almost loss their 
nanofibrous structure after 10 days degradation as shown in Fig. 3.1d. The cell 
proliferation on Gel/PLLCL(60) scaffold was significantly higher than cells on 
Gel/PLLCL(50). The effect of fiber diameter on cell proliferation has been explored, with 
the conclusion that smaller fibers seem to encourage better cell proliferation and 
signaling [225, 226]. Moreover, the large diameter (970 nm) of Gel/PLLCL(50) will 
restrain its high surface-to-volume ratio and binding sites, then lead to less cell 
proliferation on Gel/PLLCL(50) nanofibers.  
 
After 9 days of cell culture, the cell proliferation on Gel/PLLCL(60) nanofibers was the 
highest among all the electrospun NFS. We observed 15%, 7%, 10% and 84% higher cell 
proliferation on Gel/PLLCL(60) compared to cell proliferation on Gel/PLLCL(80), 
Gel/PLLCL(70), Gel/PLLCL(50) and PLLCL nanofibers, respectively. The percentage 
increase in the rate of proliferation from day 3 to day 9 on Gel/PLLCL(80), 
Gel/PLLCL(70), Gel/PLLCL(60), Gel/PLLCL(50) and PLLCL nanofibrous scaffolds was 
found to be 124%, 151%, 195%, 202% and 200% respectively. Results of cell 
proliferation assay suggested that HDFs cultured on the electrospun Gel/PLLCL(60) 
nanofibers had better cell proliferation compared to other electrospun NFS. In addition, 
Gel/PLLCL(60) showed proper mechanical properties in both dry and wet conditions. On 
the basis of the results above, the electrospun Gel/PLLCL(60) nanofibers could be an 
ideal scaffold for skin tissue engineering and the capability of Gel/PLLCL(60) as a skin 
graft was further evaluated both in vitro and in vivo.  
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3.3.3 Cell morphology on nanofibers  
 
The cell morphology on Gel/PLLCL(60), PLLCL and TCP were studied by SEM on day 
9 and the results are shown in Fig. 3.4. Fibroblasts attached on the scaffolds and stretched 
across the nanofibrous substrates upon proliferation. Much more fibroblasts attached on 
Gel/PLLCL(60) (Fig. 3.4A) nanofibers compared to the cells attached on PLLCL 
nanofibers (Fig. 3.4B). The morphology of fibroblasts attached on Gel/PLLCL(60) 
nanofibers was a characteristic spindle shape and comparable to the cells attached on TCP, 




Fig. 3.4 SEM images of HDFs on Gel/PLLCL/(60), PLLCL and TCP. 
 
To understand the interaction of fibroblasts with Gel/PLLCL(60) scaffolds, phalloidin 
and vinculin staining were carried out after 9 days of cell culture and the F-actin stains 
showed a cytoplasmic filamentous distribution under LSCM (Fig. 3.5). Vinculin is a 
widely distributed protein associated with the cytoplasmic surface of the plasma 
membrane where it is believed to link actin filaments to adhesion plaque structures [227]. 
HDFs attached on Gel/PLLCL(60) showed sufficient cell-to-cell communication. The 
number of vinculin-expressed HDFs on Gel/PLLCL(60) (Fig. 3.5) was higher compared 
to the number of cells on TCP and much better than the cells on PLLCL. The results 
confirmed that the biocompatibility of Gel/PLLCL(60) and it could be a promising 





Fig. 3.5 Dual immunocytochemical analysis for the expression of F-actin, vinculin and 
the merged images showing the dual expression of both F-actin and vinculin on 
electrospun Gel/PLLCL/(60), PLLCL nanofibers and TCP. 
 
3.3.4 Collagen expression 
 
The wound healing process is characterized predominantly by ECM synthesis and 
remodeling into a highly organized architecture [228]. During wound healing, fibroblasts 
produce collagen-based ECM that ultimately replace the provisional fibrin-based matrix 
and help reapproximate wound edges through their contractile properties [42]. Collagen 
staining with Picro-sirius red confirmed the secretion of ECM by the cells in culture. Fig. 
3.6 shows the secretion of collagen by fibroblasts grown on different electrospun 
scaffolds after 9 days of cell culture. The dark red dots indicate collagen produced by 
HDFs. The secretion of collagen was more predominant on Gel/PLLCL(60) scaffold (Fig. 
3.6A) compared to the other materials as characterized by the Sirius-red staining. In our 
study we found that the higher cell proliferation on Gel/PLLCL(60) contributed to 
increased collagen stains on this scaffold. This abundant secretion of ECM by the cells 






Fig. 3.6 Collagen staining on nanofibrous scaffolds: (A) Gel/PLLCL(60), (B) PLLCL and 
(C) TCP. 
 
3.3.5 Wound size measurements 
 
Materials for wound dressing made from the electrospinning product have been 
increasingly investigated [229]. The electrospun nanofiber is appropriate for use as a 
wound dressing material due to its useful properties, including oxygen-permeable high 
porosity, variable pore-size distribution, high surface-to-volume ratio, and most 
importantly, morphological similarity to the natural ECM in the skin, all of which 
promote cell adhesion, migration and proliferation [230, 231]. The in vivo evaluation of 
Gel/PLLCL(60) as a skin graft has been carried out in a mouse model. The wounds in 
NFS-treated group have completely closed after 14 days (Fig. 3.7I). However, around 21% 
of wounds are still can be found in the control group. Fig. 3.7I also shows that 
Gel/PLLCL(60) can promote wound healing form day 2 to day 14. The initial FTSW of 8 
× 8 mm wounds were shown in Fig. 3.7II in both groups on day 0. After 5 days, the 
wounds in NFS-treated group are apparently smaller than the wounds in control group.  
On day 10, the wounds in NFS-treated groups were almost closed, however, the largest 
un-epithelialized wounds were still can be found in the control group. It takes 18 days for 





Fig. 3.7 Wound size measurements and appearances at different time points. (I) 
Percentages of unepithelialized wound area in different groups from day 1 to 14. (II) 
Appearances of wounds in different groups on days 0, 5 and 10.  
 
3.3.6 Histological analysis 
 
The histological structures (obtained by H&E staining) of wounds in different groups are 
shown in Fig. 3.8. Compared to normal healthy skin, full-thickness wounds displayed 
hyperplasia of epidermis, granulation tissue formation and the presence of inflammatory 
cells (Fig. 3.8). After 5 days wound healing, inflammatory cells and fibroblasts densely 
infiltrated the wounds from control groups. However, the newly formed capillary (red 
dots) can be found in the NFS-treated wounds. On day 10, the wounds from control 
group were still thickly filled with inflammatory cells and fibroblast. Moreover, the 
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capillary hyperproliferation was found in the control group. All these observations 
indicated that wounds in control group still remained in inflammatory phase. In contrast, 
wounds in NFS-treated group demonstrated epithelialization without capillary 
hyperplasia. Moreover, the skin appendage sebaceous glands could be found in the 
NFS-treated groups.  
 
 
Fig. 3.8 Hematoxylin and eosin staining in different groups on days 5 and 10. Scale bars: 
200 mm (low magnification), 100 mm (high magnification). F, fibrinous debris; N, 
neutrophils; C, capillary; S, sebaceous gland; E, epithelialization.  
 
Our results demonstrated that the optimized Gel/PLLCL(60) can accelerate wound 
closure by 4 days compared with the control groups. Moreover, Gel/PLLCL(60) was 
found to promote wound reepithelialization and the newly formed epidermis is 
comparable to the epidermis of normal skin. Our animal studies further confirmed the 
promising application of the cost-effective nanofibers in skin tissue engineering. 
3.4 Conclusion  
 
In the present study, different amount of gelatin containing NFS were fabricated by 
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electrospinning. The mechanical properties of these electrospun nanofibers were 
evaluated in both dry and wet conditions. Moreover, the comparative cell proliferation on 
these NFS was studied by cell proliferation assay. Our results demonstrated that 
Gel/PLLCL(60) which had sufficient mechanical properties in both dry and wet 
conditions, along with the highest cell proliferation was the optimized NFS for skin tissue 
engineering. The capability of Gel/PLLCL(60) in promoting wound healing was further 
evaluated in a mouse model. In vivo results showed that wounds in NFS-treated group 
completed closure 4 days earlier than the control group and realized epithelialization. Our 
study demonstrated that the cost-effective Gel/PLLCL(60) NFS was suitable applied in 
wound healing and skin tissue engineering. Further improvements such as encapsulating 
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Stem cell epidermal differentiation on multiple epidermal 




Globally, over 6 million patients suffer from severe burns each year among which more 
than 300 000 persons die annually [232, 233]. Even today, acute burn care, rehabilitation 
and reconstruction remain a major problem worldwide [234]. Unlike disruptive or 
incisional wounds, burn injury damages blood vessels in the immediate area of the wound 
to cause restriction or cessation of blood flow at the site of injury and modifications to 
blood flow occur in the surrounding area [235]. Thus, the management and treatment of 
burn injuries involving damaged blood vessels is a challenge among the clinicians and 
investigators. Different strategies have been explored by various researchers to improve 
the wound healing process from hemostasis to reepithelialization. Hemostasis begins 
immediately after injury and fibrin pad was demonstrated to prevent bleeding. These 
researchers found that fibrin pad was as effective as a conventional therapy for the 
primary management of severe bleeding with minimal time requirement for surgery [236]. 
Moreover, chitin was found to accelerate macrophage migration and its degradation 
products, and is able to stimulate macrophages and positively influence collagen 
deposition, thus accelerating the wound healing process [230]. Hydrogels with spatially 
specific cues are also known to promote wound remodeling and re-epithelialization [237, 
238]. A variety of mediators have been identified as involved in wound healing process 
and these mediators act via multiple (specific) receptors facilitating wound closure [239]. 
Epidermal growth factor (EGF) plays an important role in the wound healing process, 
especially in stimulation of proliferation and migration of keratinocytes [240] and EGF 
has also been shown to accelerate wound healing in vivo [241]. Similarly, it was 
demonstrated that high doses of insulin can be safely administered to massively burned 
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patients to improve wound matrix formation [242]. Other bio-reagents such as 
hydrocortisone and retinoic acid (RA) has the capacity to promote keratinocyte growth 
[243] and are applied as agents to guide epithelial differentiation of stem cells [244]. 
Incorporation of such growth factors and bioreagents in biocompatible and biodegradable 
nanofibers might be a potential alternative to regulate cell proliferation, migration and 
differentiation, thus enhancing skin tissue regeneration by providing adequate signaling 
and concentration of growth factors. However, optimizing the release profiles of these 
mediators for wound healing for a desired period of time remains a huge challenge. This 
is mainly because, protein based growth factors (EGF, insulin, etc.) are easily being 
attacked by the hydrolytic enzymes present at the wound sites. Moreover, the dilution of 
the released growth factors by body fluids such as blood and lymphatic fluids reduce the 
therapeutic efficacy of these growth factors at the wound sites [199]. Electrospun 
naonfibers were used to encapsulate and control the release rates of therapeutic proteins 
and drugs [245, 246]. However, low delivery efficiency and burst release are some of the 
problems with electrospun nanofibers fabricated from polymer solutions blended with 
growth factors. Gandhi et al. examined the release of two model protein compounds, 
bovine serum albumin (BSA) and an anti-integrin antibody (AI), from electrospun 
polycaprolactone (PCL) nanofibers, where the proteins were directly blended with the 
polymeric solution of PCL. Up to 87% and 55% burst release of BSA and AI, 
respectively was observed [247]. Recently, Jiang et al. utilized a scaffold-based approach 
to direct the neuronal differentiation of stem cells. For this, 3 mg ml
-1
 of retinoic acid 
(RA) solution was added to a mixture of PCL and gelatin solution and electrospun to 
obtain RA-encapsulated fibers. Results of their studies showed enhanced expression of 
neuronal specific markers such as Tuj-1 and MAP2, but a 35% burst release was 
observed within the first day from the RA-encapsulated fibers [248]. Such burst release 
may discredit the stem cell differentiation effect and similar shortcoming was also 
observed by other researchers [249, 250]. In order to overcome the problem of burst 
release to a certain extent, core-shell structured nanofibers have been developed. With 
application of core-shell nanofibers, the unstable biological agents can be protected from 
harsh environments, deliver the bioactive molecules or drugs in a sustained way, and 




Besides the positive effects of mediators in wound healing, selection of a suitable cell 
source is also important for tissue engineering. Adipose-derived stem cells (ASCs) are 
known to significantly reduce the wound size and accelerate the re-epithelialization 
process [159]. In addition, ASCs promote the proliferation of human dermal fibroblasts 
(HDF), not only by cell-to-cell direct contact, but also by paracrine activation through 
secretory factors [42]. Meanwhile, Davis et al. demonstrated that purified ASCs delivered 
in a trans-glutaminase gel significantly accelerated wound closure in chronically 
irradiated animals compared to the controls (gel alone without cells) [251]. Furthermore, 
it was also demonstrated that ASCs could accelerate wound healing through epithelial 
differentiation and might represent a novel therapeutic approach in cutaneous wounds 
[159].  
 
Aiming to protect the wound healing mediators from the attack by hydrolytic enzymes at 
the wound sites and to achieve sustained release of the mediators; we fabricated EIF 
encapsulated core-shell nanofibers by co-axial electrospinning. Parallely, we prepared 
EIF blended nanofibers by electrospinning a blend solution of EIF with gelatin and 
PLLCL. The release profile of EGF from both kinds of nanofibers was evaluated by 
performing epidermal differentiation of ASCs on the EIF-containing nanofibrous 
scaffolds and differentiation effect was evaluated. 




Human adipose-derived stem cells (ASCs) were obtained from Lonza (Portsmouth, NH). 
DMEM/F12, FBS, penicillin-streptomycinsolution, DAPI, Alexa Fluor 488 and Alexa 
Fluor 594 were all purchased from Invitrogen (Carlsbad, CA). Epidermal growth factor 
(EGF), hydrocortisone, insulin, retinoic acid (RA), bovine serum albumin, gelatin and 
HFP were all purchased from Sigma-Aldrich (Singapore) and CD 105 was purchased 
from Abcam (USA). Mouse anti-human keratin 10 (Ker 10) and filaggrin antibodies were 
obtained from Thermo Fisher Scientific (Singapore). PLLCL co-plomer was purchased 
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from Boehringer Ingelheim Pharma GmbH (Ingelheim, Germany). 
4.2.2 Electrospinning of nanofibers 
 
8% (w/v) of PLLCL solution was prepared by dissolving block copolymer in HFP. 
Gelatin and PLLCL were dissolved in HFP at a ratio of 60:40 (wt.%) to obtain 10% (w/v) 
solution and stirred overnight. The solutions were individually placed in a 3 ml standard 
syringe attached with blunted steel needles with 27 G inner diameters. Then, the solution 
loaded syringe was located in a syringe pump (KDS 100, KD Scientific, Holliston, MA) 
at a flow rate of 1.0 ml h
-1
. Nanofibers were fabricated via electrospinning at 15 kV 
(Gamma High Voltage Research, Ormond Beach, FL) and collected on an aluminum foil 
wrapped flat grounded steel plate at a distance of 12 cm from the needle tip. A vacuum 
desiccator was used to evaporate residual solution of the nanofibers collected on 15 mm 
coverslips. 
 
To fabricate EIF encapsulated electrospun nanofibers, the loading level of each growth 
factor in epidermal induction medium was calculated based on the study by Jiang et al 
[248]. The concentrated epidermal induction medium (CEIM) includes 17 μl of 0.1 mg 
ml
-1
 EGF, 68 μl of 12.5 mg ml-1 insulin, 340 μl of 200 µg ml-1 hydrocortisone and 85 µl 
of 10 mM RA. To fabricate EIF blended nanofibers, CEIM was added into 
gelatin-PLLCL solution for electrospinning. The resulting drug-loaded polymeric 
solution was further charged at 15 kV and fed at a flow rate of 1 ml h
-1
. All fibers were 
finally collected on an aluminum foil wrapped collector at a distance of 12 cm from the 
needle tip. The electrospinning process was also protected from light to minimize the 
degradation of EIF. 
 
To fabricate EIF encapsulated core-shell nanofibers, gelatin and PLLCL were dissolved 
in HFP at a ratio of 60:40 (wt.%) to obtain a 10% (w/v) shell solution. The CEIM was 
diluted into 1 ml solution with 5% bovine serum albumin (BSA) and it was used as the 
core solution. A two-fluid coaxial spinneret was designed for electrospinning (Scheme 
4.1). The inner needle has an inner diameter of 0.8 mm and an outer diameter of 1 mm; 
the outer needle has an inner diameter of 1.8 mm. The spinneret was designed such that 
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the fluids were immiscible before exiting the nozzle. Two syringe pumps (KD Scientific, 
Inc.) were provided to pump a constant-volume flow rate of 0.3 mL/h for the core 
solution and 1.0 mL/h for the shell solution. A high-voltage electric field (DC 
high-voltage power supply from Gamma High Voltage Research) was applied at the tip 
of the spinneret of 15 kV. A Taylor cone was formed at the coaxial tip with an outer 
droplet surrounding the inner one. The outer droplet was then transformed into a jet, 
because of the surface charges created whereas no surface charges were created for the 
inner droplet owing to the rapid evaporation of the solvent, which reduces the solvent 
mixing during this process, thereby producing core-shell fibers. A collector plate was 
placed at a distance of 12 cm from the tip of the spinneret to collect the core-shell fibers. 
Hereafter, in this manuscript EIF encapsulated core-shell nanofibers and EIF blended 




Scheme 4.1 Basic set-up for coaxial electrospinning and EIF encapsulated core-shell 
nanofibers. 
 
4.2.3 Morphology and characterization of electrospun nanofibers 
 
FESEM (FEI-QUANTA 200F, Netherlands) was used to study the morphology of the 
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electrospun nanofibers at an accelerating voltage of 10 kV, after sputter coating with gold 
(JEOL JFC-1200 fine coater, Japan). The obtained SEM images were applied to obtain 
the diameters of the electrospun fibers using image analysis software (Image J, National 
Institutes of Health, USA). The core-shell structure of Gel/PLLCL/EIF(cs) was examined 
using a JEOL JEM-2010F transmission electron microscopy (TEM). To determine the 
distribution of EIF within the core-shell nanofibers, the electrospun Gel/PLLCL/EIF(cs) 
and Gel/PLLCL/EIF(b) with FITC-dextran were also observed under the laser scanning 
confocal microscopy (Olympus FLUOVIEW FV1000, Japan). CFP-1200-A capillary 
flow porometer (PMI, New York, NY) was used in this study to measure the pore size. 
Calwick with a defined surface tension of 15.9 dynes/cm (PMI, New York, NY) was used 
as the wetting agent for porometry measurements. Nanofibers were cut into 3 cm × 3 cm 
squares for porometry measurement. Nanofibers with similar thickness were obtained 
and each sample was tested individually. Functional groups of the electrospun 
nanofibrous scaffolds were evaluated by ATR-FTIR spectroscopic analysis in a Nicolet 
Avatar 380 spectrometer (Thermo Nicolet, Waltham, MA) over the range 600-3800 cm
-1 
at 
a resolution of 4 cm
-1
. A tabletop tensile tester (Instron x345, Canton, MA) was applied to 
determine the tensile properties of the electrospun nanofibrous scaffolds at a load cell 
capacity of 10 N. The specimens were cut into approximately 20 mm × 10 mm (length × 
width) in order to be loaded into the uniaxial testing machine. Specimens were measured 
with a 10 N load cell under a cross-head speed of 10 mm min
-1
 (n = 5). The tensile stress 
strain values obtained from the instrument were plotted using an Excel sheet. 
4.2.4 Culture of ASCs on the scaffolds  
 
The method of ASCs culture and scaffolds sterilization is the same to that mentioned in 
section 3.2.4. The density of ASCs seeded on the scaffolds 5,000 cells/well.  
4.2.5 Drug release study 
 
To evaluate the drug delivery behavior, individual scaffolds of Gel/PLLCL/EIF(cs) and 
Gel/PLLCL/EIF(b) (average weighing 50mg, n = 3) was soaked in a 15-mL centrifuge 
tube with 10 mL of phosphate-buffered saline (PBS). To account for possible dissolution 
of gelatin from the nanofibers, Gelatin/PLLCL nanofibers (average weight 50 mg, n = 1) 
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were used as the control. The fibrous mats were protected from light and incubated at 
37 °C in a continuous horizontal shaker. At predetermined time points (1, 3, 6, 9, 12 and 
15 day), 1 ml of supernatant was retrieved and replenished with 1 ml of fresh PBS. 
Quantikine human EGF kit was used to determine the quantity of EGF released at 
different time intervals following the instructions of the manufacturer. The Quantikine 
Human EGF Immunoassay kit is a 4.5 hour solid phase ELISA designed to measure EGF 
level and employs the quantitative sandwich enzyme immunoassay technique, whereby 
the minimum detectable dose of EGF was typically less than 3.9 pg/mL. The optical 
density for each sample was determined by microplate reader (Genios, Tecan, Basel, 
Switzerland), and the results were expressed by cumulative release as a function of 
release time: 
Cumulative amount of release (%) = Mt/Mx ×100% 
where Mt is the weight of EGF released at time t and Mx is the total amount of EGF in 
the nanofibers theoretically. All experiments were tested in triplicate. 
4.2.6 Cell proliferation assay 
 
The comparative proliferation of ASCs on electrospun NFS was determined using the 
colorimetric MTS assay (CellTiter 96 AQueous One solution, Promega, Madison, WI). 
After culturing the cells for a period of 5, 10 and 15 days, cells were rinsed with PBS to 
remove any unattached cells and incubated with 20% MTS reagent in serum free medium 
for a period of 3 hrs at 37 °C. Absorbance of the obtained dye was measured at 490 nm 
using a spectrophotometric plate reader (FLUOstar OPTIMA, BMG lab Technologies). 
The amount of formazan crystals formed is directly proportional to the number of live 
cells, which was also directly proportional to the absorbance values obtained. 
4.2.7 Induction of ASCs towards the epidermal lineage 
 
For induction of ASCs to epidermal lineage, ASCs were seeded at a concentration of 
5000 cells on the scaffolds per well in 24-well plates using basic epidermal induction 
medium (BEIM) comprising of Ham’s F12 medium (3:1) including 10% FBS, 100 IU 
ml
-1
 penicillin and 100 μg ml-1 streptomycin without supplements. All samples were 
incubated for 15 days under standard culture conditions (37 °C with 5% CO2) and the 
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culture medium was changed every 3 days.  
4.2.8 Immunostaining analysis of differentiated ASCs  
 
ASCs grown on Gel/PLLCL/EIF(cs), Gel/PLLCL/EIF(b) and Gelatin/PLLCL, PLLCL 
and TCP using BEIM for 15 days were processed for immunocytochemistry. The cell 
scaffold composites were fixed by 2.5% paraformaldehyde at room temperature for 15 
min. Then PBS was used to wash the composites and incubated with 2% BSA to block 
any non-specific binding. The cells were further stained with primary antibody Ker 10 
for 2 h at room temperature. Subsequently, the cell-scaffold composites were revealed 
with Alexa Fluor 594 (red) secondary antibody for 60 min at room temperature. After 
that, the samples were washed three times with PBS and treated with diluted filaggrin 
(1:100) for 2 h at room temperature. Then, the secondary antibody Alexa Fluor 488 
(green) was added for 60 min at room temperature. Finally, the samples were treated with 
DAPI after washing thrice with PBS and incubated for 30 min at room temperature. The 
stained samples were mounted on a glass slide and examined by LSCM. 
 
To confirm the differentiation of ASCs along the epidermal lineage, double 
immunostaining was performed. After 15 days, the cell-scaffold composites were washed 
with PBS, fixed with 2.5% paraformaldehyde. The ASCs on Gel/PLLCL/EIF(cs), 
Gel/PLLCL/EIF(b), Gelatin/PLLCL, PLLCL nanofibers and TCP for 15 days were 
blocked for nonspecific staining using 2% BSA then immunostained with ASC-specific 
marker CD 105 for 2 h at room temperature. Subsequently, the cell-scaffold composites 
were revealed with Alexa Fluor 488 (green) secondary antibody for 60 min at room 
temperature. After that, the samples were washed three times with PBS and treated with 
diluted Ker 10 (1:100) for 2 h at room temperature. Then, the secondary antibody Alexa 
Fluor 594 (red) was added for 60 min at room temperature. Finally, the samples were 
treated with DAPI after washing thrice with PBS and incubated for 30 min at room 
temperature. The stained samples were mounted on a glass slide and examined by LSCM. 
4.2.9 Morphology of differentiated ASCs 
 
Morphological evaluation of ASCs grown on electrospun Gel/PLLCL/EIF(cs), 
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Gel/PLLCL/EIF(b), Gelatin/PLLCL, PLLCL nanofibers and TCP using BEIM was 
performed after 15 days of cell culture by SEM. The cell-scaffold constructs were rinsed 
twice with PBS and fixed in 3% glutaraldehyde for 3 h. The scaffolds were further rinsed 
in deionized water and dehydrated with increasing concentrations of ethanol (50%, 70% 
90%, and 100%) for 10 min each. Finally, the cell-scaffold constructs were treated with 
hexamethyldisilazane and air dried in a fume hood overnight. 
4.2.10 Statistical analysis 
 
All the data presented are expressed as mean ± standard deviation (SD) of the mean. 
Each experiment was repeated three times. Statistical differences were determined by 
Student’s two-sample t test. Differences were considered statistically significant at p ≤ 
0.05.  
4.3 Results and discussion 
 
Electrospun nanofibers, with high porosity and large surface-to-volume ratio, can provide 
more structural space for accommodating the migrating and proliferating cells, enable 
sufficient nutrient delivery, gas exchange and waste excretion and at the same time, the 
small pore size of nanofibers can protect the wound from bacterial penetrations [15]. To 
improve the biofunctionality of electrospun naonfibers, core-shell nanofibers were 
fabricated by incorporating therapeutic growth factors as the core into the 
Gelatin/PLLCL shell, thereby protecting the growth factors from harsh chemical 
environment faced during the normal electrospinning of a polymer-solvent mixture. An 
enormous number of studies have shown the potential benefits of the topical treatment of 
wound using growth factor, such as EGF [252], basic fibroblast growth factor [253], etc. 
which enhanced the wound-healing ability in primate models and in clinical trials. In this 
study, we dissolved gelatin and PLLCL in HFP and electrospun core-shell naonfibers to 
deliver EIF in a sustained manner, and we aimed to retain the bioactivity of EIF within 
the core of the nanofibers, while avoiding direct contact of EIF with HFP. It is know 
from literature that HFP is effective in solubilizing a wide range of polymers and is 
widely used for the preparation of solutions for electrospinning. It has been suggested 
that collagen dissolved in HFP may result in structures composed merely of gelatin fibers 
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[254]. However, literature also revealed minor differences between the structures of 
electrospun collagen dissolved in HFP, in PBS, or in PBS/ethanol binary mixtures, 
indicating that the structural properties of collagens are retained even with the use of 
HFP [255]. Accordingly, unlike the structure of collagen, gelatin with its fibrillar 
structure and lack of internal structure will most likely retain its bioactivity within HFP 
compared to collagen. Moreover, in this study, we used a synthetic polymer PLLCL 
along with gelatin to fabricate a ‘composite’ scaffold of Gelatin/PLLCL, thereby 
increasing the mechanical stability while maintaining its bioactivity. 
4.3.1 Morphology, chemical and mechanical characterization of electrospun nanofibers 
 
Nanofibers of Gel/PLLCL/EIF(cs), Gel/PLLCL/EIF(b), Gelatin/PLLCL and PLLCL 
were fabricated by electrospinning and the fiber morphology was examined under 
scanning electron microscope (SEM). SEM micrographs of electrospun nanofibrous 
scaffolds revealed porous, beadless, nano-scaled fibrous structures under the optimized 
spinning conditions utilized during this study (Fig. 4.1A-D). Uniform nanofibers of 
Gel/PLLCL/EIF(cs), Gel/PLLCL/EIF(b), Gelatin/PLLCL and PLLCL with fiber 
diameters of 366 ± 125, 299 ± 46, 382 ± 100 and 456 ± 62 nm, respectively, were 
obtained. Applied with low pressure, capillary flow porometry provides a simple and 
non-destructive technique for rapid and accurate measurement of pore size [256, 257]. 
Therefore, capillary flow porometry can provide reproducible pore size measurements 
with ignorable distortion errors [218]. However, the fiber diameter and fiber mass plays a 
dominant role in controlling the pore diameter of the networks [218, 258]. The pore size 
as determined by capillary flow porometer, for the Gel/PLLCL/EIF(cs), 
Gel/PLLCL/EIF(b), Gelatin/PLLCL and PLLCL was 0.72, 0.51, 0.88 and 1.48 µm, 
respectively. In our study, the thickness of Gel/PLLCL/EIF(cs), Gel/PLLCL/EIF(b), 
Gelatin/PLLCL and PLLCL was kept identical at approximately 35 µm. The mean pore 
sizes obtained for the nanofibers were found inversely proportional to the diameter of the 
fibers and our results were also in agreement with the results reported by Li et al [218]. 
They found that at a given network mass per unit area and porosity, an increasing fiber 




PLLCL nanofibrous scaffolds were found to be highly hydrophobic with a contact angle 
of 136 ± 2 °C. However, with the incorporation of gelatin, the Gel/PLLCL/EIF(cs), 
Gel/PLLCL/EIF(b) and Gelatin/PLLCL nanofibers became more hydrophilic, with a 
contact angle of 25 ± 6 
0
, 35 ± 9 
0
 and 38 ± 2 
0
, respectively. The TEM images (Fig. 4.1E, 
4.1F) and laser scanning confocal microscopic (LSCM) images (Fig. 4.1G, 4.1H) of 
Gel/PLLCL/EIF(cs) and Gel/PLLCL/EIF(b) were respectively obtained.  
 
 
Fig. 4.1 Characterizations of electrospun nanofibers. SEM morphology of (A) 
Gel/PLLCL/EIF(cs), (B) Gel/PLLCL/EIF(b), (C) Gelatin/PLLCL and (D) PLLCL 
nanofibers. TEM micrographs of (E) Gel/PLLCL/EIF(cs), (F) Gel/PLLCL/EIF(b) and 
fluorescence microscopic images of (G) Gel/PLLCL/EIF(cs) with FITC-dextran in the 
core, (H) Gel/PLLCL/EIF(b) with FITC-dextran stained all over the fibers. (I) FTIR 
spectra of Gel/PLLCL/EIF(cs), Gel/PLLCL/EIF(b), Gelatin/PLLCL and PLLCL 




The core-shell structure of the Gel/PLLCL/EIF(cs) was clearly demonstrated in Fig. 4.1E 
and it was even more clearly disclosed by the application of FITC-dextran through 
LSCM. Fig. 4.1G shows that the electrospun nanofibers consisted of green core and a 
dark outer layer, and the boundary between the two produced a sharp distinction. Fig. 
4.1G suggested that EIF were encapsulated in the core area of the Gel/PLLCL/EIF(cs) 
and Fig. 4.1H suggested that EIF were uniformly distributed throughout the whole single 
fiber. Fig. 4.1I shows the ATR-FTIR spectra of electrospun Gel/PLLCL/EIF(cs), 
Gel/PLLCL/EIF(b), Gelatin/PLLCL and PLLCL nanofibers. The characteristic ester 
absorption peak of PLLCL was observed at 1760 cm
-1
, and C-O-C stretching vibrations 
were observed at 1097, 1133 and 1187 cm
-1
. The Gel/PLLCL/EIF(cs), Gel/PLLCL/EIF(b) 
and Gelatin/PLLCL nanofibrous scaffolds showed the characteristic amide I and amide II 
peaks of gelatin at 1650 cm
-1
 and 1550 cm
-1
 in addition to the characteristic peaks of 
PLLCL. The mechanical properties of electrospun nanofibrous scaffolds were studied 
and Fig. 4.1J shows the stress-strain curves of different electrospun nanofibers under 
tensile loading. Mechanical evaluations of all scaffolds in Fig. 4.1J show a linear 
segment up to the proportionality limit, followed by a non-linear curve, which was 
characterized by considerable elongation without a corresponding increase in loading 
stress. This feature is mainly attributed to fiber arrangement in the mat. The fiber 
arrangement in the mat is expected to change during the stress–strain measurement. It 
was demonstrated that fibers tend to align in the direction of applied force before getting 
thinner and finally the breaking occurs [186, 223]. The Young’s modulus of 
Gel/PLLCL/EIF(cs), Gel/PLLCL/EIF(b), Gelatin/PLLCL and PLLCL nanofibers was 
58.44 ± 6.35, 55.77 ± 18.92, 36.29 ± 7.24 and 24.66 ± 4.99 MPa, respectively. 
Comparing the stress-strain curves of gelatin containing nanofibrous scaffolds with those 
of the stress-strain curve of PLLCL in Fig. 4.1J, we found that the incorporation of 
higher amounts of gelatin to PLLCL led to a significant decrease in ultimate strain of the 
electrospun composite scaffolds (p ≤ 0.05). In our study, among the gelatin containing 
scaffolds, Gel/PLLCL/EIF(b) showed the highest ultimate tensile stress (followed by 
Gel/PLLCL/EIF(cs)). Wong et al. studied the effect of fiber diameter towards the tensile 
properties of electrospun fibers. They found that the effect of fiber diameter on tensile 
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strength became more predominant for fibers with diameters less than ~700 nm [259][40]. 
It was found that the crystalline morphology of electrospun nanofibers strongly 
influenced the mechanical properties of polymers [221, 222] and gelatin mainly 
contributes to the crystallinity of the electrospun membrane [220]. Lim and colleagues 
confirmed that the fibers with smaller diameter have higher degree of crystallinity and 
molecular orientation in the form of oriented fibrillar structure. The fibrillar structure 
would result in higher resistance to axial tensile force due to the higher degree of 
molecular orientation in the direction of applied stress [222]. This could be the reason for 
the higher strength of Gel/PLLCL/EIF(b) nanofibers compared to the other gelatin 
containing fibers. However, compared to pure PLLCL nanofibers, the gelatin containing 
nanofibers had a higher degree of molecular orientation and crystallinity, and thus higher 
elastic modulus with low ductility. The tensile properties of nanofibrous substrates are 
summarized in Table 4.1.  
 
Table 4.1 Tensile properties of the electrospun nanofibers 




58.44 ± 6.35 55.77 ± 18.92 36.29 ± 7.24 24.66 ± 4.99 
Tensile Stress 
(MPa) 
2.50 ± 0.01 2.65 ± 0.07 2.16 ± 0.02 3.18 ± 0.13 
Strain at break 
(%) 
62.61 ± 3.84 49.80 ± 2.53 77.63 ± 2.40 98.00 ± 3.93 
 
The tensile modulus of Gel/PLLCL/EIF(cs) (58.44 ± 6.35) was the highest among the 
different nanofibrous scaffolds of this study and the value lies well within the range of 
the tensile modulus of human skin (15-150 MPa) [260]. The tensile modules of 
Gel/PLLCL/EIF(cs) provides the scaffold with good resilience and compliance to 
movement as a skin graft. To further evaluate the potential of electrospun nanofibers as 
skin graft, the degradations of electrospun nanofibers were studied. Fig. 4.2A shows the 
morphological changes of different electrospun nanofibers after degradation in PBS at 
three different time points (day 5, 10 and 15). After 5 days of degradation, the gelatin 
containing nanofibers appeared to have swollen and lost their initial surface smoothness 
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compared to pure PLLCL fibers (Fig. 4.1D). After 10 days of degradation in PBS, the 
gelatin containing nanofibers had apparently swelled (Fig. 4.2A). This can be explained 
by the dissolution of gelatin in the buffer. However, after 15 days of degradation there 
were no further morphological changes observed on the fiber surfaces. Being a synthetic 
polymer, we did not observe any changes in the morphology of electrospun PLLCL 
nanofibers.  
 
Fig. 4.2 Release profiles of electrospun nanofibers and their effect on proliferation of 
ASCs. (A) Morphological changes of Gel/PLLCL/EIF(cs), Gel/PLLCL/EIF(b), 
Gelatin/PLLCL and PLLCL nanofibers after degradation in PBS for 5, 10 and 15 days. 
(B) Release profiles of EGF from Gel/PLLCL/EIF(cs) and Gel/PLLCL/EIF(b). (C) ASCs 
proliferation on electrospun Gel/PLLCL/EIF(cs), Gel/PLLCL/EIF(b), Gelatin/PLLCL 
and PLLCL nanofibers. 
*
Significant against cell proliferation on PLLCL at p ≤ 0.05; 




4.3.2 Drug release study 
 
It is believed that EGF stimulates the growth of keratinocytes in vivo and promotes the 
epidermal differentiation of stem cells in vitro, and it plays an important role in the 
process of wound healing [176, 260]. Coaxial electrospinning would provide an 
alternative and simple means to encapsulate drugs. With coaxial electrospinning, two 
components can be coaxially and simultaneously electrospun through different feeding 
the capillary channels to generate composite nanofibers in the form of core-shell 
structure. The controlled release of EGF from composite fibrous mats were studied and 
their release profiles from electrospun nanofibrous mats at a temperature of 37 °C and pH 
7.4 are shown in Fig. 4.2B. The experiments were performed in triplicate and the error 
bars indicate the standard deviation. The release profile of EGF was studied at three 
stages: an initial burst release (stage I), further a decreased release (stage II), followed by 
constant release (stage III).  
 
As shown in Fig. 4.2B, an initial burst release of EGF was observed within the first three 
days (stage I) from the Gel/PLLCL/EIF(b) scaffolds. From day 3 to day 6 (stage II) the 
release curves exhibited a decreasing release rate of EIFs. By day 15, the amount of EGF 
released from Gel/PLLCL/EIF(b) scaffolds reached 77.8%. For the Gel/PLLCL/EIF(b) 
fibers, which was prepared by blend spinning, the initial burst release can be attributed to 
the EGF that was located near the surface of the nanofibers. Fig. 4.2B also shows the 
cumulative release profiles of EGF from Gel/PLLCL/EIF(cs) and no burst release was 
observed within the first 3 days (stage I), and at the same time the release of EGF was 
stable and sustained. The amount of released EGF reached 50.9% after 15 days from 
Gel/PLLCL/EIF(cs) scaffolds. The initial burst release was apparently alleviated and the 
sustainability of nanofiber-based releasing devices was improved for Gel/PLLCL/EIF(cs) 
nanofibers. This conclusion is in agreement with the results obtained from other similar 
core-shell structured fibers [261]. The release of the proteins can be varied by altering the 
method of electrospinning, whether it is blending or coaxial electrospinning. Furthermore, 
the diffusion rate is affected by the method of protein loading. When the protein is 
encapsulated in the core of the fibers, the release profile follow a slow and steadily 
Chapter 4 
 81 
increasing profile, however, when the drug or protein is within the blended nanofiber, an 
initial burst release occurs at the beginning of the release process.  
4.3.3 ASCs proliferation on electrospun nanofibers 
 
The proliferation capacity of ASCs on electrospun Gel/PLLCL/EIF(cs), 
Gel/PLLCL/EIF(b), Gelatin/PLLCL and PLLCL nanofibrous scaffolds in BEIM after 5, 
10 and 15 days was determined by MTS assay (Fig. 4.2C). The presence of a natural 
ECM protein (gelatin) in Gelatin/PLCL nanofibers caused an increase in proliferation of 
ASCs on Gelatin/PLLCL nanofibrous scaffolds compared to those on PLLCL scaffolds. 
A still higher cell proliferation was obtained for both the EIF loaded scaffolds 
(Gel/PLLCL/EIF(cs) and Gel/PLLCL/EIF(b)); than the cell proliferation on 
Gelatin/PLLCL and PLLCL nanofibers. This can be attributed to the presence of EIF and 
its release from both the EIF loaded scaffolds, thus enhancing cell proliferation on them 
compared to the EIF-deprived scaffolds. After 15 days, the proliferation of ASCs on 
Gel/PLLCL/EIF(cs) was 43.6 % higher than the cell proliferation on Gel/PLLCL/EIF(b) 
and this is because of the different release profiles between Gel/PLLCL/EIF(cs) and 
Gel/PLLCL/EIF(b). BEIM was changed every 3 days to mimic the dynamic environment 
induced by body fluids. After 3 days, 44.9% EIF released from Gel/PLLCL/EIF(b) were 
removed during medium renewal (Fig. 4.2B). However, only 8.3% of EIF released from 
Gel/PLLCL/EIF(cs) were removed during medium renewal after 3 days. The initial loss 
of EIF in Gel/PLLCL/EIF(b) led to a lower cell proliferation on Gel/PLLCL/EIF(b) 
compared to the cell proliferation on Gel/PLLCL/EIF(cs) scaffolds. The results of the 
day 15 MTS assay also showed that the cell proliferation on Gel/PLLCL/EIF(cs) was 
63.4% and 95.0% higher (P ≤ 0.05) than the cell growth on Gelatin/PLLCL and PLLCL 
scaffolds, respectively. The percentage increase in the rate of cell proliferation on 
Gel/PLLCL/EIF(cs) and Gel/PLLCL/EIF(b) nanofibrous scaffolds from day 5 to day 15 
was found to be 560% and 404%, respectively.  
4.3.4 Induced epidermal morphology 
 
The epidermal differentiation capacity of ASCs was performed on all the electrospun 
nanofibrous scaffolds for a period of 15 days. Adipose tissue as a stem cell source is 
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ubiquitously available and has several advantages compared to other sources. It is easily 
accessible in large quantities with a minimal invasive harvesting procedure, and the 
isolation of ASCs yields a high amount of stem cells, which is essential for most of the 
stem cell-based therapies and accompanied tissue regeneration [262]. Moreover, ASCs 
have several advantages like (i) they are abundant, (ii) more accessible and (iii) have 
lower donor morbidity, especially from a clinical perspective where large cell numbers 
are required for regeneration, and it appears that ASCs are the most useful cell type than 
even the bone marrow derived mesenchymal stem cells. Here we studied the plasticity of 
ASCs towards epithelial cells on electrospun nanofibers. ASCs seeded with normal 
growth medium on TCP attached and remained undifferentiated with a fibroblastic 
phenotype (Fig. 4.3A). 
 
The epidermal differentiation capacity of ASCs on EIF incorporated ‘core-shell’ and 
‘blend’ fibers were studied in BEIM after 15 days and analyzed by immunostaining 
studies. The predominant EIF of skin tissue regeneration such as the EGF, insulin, 
hydrocortisone and RA were incorporated in Gel/PLLCL/EIF(cs) and Gel/PLLCL/EIF(b) 
scaffolds. Two types of antibodies were used to detect the expression of proteins specific 
to epidermal differentiation at two different stages: early (Ker 10) and intermediate 
(filaggrin). Expression of Ker 10 (Fig. 4.3B) and filaggrin (Fig. 4.3B) were observed 
after 15 days of cell culture on Gel/PLLCL/EIF(cs) and Gel/PLLCL/EIF(b) scaffolds. 
Direct observation of the cells under LSCM for Ker 10 (red) showed a filamentous 
cytoplasmic distribution. The same pattern of filaggrin distribution was observed after 
staining a green color (Fig. 4.3B). The distinguishable phenotypical features of 
keratinocyte-like cells were observed on Gel/PLLCL/EIF(cs) in BEIM. However, only a 
few cells showed polygonal and round morphologies on the Gel/PLLCL/EIF(b) in BEIM. 
This could also be due to the differences in the release profiles of the EIF occurring from 
core-shell and blended fibers. Briefly, the initial loss of EIF in Gel/PLLCL/EIF(b) led to 
insufficient cell differentiation on Gel/PLLCL/EIF(b) compared to the cell differentiation 
on Gel/PLLCL/EIF(cs) scaffolds. And hence, more keratinocyte-like cells were observed 
on Gel/PLLCL/EIF(cs) scaffolds. The 3D expression of Ker 10 and filaggrin (Fig. 4.3C) 




Fig. 4.3 Protein expression and cell morphology studies. (A) Laser scanning confocal 
microscope (LSCM) image of undifferentiated ASCs stained with CD 105 on TCP and 
SEM image showing the cell morphology, observed on day 15. (B) Two dimensional 
immunostaining images show the expression of Ker 10, filaggrin and the merged image 
on electrospun Gel/PLLCL/EIF(cs), Gel/PLLCL/EIF(b) at 60 x magnification. (C) Three 
dimensional immunostaining images show a filamentous cytoplasmic distribution of Ker 
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10 (red) and filaggrin (green). (D) SEM images of epidermally differentiated ASCs on 
Gel/PLLCL/EIF(cs) and Gel/PLLCL/EIF(b); undifferentiated ASCs on Gelatin/PLLCL, 
PLLCL and TCP. 
 
Fig. 4.3D shows the comparative SEM images of ASCs on Gel/PLLCL/EIF(cs) and 
Gel/PLLCL/EIF(b) after 15 days of differentiation time. There were more ASCs on 
Gel/PLLCL/EIF(cs) and they acquired polygonal and round morphologies compared to 
the cells on Gel/PLLCL/EIF(b). However, ASCs on Gelatin/PLLCL, PLLCL and TCP 
remained undifferentiated with a fibroblastic phenotype. Fig. 4.4 shows the results of 
dual immunocytochemical analysis of ASCs on all the different electrospun scaffolds and 
TCP. The total cell number was obtained by counting the total number of cell nuclei 
(blue). Cells were stained for ASC-specific marker CD 105, while epidermally 
differentiated cells were counted based on the expression of Ker 10 (red stain). The 
percentage of differentiated epidermal cells on the Gel/PLLCL/EIF(cs) and 
Gel/PLLCL/EIF(b) were calculated, which gave figures of 62.2% and 43.0%, 
respectively. Due to the absence of EIF, very little expression of Ker 10 was observed for 
ASCs on Gelatin/PLLCL, PLLCL nanofibrous scaffolds and TCP in BEIM. ASCs on 
Gel/PLLCL/EIF(cs) showed less CD 105 expression compared with ASCs on 
Gel/PLLCL/EIF(b) (Fig. 4.4C and 4.4G). This also demonstrated that a higher percentage 
of ASCs on Gel/PLLCL/EIF(cs) differentiated to keratinized epithelial cells, compared 
with those on Gel/PLLCL/EIF(b). The results of our immunocytochemical studies 
proved that the electrospun Gel/PLLCL/EIF(cs) can act as a suitable substrate for 
epidermal differentiation of ASCs. Our findings also indicate that the differentiated ASCs 
were in the early and intermediate stages of epidermal differentiation. The studies open 
up new opportunities for transplantation of wound healing mediators containing 





Fig. 4.4 Dual immunocytochemical analysis for the expression of Ker 10, CD 105 and 
merged image showing the dual expression of both CD 105 and Ker 10 on (A-D) 
Gel/PLLCL/EIF(cs); (E-H) Gel/PLLCL/EIF(b); (I-L) Gelatin/PLLCL; (M-P) PLLCL and 
(Q-T) TCP at 20 × magnification. 
 
4.4 Conclusion  
 
In the present study, a few major epidermal induction factors were incorporated into 
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polymeric gelatin-PLLCL solutions to obtain core-shell and blended nanofibers and the 
results of the release studies demonstrated that the core-shell nanofibers achieved 
sustained release without burst release. The expression of early and intermediate 
epidermal differentiation markers was observed by performing the differentiation of 
ASCs to epidermal lineages on both Gel/PLLCL/EIF(b) and Gel/PLLCL/EIF(cs). With 
sustained release of EIF from Gel/PLLCL/EIF(cs), the percentage of epidermally 
differentiated ASCs on core-shell nanofibers was significantly higher than that on 
Gel/PLLCL/EIF(b). Our study not only provides insight into the design of a site-specific 
niche-like microenvironment for ASCs epidermal differentiation, but also sheds light on 







Electrospun photosensitive nanofibers for photocurrent 




Human skin acts as an anatomical barrier from pathogens and damage between the 
internal and external environment in bodily defense and it plays a key role in protecting 
the body against excessive water loss [44, 53]. However, skin wounds such as burn 
injuries cause millions of patients to remain disabled and it also requires hospitalization 
[233, 263]. Several bioengineered grafts including the autografts and xenografts have 
been employed to cure skin wound, and autografts have been regarded as the golden 
standard for treating full-thickness wounds. However, problems associated with limited 
donor sites restrict the application of autografts [264]. Skin tissue-engineering (TE) 
involves the use of scaffolds that support cell attachment and proliferation, together with 
the formation of skin tissue-like structure to substitute the skin [265]. Photocurrent 
therapy with participation of light and electrical stimulations could be an innovative and 
promising approach in skin regenerative medicine [266]. The effects of electrical and 
photic signals on cell behaviors have been studied for a long time and the main signals 
used for electrical stimulation (ES) are DC electrical signal, pulsed cathodal electrical 
signal and electromagnetic field. DC electrical signal was found to be a directional cue 
which can significantly affect the spatial organization of the vascular structure [267]. 
Feedar et al found that a pulsed cathodal ES has a beneficial effect on healing chronic 
dermal ulcer [268]. Three types of electromagnetic fields (inductive coupling, capacitive 
coupling, and combined electromagnetic fields) were applied by Brighton et al. to 
stimulate bone cells. A significant increase in DNA content was achieved by stimulation 
of these electromagnetic fields compared to the controls without stimulation [269]. 
Concurrently, phototherapy is the therapy in the presence of light irradiation and clinical 
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application of phototherapy or the therapeutic applications of light has been increased 
over the recent years. Accelerated repair of chronic skin wounds was realized by the 
stimulation from near-infrared (600-700 nm) and infrared (700-1200 nm) light delivered 
through light-emitting diodes or lasers [270]. Phototherapy can reduce inflammatory 
reactions; increase the production of basic fibroblast growth factor; enhance cell 
proliferation and accelerate cutaneous wound healing [271]. With electrotherapy and 
phototherapy having positive effects on regenerative medicine, it is also thought that 
photocurrent (the current generated under light stimulation) could be a promising method 
which can be applied in regenerative medicine. 
 
Aiming to prepare a suitable scaffold for photocurrent therapy in skin TE, we fabricated 
photosensitive nanofibrous scaffolds by electrospinning. Electrospinning is capable of 
producing continuous fibers with diameters down to nanometers to mimic the fiber size 
and orientation of in vivo extracellular matrix (ECM) [168]. Poly (3-hexylthiophene) 
(P3HT) is one of the most promising photovoltaic polymers and it shows great promise 
for a range of applications, including organic LEDs and photocurrent therapy [272]. It is 
used in polymer-based photovoltaic cells mainly because P3HT possess a high absorption 
coefficient close to the maximum photon flux in the solar spectrum and high 
charge-carrier mobility [273]. However, electrospinning of pure P3HT (though 
attempted), is not possible mainly due to the absence of chain entanglement [272, 274]. 
Polycaprolactone (PCL) is a bio-resorbable and biocompatible polymer, and it has been 
studied as a wound dressing material since 1970s. Extensive research has been conducted 
on its biocompatibility and efficacy, both in vitro and in vivo, resulting in FDA approval 
of a number of medical and drug delivery devices composed of PCL [191]. Polymer 
blending is one of the most effective methods for preparing desirable biocomposite 
scaffolds for particular applications [275] and during this study we blended PCL with 
P3HT to fabricate PCL/P3HT nanofibers via electrospinning. The chemical, mechanical 
and photovoltaic characteristics of the electrospun nanofibers, together with its cell 
biocompatibility evaluations were carried out. Our study results demonstrated that the 
PCL/P3HT(10) could be a promising scaffold for tissue engineering, especially in 
photocurrent induced skin tissue regeneration. 
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PCL (Mw 80,000), P3HT (Mw 45,000-65,000, Aldrich 99.995 %), chloroform, methanol, 
dimethyl sulfoxide (DMSO) and phalloidin (Fluorescein Isothiocyanate Labeled) were all 
obtained from Sigma-Aldrich Pte Ltd., Singapore and used as received. Dulbecco’s 
Modified Eagle’s Medium (DMEM), fetal bovine serum (FBS), penicillin-streptomycin 
solution and 4,6-diamidino-2-phenylindole, dihydrochloride (DAPI) were purchased 
from Invitrogen Corporation, USA. 
5.2.2 Electrospinning of PCL/P3HT nanofibers 
 
PCL and P3HT with three different weight ratios (150:2, 150:10 and 150:20) were 
dissolved in chloroform/methanol/DMSO (75/20/5 v/v) to obtain 9 % (w/v) solution, 
each. The solutions were individually placed in a 3 ml standard syringe attached with 
blunted steel needles with 27 G inner diameters. Then, the solution loaded syringe was 
located in a syringe pump (KDS 100, KD Scientific, Holliston, MA) at a flow rate of 1.0 
ml h
-1
. Nanofibers were fabricated via electrospinning at 15 kV (Gamma High Voltage 
Research, Ormond Beach, FL) and collected on an aluminum foil wrapped flat grounded 
steel plate at a distance of 12 cm from the needle tip. A vacuum desiccator was used to 
evaporate residual solution of the nanofibers collected on 15 mm coverslips.  
Hereafter, in this manuscript P3HT containing PCL nanofibers with three different weight 




UV-Vis spectra of the polymer solutions were measured using Shimadzu UV-3600 
UV-Vis-NIR spectrophotometer after dispersing the materials in chloroform and 
methanol (75/25 v/v). FESEM (FEI-QUANTA 200F, Netherlands) was used to study the 
morphology of the electrospun nanofibers at an accelerating voltage of 15 kV, after 
sputter coating with gold (JEOL JFC-1200 fine coater, Japan). The obtained SEM images 
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were applied to obtain the diameters of the electrospun fibers using image analysis 
software (Image J, National Institutes of Health, USA). The pore size and distribution of 
each electrospun nanofibers was evaluated by a CFP-1200-A capillary flow porometer 
(PMI, New York, NY). The wetting agent used for porometry measurements is Calwick 
with a defined surface tension of 15.9 dynes/cm (PMI, New York, NY). Nanofibers with 
similar size (3 cm × 3 cm) and thickness were obtained and each sample was tested 
individually. The J-V characteristics of and the different PCL/P3HT composite nanofibers 
were recorded under inert atmosphere and at room temperature using a calibrated San-Ei 
XES-151 S (Japan) class A solar simulator under standard conditions (1 Sun, 1.5 G). 
Before test, The FTO plate having the photosensitive nanofiber was pressed against an 
aluminium (Al) sputtered FTO using binder clips and connected to stimulator with wires. 
Photoluminescence (PL) spectra were recorded using the photonic multichannel spectral 
analyzer (Hamamatsu Photonics K.K., PMA 11) and the wavelength of the excitation 
beam was set between 380 and 420 nm.  
5.2.4 Human dermal fibroblast culture 
 
This method is the same to that mentioned in section 3.2.4. 
5.2.5 Light stimulation 
 
To study the effects of different amount of P3HT incorporated in PCL nanofibrous 
scaffolds on fibroblast proliferation under light stimulation, illumination of human dermal 
fibroblasts on PCL, PCL/P3HT(2), PCL/P3HT(10) and PCL/P3HT(20) was performed 
using white color light emitting diodes (LEDs) (DIODER Lighting strip, IKEA, 
Singapore). The calibration of LEDs was performed with a USB 2000 spectrometer 
(Ocean optics, FL, USA). The wavelength of white LED is 421 to 670 nm, within the 






Fig. 5.1 Schematic explanation of the method used for light irradiation on cell-scaffold 
constructs. PCL (white) and P3HT containing nanofibrous scaffolds (purple) were put in 
24 well plates and directly located under LED. 
 
After seeding cells, the 24 well plates containing cell-scaffold composites were directly 
located under LEDs. Light stimulation study was carried out for 6 days and fibroblasts on 
PCL, PCL/P3HT(2), PCL/P3HT(10) and PCL/P3HT(20) were irradiated for 1 hour once 
every 24 hours. After culturing the cells for a period of 6 days, cell proliferation was 
evaluated after light stimulation by colorimetric MTS assay (CellTiter 96 AQueous One 
solution, Promega, Madison, WI). After culturing the cells for a period of 2, 4 and 6 days, 
cells were rinsed with PBS to remove unattached cells and incubated with 20 % MTS 
reagent in serum free medium for a period of 3 hrs at 37 °C. Absorbance of the obtained 
dye was measured at 490 nm using a spectrophotometric plate reader (FLUOstar 
OPTIMA, BMG lab Technologies). The absorbance of the formazan dye is measured at 
490 nm and the amount of formazan crystals formed is directly proportional to the 
number of live cells. As a control, cells were also cultured on the scaffolds under 
non-stimulative conditions to understand the specific effect of light stimulation towards 
cell proliferation after seeding cells on the same scaffolds. 
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5.2.6 F-actin staining 
 
This method is the same to that mentioned in section 3.2.6. 
5.2.7 Expression of collagen  
 
This method is the same to that mentioned in section 3.2.7. 
5.2.8 Statistical analysis 
 
All the data presented are expressed as mean ± standard deviation (SD) of the mean. Each 
experiment was repeated three times. Statistical differences were determined by Student’s 
two-sample t test. Differences were considered statistically significant at p ≤ 0.05.  
5.3 Results and discussion 
5.3.1 UV-vis spectra  
 
Fig. 5.2 shows the UV-vis absorption spectra of PCL, PCL/P3HT(2), PCL/P3HT(10) and 
PCL/P3HT(20) in chloroform and methanol. No absorption peak was observed for PCL 
solution. Evidently, an increase in P3HT concentration resulted in an increase in the 
intensity of bands in the UV-vis spectra for PCL/P3HT(2), PCL/P3HT(10) and 
PCL/P3HT(20) solutions. The surface plasmon absorption bands for P3HT containing 
PCL solutions were centered around 410 nm, which is characteristic of the π–π* 
transition [274]. Moreover, the absorption wavelength of P3HT (410 nm) lies within the 
range of the visible light (390 to 750 nm). The most common visible light that we 
encounter daily in our life is the day light (sunlight) and half of its spectrum lies in the 
visible short-wave region of the electromagnetic spectrum. Human skin is the outer 
covering of the body and it is under the frequent exposure of sunlight. Photocurrent 
therapy with PCL/P3HT nanofibers for skin TE could be very feasible if carried out 






Fig. 5.2 UV-Visible absorption spectra of pure PCL, PCL/P3HT(2), PCL/P3HT(10), and 
PCL/P3HT(20) solutions dispersed in chloroform and methanol (75/25 v/v). The 
concentration of each solution was 9 % (w/v). 
 
5.3.2 Morphology and characterization 
 
SEM micrographs of the electrospun nanofibrous scaffolds revealed uniform, beadless, 
nano-scaled fibrous structures under the optimized spinning conditions utilized during 
this study (Fig. 5.3). Uniform nanofibers of PCL, PCL/P3HT(2), PCL/P3HT(10) and 
PCL/P3HT(20) with fiber diameters in the range of 608 ± 168, 503 ± 116, 424 ± 128 and 
314 ± 101 nm, were respectively obtained. The diameters of PCL/P3HT nanofibers 
decreased with the increase of P3HT concentration in PCL solutions. P3HT is a 
photosensitive and conductive polymer and including P3HT in PCL solution will improve 
the conductivity of the solution [274]. The increase of P3HT concentration in PCL 
solution resulted in increased conductivity of the solutions and under the same 
electrospinning conditions, the high conductivity of the P3HT containing polymer 
solution favored the formation of fibers with smaller diameters [276, 277]. Hence the 
PCL/P3HT(20) had smaller fiber diameters compared to PCL/P3HT(10) than 
PCL/P3HT(2). The porosity of the electrospun scaffolds was studied by capillary flow 
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porometer (CFP-1200-A) and the pore size of PCL, PCL/P3HT(2), PCL/P3HT(10) and 
PCL/P3HT(20) was obtained as 4.3 µm, 3.0 µm, 2.1 µm and 1.9 µm, respectively. 
Capillary flow porometry can provide a simple and non-destructive technique to mesure 
pore size and distribution of electrospun nanofibrous scaffolds [217, 278]. It was found 
that fiber mass and diameter can significantly affect the pore diameter of the networks 
[218, 258]. In our study, the thickness of PCL, PCL/P3HT(2), PCL/P3HT(10) and 
PCL/P3HT(20) was kept identical (approximately 35 µm). The mean pore sizes obtained 
for the nanofibers were found inversely proportional to the diameter of the fibers and our 
results were also in accordance with the results reported by Li et al [258]. Uniform 
distribution of pore sizes was observed for PCL, PCL/P3HT(2), PCL/P3HT(10) and 
PCL/P3HT(20) (Fig. 5.3). 
 
 
Fig. 5.3 SEM images of electrospun (A) PCL/P3HT(2), (B) PCL/P3HT(10), (C) 
PCL/P3HT(20) and (D) PCL nanofibers and pore size distribution of i) PCL/P3HT(2), ii) 




Photoluminescence (PL) is a process in which a substance absorbs photons and then 
re-radiates photons. PL spectra of electrospun nanofibers were collected to probe into the 
electronic states of the P3HT present in the scaffolds. Fig. 5.4 shows the 
photoluminescence spectra of electrospun PCL, PCL/P3HT(2), PCL/P3HT(10) and 
PCL/P3HT(20) nanofibrous scaffolds. Spectra of every electrospun scaffolds containing 
P3HT indicated the same maximum emission intensity, at 699 nm. Chan et al. studied the 
structure of electrospun and casted P3HT membranes via PL spectroscopies and found the 
occurrence of blue shift in the PL spectra for electrospun P3HT membranes compared to 
cast film due to the presence of nano-voids in the electrospun fibers [279]. In our study, 
no blue or red shifts were observed. A broader peak was observed in the emission 
spectrum of PCL/P3HT(20) compared to PCL/P3HT(10) than PCL/P3HT(2). The 
broadening of the peak can be correlated to the existence of a large distribution of P3HT 
within PCL nanofibers.  
 
 
Fig. 5.4 PL spectra for PCL, PCL/P3HT(2), PCL/P3HT(10) and PCL/P3HT(20) under 




The relative peak intensity of electrospun PCL/P3HT nanofibers was directly proportion 
to the amount of P3HT included in the PCL nanofibers. No emission intensity was 
however observed for electrospun PCL nanofibrous scaffolds. We therefore presumed 
that the P3HT was successfully conjugated with PCL within the nanofibers upon 
electrospinning. 
5.3.3 Photovoltaic study 
 
P3HT is a conjugated material with a band gap of 1.9-2.0 eV [280]. Upon illumination, 
certain electrons were generated due to the photosensitive properties of electrospun 
PCL/P3HT(2), PCL/P3HT(10) and PCL/P3HT(20), which was evaluated using a 
calibrated San-Ei XES-151 S (Japan) class A solar simulator. P3HT absorbs photons of 
light with appropriate wavelength (around 410 nm) and gets promoted to a higher energy 
level called the HOMO (highest occupied molecular orbital). The electrons getting to the 
HOMO level have high mobility in the delocalized orbitals of P3HT and they are free to 
move within a small space in P3HT chains based on the particle in a box model, similar 
to the movement of a particle free to move in a small space surrounded by impenetrable 
barriers. When the photoinduced electrons move within the P3HT chains, an electrical 
current is formed. Initial measurements of the current density versus voltage (J-V) of the 
PCL/P3HT(2), PCL/P3HT(10) and PCL/P3HT(20) were carried out under standard 
operating conditions (1 Sun, 1.5G) and showed in Fig. 5.5. The ‘efficiency’ which 
determines the amount of radiated quantity of light that is converted into useable 











respectively. The efficiency of photosensitive 
nanofibrous scaffolds was proportion to the amount of P3HT incorporated in the PCL 
nanofibers (Fig. 5.5A). The low efficiency of the photosensitive nanofibers can be 
explained due to the structure change of P3HT chains. The P3HT polymer chains exist in 
two resonant structures [281]: aromatic (i) and quinoid (ii), as shown in Fig. 5.5B. When 
the polymer chains gets more disordered, the aromatic structure becomes more favorable 
compared to quinoid structure, because the adjacent rings in A are connected by a single 
bond making the chains more flexible and this was inferred during our studies too, when 





Fig. 5.5 (A) J-V graph of the PCL/P3HT(2), PCL/P3HT(10) and PCL/P3HT(20) 
photosensitive scaffolds measured under 1 Sun conditions. (B) the resonant structures, (i) 
aromatic and (ii) quinoid, of poly (3-alkylthiophenes) chains 
 
This implies that even if the charge transfer occurs, the effect of disordering might 
overcome the effect of charge transfer [282] and as a result, less electrons might get 
transited to the electron acceptor. Photocurrent was thus generated in the fiber, though of 
low intensity and this amount was sufficient to meet the essential requirement for 
application of electrospun photosensitive scaffolds in photocurrent therapy. 
5.3.4 Light stimulation  
 
The effect of light stimulation as well as the effect of different amounts of P3HT 
incorporated within the PCL scaffolds towards the proliferation of HDFs was evaluated 
by MTS assay (Fig. 5.6). In non-stimulated (NS) conditions, the proliferation of HDFs on 
PCL nanofibrous scaffold showed higher fibroblast proliferation compared to the 
proliferation of HDFs on PCL/P3HT(2), PCL/P3HT(10) and PCL/P3HT(20). Moreover, 
the proliferation of HDFs on PCL/P3HT(20) non-stimulated showed the lowest 
proliferation of cells due to higher amounts of P3HT present in PCL/P3HT(20). Hence, it 
was clear that the biocompatibility of P3HT containing PCL naonfibrous scaffolds is not as 
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good as pure PCL nanofibrous scaffold. 
 
 
Fig. 5.6. (A) HDF proliferation on electrospun PCL, PCL/P3HT(2), PCL/P3HT(10) and 
PCL/P3HT(20) nanofibrous scaffolds stimulated (S) compared to HDF proliferation on 
electrospun PCL/P3HT(2), PCL/P3HT(10), PCL/P3HT(20) and PCL nanofibrous 
scaffolds non-stimulated (NS) by MTS assay. 
*
Significant against cell proliferation on 
TCP (NS) at p ≤ 0.05; 
◆
Significant against cell proliferation on PCL/P3HT(2) (S) at p ≤ 
0.05. 
#
Significant against cell proliferation on PCL/P3HT(20) (S) at p ≤ 0.05. 
※
Significant against cell proliferation on PCL/P3HT(10) (NS) at p ≤ 0.05. ▼Significant 
against cell proliferation on PCL/P3HT(10) and PCL (S) at p ≤ 0.05. 
☆
Significant against 
cell proliferation on PCL/P3HT(10) and PCL (NS) at p ≤ 0.05. (B) Growth rate of cells on 
stimulated PCL/P3HT(2), PCL/P3HT(10), PCL/P3HT(20), PCL and TCP with respect to 
the non-stimulated scaffolds on day 2, day 4 and day 6. 
 
However, the proliferation of HDFs under light stimulation (S) on PCL/P3HT(10) was 
significantly higher compared to the cell proliferation on other nanofibrous scaffolds. The 
ability of the photosensitive PCL/P3HT(10) in promoting the proliferation of HDFs was 
further confirmed after 6 days of MTS studies. It was demonstrated by Desmet et al. that 
light stimulation itself can promote cell proliferation [271]. However, the cell proliferation 
on TCP under light stimulation after 6 days, was merely 5.4 % (p ≤ 0.05) higher compared 
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to cell proliferation on the non-stimulated TCP. On the other hand, the extent of cell 
proliferation was greatly improved by the combination of light stimulation with 
assistance of photosensitive P3HT containing scaffolds. Using PCL/P3HT(10) as the 
substrate, we found higher proliferation (25.5 %) of HDFs (p ≤ 0.05) under stimulated 
conditions compared to cell proliferation in non-stimulated (NS) conditions. The 
significant increase in cell proliferation on PCL/P3HT(10) scaffold was due to the 
photosensitive ability of PCL/P3HT(10) nanofibers under light stimulation. Meanwhile, 
the cell proliferation on stimulated PCL/P3HT(10) scaffolds was 16.1 % higher compared 
to HDF proliferation on non-stimulated PCL. This result also supported the fact that the 
incorporation of optimized amount of P3HT in PCL/P3HT(10) favored cell proliferation 
through light stimulation. Furthermore, the proliferation of HDFs on PCL/P3HT(10) 
showed 12.8 % ,11.9 % and 11.6 % (p ≤ 0.05) higher than the cell growth on PCL, 
PCL/P3HT(2) and PCL/P3HT(20) under light stimulated conditions, respectively (Fig. 
5.6A). After 2, 4 and 6 days, the growth rate of cells on stimulated PCL/P3HT(2), 
PCL/P3HT(10), PCL/P3HT(20), PCL and TCP with respect to the non-stimulated 
scaffolds was also calculated (Fig. 5.6B). The proliferation of HDFs on day 2 and day 4 
for light stimulated PCL scaffolds was less compared to HDFs proliferation on 
non-stimulated PCL. This could be because of the absence of P3HT (photosensitive 
material) within this scaffold. The inference was confirmed as we observed a similar 
effect on the scaffolds that contained minimum amounts of P3HT of our study, namely 
the PCL/P3HT(2) on day 2, which further picked up in its cell proliferation from day 4 
onwards. By day 6, we observed that the growth of cells on all the stimulated scaffolds 
was higher compared to cells on corresponding non-stimulated scaffolds. Moreover, the 
cell proliferation on stimulated PCL/P3HT(10) scaffolds demonstrated both higher cell 
number and cell growth rate compared to the non-stimulated PCL. In conclusion, the 
amount of P3HT included in PCL/P3HT(10) was the optimized amount, most suitable 
scaffold for performing light stimulative regenerative experiments and regenerative 
medicine.  
 
The morphology of HDFs on electrospun PCL and PCL/P3HT(10) nanofibrous scaffolds 
was studied after 6 days light stimulation and the results are shown in Fig. 5.7. Fibroblasts 
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attached on the scaffolds and stretched across the nanofibrous substrates upon 
proliferation. The number of cells that attached on PCL/P3HT(10) stimulated was higher 
than the number of cells attached on the same scaffold non-stimulated. Fibroblasts attached 
on PCL/P3HT(10) under light stimulation showed a characteristic spindle shape (Fig. 
5.7A); however, fibroblasts attached on PCL and PCL/P3HT(10) nanofibrous scaffolds in 
non-stimulated conditions showed irregular morphology (Fig. 5.7D and 5.7E). From the 
SEM micrographs, we further established the non-toxicity of the PCL/P3HT(10) with 
successful adherence and proliferation of HDFs on PCL/P3HT(10) substrates under light 
stimulation, and confirmed their morphologies. 
 
 
Fig. 5.7. SEM images of HDFs on electrospun (A) PCL/P3HT(10) (S), (B) PCL (S), (C) 
TCP (S), (D) PCL/P3HT(10) (NS), (E) PCL (NS) and (F) TCP (NS). 
 
The explanatory mechanism of action could be such that the photosensitive polymer 
P3HT absorbs light (proved by UV-vis spectra), and photo-induced current was further 
generated in the P3HT containing PCL fibers (shown as J-V curve), while the 
electromagnetic field was created. When the cells were stimulated by the electromagnetic 
field, Ca
2+
 ions translocated through the cell-membrane voltage-gated calcium channels 
[283] and this led to an increase in cytosolic Ca
2+
. The cytosolic Ca
2+
 would complex 
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with the low molecular weight protein calmodulin, which then activated several key 
intracellular processes leading to cell division [284]. Calmodulin was also thought to play 
a role in regulating the initiation of DNA synthesis. The increase in calmodulin-binding 
proteins in the nuclear fraction of cells stimulated cell proliferation [285]. As a result, the 
increase in cytosolic Ca
2+
 led to an increase in cell proliferation (Fig. 5.8 Green line). The 
effects of light (low power laser and light emitting diode) stimulation on cell behavior 
were studied during the past few years and many mechanisms were proposed and one 
such mechanism was that the light irradiation (He-Ne laser, 632.8 nm) could induce the 
phosphorylation of tyrosine protein kinase receptor (TPKR) such as c-Met, receptor of 
hepatocyte growth factor [286, 287]. After phosphorylation, TPKR will become an 
activated TPKR and it could promote the catalytic activity of phospholipase C 
(PLC)-gamma. The activated PLC c catalyzes the hydrolysis of some phospholipids 
which contain diacylglycerol (DAG) and inositol triphosphate (IP3). Further the 
concentration of DAG and IP3 increase in the cytoplasm and the IP3 encourage the 
endoplasmic reticulum (ER) to release Ca
2+
, which works with DAG to activate protein 
kinase C (PKC) [288, 289]. These are the routes through which PKCs are involved in 
improving the cell proliferation [288, 290] (Fig. 5.8).  
 
 
Fig. 5.8 Signal pathway involved in light stimulation induced cell proliferation (Black 
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line) and photocurrent induced cell proliferation (Green dotted line) 
 
Minana et al. have previously shown that PKC inhibitors, namely H7 and calphostin C 
prevent the proliferation of primary cell cultures [291]. Similar results were also shown 
by Yoshimura et al. where they found that the proliferation of Schwann cells was 
significantly inhibited by staurosporine, a PKC inhibitor [292]. Instead of inhibiting PKC, 
light stimulation activated PKC and improved the cell proliferations and this was also 
confirmed in our study, where we found higher HDF proliferation on PCL/P3HT(10) 
after light stimulation by MTS assay. It was proved that the biocompatibility of P3HT 
containing PCL naonfibrous scaffolds were not as good as pure PCL nanofibrous scaffold. 
As a result, the amount of P3HT that might be optimum enough to be non-toxic to cells and 
support the proliferation of cells after light stimulation was considered necessary to be 
investigated in detail. Therefore, we followed a novel approach of incorporating various 
amounts of P3HT in PCL and studied the proliferation of fibroblasts cultured on P3HT 
containing nanofibrous scaffolds. Our results demonstrated that the PCL/P3HT(10) 
favored cell proliferation after light stimulation and could be a suitable substrate for 
wound healing. Therefore performed cell-scaffold interaction studies on PCL/P3HT(10) 
by SEM, F-actin staining and collagen expression and such studies were not carried out 
on PCL/P3HT(2) and PCL/P3HT(20). 
5.3.5 F-actin staining 
 
To understand the interaction of fibroblasts with PCL/P3HT(10) and PCL nanofibrous 
scaffolds under light stimulation, phalloidin staining was carried out. Phalloidin is a 
bicyclic peptide that belongs to a family of toxins isolated from the deadly Amanita 
phalloides “death cap” mushroom and is commonly used in imaging applications to 
selectively label filamentous actin in fixed cells [293]. Phalloidin staining was carried out 
after 6 days of light stimulation and the F-actin stains showed a cytoplasmic filamentous 
distribution under LSCM. It was found that the cell density of proliferated HDF under light 
stimulation (Fig. 5.9A-C) was higher compared to HDFs proliferated under non-stimulated 





Fig. 5.9 Laser scanning confocal microscopic (LSCM) micrographs of HDFs grown on 
(A) PCL/P3HT(10) (S), (B) PCL (S), (C) TCP (S), (D) PCL/P3HT(10) (NS), (E) PCL 
(NS) and (F) TCP (NS), expressing F-actin.  
 
We observed that the cell density and morphology was better on PCL/P3HT(10) under 
light stimulation compared to other electrospun nanofibrous scaffolds (Fig. 5.9). The 
spindle shaped morphology of the HDFs on PCL/P3HT(10) under light stimulation (Fig. 
5.9A) was comparable to its phenotype on tissue culture plate (Fig. 5.9C). HDFs attached 
on PCL/P3HT(10) under light stimulation showed sufficient cell to cell communication. 
However, HDFs attached on PCL/P3HT(10) non-stimulated (Fig. 5.9D) showed limited 
cell-cell communication with limited distribution of cells. As a result, the cell density on 
PCL/P3HT(10) non-stimulated was lower than the cells proliferated on the same scaffold 
under light stimulation.  
5.3.6 Collagen expression 
 
Collagen staining with Picro-sirius red confirmed the secretion of ECM by the cells in 
culture. Fig. 5.10 shows the secretion of collagen on fibroblasts grown on PCL and 





Fig. 5.10 Collagen staining on fibroblasts on nanofibrous scaffolds: A) PCL/P3HT(10) 
(S), (B) PCL (S), (C) TCP (S), (D) PCL/P3HT(10) (NS), (E) PCL (NS) and (F) TCP 
(NS).  
 
Results showed that the secretion of collagen on PCL/P3HT(10) under light stimulation 
was better than other scaffolds. HDFs proliferated on PCL/P3HT(10) under light 
stimulation showed highest amount of collagen stains. Huang et al. evaluated the 
influence of LED photoirradiation (LED-PI) on fibroblast proliferation and collagen 
production in vitro and found that the collagen production increased significantly with 
LED-PI [294]. It was also found that electrical stimulation (ES) promoted collagen 
synthesis. Morris et al. developed the Ahn/Mustoe lapine wound model for systematic 
investigation of the effects of ES on ischemic wound therapy. Both type I collagen 
(COL-I) and type V collagen (COL-V) showed significantly higher expressions between 
day 7 and day 14 over a longer duration of electrical pulse treatment [130]. In our study 
we found that the higher cell proliferation on PCL/P3HT(10) under light stimulation 
contributed to increased collagen stains on these scaffolds. However, no obvious collagen 
stains were observed on TCP. The secretion of collagen on PCL/P3HT(10) proves the 
biocompatibility of PCL/P3HT(10) stimulated under light stimulation and its ability to 
induce cells for collagen expressions, thus potentially suitable as substrates for wound 




Polymeric nanofibers are studied individually for skin TE and the photovoltaic property 
of solar cells has also been separately investigated by various researchers. However, to 
the best of our knowledge, there are no studies that focused on the application of 
nanofibrous scaffold with photovoltaic ability for tissue regeneration. The photovoltaic 
ability of PCL/P3HT nanofiber scaffolds was demonstrated in this study by studying the 
current density versus voltage. The electrospun fiber can definitely absorb visible light 
and convert the optical energy to electrical energy causing the photocurrent effect. An 
optimized amount of P3HT was incorporated in PCL and our studies found higher HDF 
proliferation with collagen stains on PCL/P3HT(10) scaffolds after light stimulation. All 
these results proved that PCL/P3HT(10) could be a promising substrate for photocurrent 
therapy in skin TE. 
5.4 Conclusions 
 
Functional photosensitive P3HT containing PCL nanofibrous scaffolds were fabricated by 
electrospinning. Fibroblast proliferation on PCL, PCL/P3HT(2), PCL/P3HT(10) and 
PCL/P3HT(20) nanofibrous scaffolds under light stimulation was studied and the results 
of our study suggest that fibroblasts cultured on PCL/P3HT(10) after light stimulation had 
better proliferation and morphology than fibroblasts cultured on electrospun PCL, 
PCL/P3HT(2) and PCL/P3HT(20) nanofibers. Electrospun PCL/P3HT(10) nanofibrous 
scaffold was capable of supporting cell proliferation and favoring cell ECM secretion. We 
concluded that the electrospun PCL/P3HT(10) nanofibers are suitable substrates for 







Electrospun biomimetic and photosensitive core-shell 




Burn injuries, chronic wounds (pressure and leg ulcers), tumors and excision of skin are 
the main forms of skin damage [1, 190]. Burn injuries cause damage to blood vessels in 
the immediate area of the wound and lead to restriction or cessation of blood flow at the 
site of injury [235]. According to WHO, 300,000 deaths are annually reported in 
hospitals due to burn injuries, while 6 million patients worldwide suffer from burns every 
year [3]. For patients with very large total body surface area wounds, insufficient donor 
sites for autografting complicate wound closure, and this increase the risk of invasive 
wound infection and mortality [9]. The need for permanent wound closure in burn 
patients has driven the development of bio-engineered skin replacements [10]. The ideal 
skin graft shall encompass several strategies such as the use of functional cellular 
components, biodegradable scaffolds with analogous extracellular matrix (ECM) 
structures and other biological factors. Rho and colleagues produced a cross-linked 
nanofibrous matrix of type I collagen via electrospinning to develop natural protein based 
biomimetic scaffolds. They examined the effect of collagen nanofibers on open wound 
healing in rats and found that collagen nanofibrous matrices promote cell adhesion and 
were effective as wound-healing accelerators in early-stage wound healing [194]. 
However, the poor mechanical properties and high cost limit the application of collagen 
in skin tissue engineering. Unlike collagen, gelatin is a natural biopolymer derived from 
collagen by controlled hydrolysis and it has been widely used in pharmaceutical and 
medical fields because of its biological origin, biodegradability, biocompatibility, 
commercial availability and due to its relatively low cost [195]. Chong and colleagues 
developed a cost-effective substrate by directly electrospinning 
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poly(ε-caprolactone)/gelatin (PCL/gelatin) nanofibers onto a commercially available 
polyurethane (PU) dressing (Tegaderm
TM
, 3M Medical) for application as a dermal 
wound healing scaffold. The presence of PCL/gelatin on PU was suggested to promote 
cell adhesion and proliferation capacity of the Tegaderm
TM
 [191]. Similarly, electrospun 
polyurethane/gelatin (PU/Gel) nanofibers were also found to enhance the regeneration of 
burn-wounds [213]. Most of these researchers focused on the development of skin grafts 
which mimic the natural ECM of skin to realize wound healing and skin regeneration. 
Unlike these researchers, Zhao and his colleagues studied wound healing in a different 
way where they used electrical signals to regulate wound re-epithelialization. In every 
species studied, the disruption of an epithelial layer instantaneously generated 
endogenous electric fields, which is crucial in wound healing [119, 120]. It was observed 
that with percolation of an electric field with a polarity that opposed the default healing 
direction, the movement of the epithelium followed the direction of the electric signal and 
the wound opened up. By reversal of the electrical polarity the wound got closed [121]. 
Oscillatory electric fields are known to induce human macrophage migration on glass 
substrate, whereby macrophages exposed to 1 Hz, 2 V/cm field showed an induced 
migration velocity of 5.2 ± 0.4 × 10
-2
 µm/min [295]. Macrophages are phagocytic cells 
that originate in the bone marrow, and they act as scavengers of cell debris and 
extracellular material in the wound site [48]. Electrical stimulation shows promising 
results in wound healing, and phototherapy is also gaining recognition for immediate 
relief of acute and chronic pain, for treatment of inflammatory conditions, and to promote 
wound healing. Light irradiation was found to significantly influence wound healing. In 
one such study, the treatment of the wounds in rat models using blue light demonstrated a 
significant decrease in the wound area [116]. On the other hand, a significantly higher 
number of fibroblasts were found under green light-emitting diode (LED) irradiation 
compared with fibroblasts irradiated with infrared LED light (p < 0.001) [117]. 
Previously in our labs, we performed electrospinning of a blend of poly(3-hexylthiophene) 
(P3HT) and PCL to prepare a photosensitive scaffold PCL/P3HT, to study the 
biocompability of the scaffolds [296]. In the current study, we incorporated 
photosensitive polymer P3HT and EGF in Gel/PLLCL core-shell nanofibers and studied 
the potential application of this core-shell nanofibers as a novel skin graft. 
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6.2 Materials and Methods 
6.2.1 Materials 
 
ASCs were obtained from Lonza (Portsmouth, NH). HDF were purchased from 
American Type Culture Collection, USA. DMEM/F12, FBS, 
penicillin-streptomycinsolution, Alexa Fluor 594, Alexa Fluor 488 and DAPI, were all 
purchased from Invitrogen (Carlsbad, CA). P3HT, gelatin, chloroform, methanol, and 
HFP, EGF and bovine serum albumin were all purchased from Sigma-Aldrich (Singapore) 
and mouse anti-human keratin 10 (Ker 10) antibody was obtained from Thermo Fisher 
Scientific (Singapore). CD 105 was purchased from Abcam (USA). PLLCL with ratio of 
70:30 was obtained from Boehringer Ingelheim Pharma GmbH (Ingelheim, Germany). 
6.2.2 Electrospinning of nanofibers 
 
8% (w/v) of PLLCL solution was prepared by dissolving block copolymer in HFP. 
Gelatin and PLLCL were dissolved in HFP at a ratio of 60:40 (wt.%) to obtain 10% (w/v) 
solution and stirred overnight. The solutions were individually placed in a 3 ml standard 
syringe attached with blunted steel needles with 27 G inner diameters. Then, the solution 
loaded syringe was located in a syringe pump (KDS 100, KD Scientific, Holliston, MA) 
at a flow rate of 1.0 ml h
-1
. Nanofibers were fabricated via electrospinning at 15 kV 
(Gamma High Voltage Research, Ormond Beach, FL) and collected on an aluminum foil 
wrapped flat grounded steel plate at a distance of 12 cm from the needle tip. A vacuum 
desiccator was used to evaporate residual solution of the nanofibers collected on 15 mm 
coverslips. 
 
To fabricate EGF encapsulated core-shell nanofibers, 1.7 μg EGF was diluted into 1 ml 
solution with 5% bovine serum albumin (BSA) and was used as the core solution. The 
amount of loaded EGF was calculated based on the study by Jiang et al. [248]. To 
fabricate EGF and P3HT encapsulated core-shell nanofibers, 1.7 μg EGF and 18 mg 
P3HT were dissolved in 1 ml chloroform/methanol (3:1 v/v) solution and was used as the 
core solution. The amount of the P3HT used in this study was optimized based on our 




A coaxial spinneret was applied for electrospinning, where the inner needle had an inner 
diameter of 0.8 mm and an outer diameter of 1 mm; the outer needle has an inner 
diameter of 1.8 mm. The fluids of the core and shell remained immiscible before exiting 
the coaxial spinneret. Two syringe pumps were provided to pump a constant volume flow 
rate of 0.3 mL/h for the core solution and 1.0 mL/h for the shell solution. The core-shell 
structured fibers were electrospun at a high-voltage of 15 kV. The distance between the 
tip of spinneret and collector was 12 cm. Hereafter, in this manuscript P3HT, EGF 
encapsulated nanofibers and EGF encapsulated nanofibers will be represented as 
Gel/PLLCL/P3GF(cs) and Gel/PLLCL/GF(cs), respectively.  
6.2.3 Characterization of electrospun nanofibers 
 
FESEM (FEI-QUANTA 200F, Netherlands) was used to study the morphology of the 
electrospun nanofibers at an accelerating voltage of 10 kV, after sputter coating with gold 
(JEOL JFC-1200 fine coater, Japan). The obtained SEM images were applied to obtain 
the diameters of the electrospun fibers using image analysis software (Image J, National 
Institutes of Health, USA). The core-shell structure of Gel/PLLCL/P3GF(cs) and 
Gel/PLLCL/GF(cs) was examined using a JEOL JEM-2010F transmission electron 
microscopy (TEM). VCA Optima Surface Analysis system (AST products, Billerica, MA) 
was applied to measure the hydrophilic/hydrophobic properties of the electrospun 
nanofibrous scaffolds. Functional groups of the electrospun nanofibrous scaffolds were 
evaluated by attenuated total reflectance fourier transform infrared (ATR-FTIR) 
spectroscopic analysis in a Nicolet Avatar 380 spectrometer (Thermo Nicolet, Waltham, 
MA) over the range 600-3800 cm
-1 
at a resolution of 4 cm
-1
. A tabletop tensile tester 
(Instron x345, Canton, MA) was applied to determine the tensile properties of the 
electrospun nanofibrous scaffolds at a load cell capacity of 10 N. Specimens with 
dimensions 10 mm × 20 mm were used for tensile test at a rate of 10 mm min
−1
. The 
tensile stress-strain curves were plotted from the data recorded by the instrument at 
ambient conditions. As a minimum, five specimens from each scaffold were tested.  
6.2.4 Light stimulation conditions 
 
To evaluate the effect of light stimulation on HDF proliferation, in vitro wound healing 
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and ASC epidermal differentiation, illumination of cells on the electrospun nanofibrous 
scaffolds was performed using white color light emitting diodes (LEDs) (DIODER 
Lighting strip, IKEA, Singapore). USB 2000 spectrometer (Ocean optics, USA) was used 
to perform the calibration of LEDs. The wavelength of white LED is 421 to 670 nm, 
within the range of visible light (390 – 750 nm). After seeding cells, the cell-scaffold 
composites were directly located under LEDs and irradiated for 1 hour once every 24 
hours. The effect of light stimulation on HDF proliferation and in vitro wound healing 
was performed for 9 days and the effect on ASC epidermal differentiation was carried out 
for 15 days.  
6.2.5 Culture of HDFs and proliferation  
 
DMEM supplemented with 10% FBS and 1% antibiotic and antimycotic solutions were 
used to culture human dermal fibroblasts (HDFs) in a 75 cm
2
 cell culture flask. Cells 
were incubated for 6 days in an incubator at 37 °C, containing 5% CO2 and the culture 
medium was changed once every 3 days. Nanofibrous scaffolds were placed in 24 well 
plate and pressed by a stainless steel ring. The specimens were exposed to UV radiation 
for 2 h, washed thrice with phosphate-buffered saline (PBS) and incubated overnight in 
DMEM. HDFs were seeded on the scaffolds at a density of 10 × 10
3
 cells/well. The 
comparative proliferation capacity of fibroblasts on Gel/PLLCL/P3GF(cs), 
Gel/PLLCL/GF(cs), Gel/PLLCL and PLLCL nanofibrous scaffolds under light 
stimulation was evaluated following the parameters as described in section 6.2.4. The cell 
proliferation was evaluated by colorimetric MTS assay (CellTiter 96 AQueous One 
solution, Promega, Madison, WI). After culturing the cells for a period of 3, 6 and 9 days, 
the culture medium was removed and cell-scaffold composites were washed 3 times with 
PBS to remove unattached cells. Then, the composites were incubated for a period of 3 
hrs at 37 °C with 20 % MTS reagent in serum free medium. A spectrophotometric plate 
reader (FLUOstar OPTIMA, BMG lab Technologies) was applied to measure the 
absorbance of the obtained dye at 490 nm. The amount of formazan crystals formed is 
directly proportional to the number of live cells, which was also directly proportional to 
the absorbance values obtained. As a control, cells were also cultured on the scaffolds 
under non-stimulative conditions to understand the specific effect of light stimulation 
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towards cell proliferation after seeding cells on the same scaffolds. 
6.2.6 In vitro wound healing on Gel/PLLCL/P3GF(cs) nanofibrous scaffold 
 
In vitro wounds were induced to study the capability of photosensitive 
Gel/PLLCL/P3GF(cs) in promoting wound healing. Before seeding cells, a sterilized 0.5 
× 0.5 cm
2
 glass slide was located in the center of the scaffold. After 9 days, when HDFs 
were grown to confluency, the glass slide on each scaffold was removed to induce the 
wound. The in vitro wound and scaffold constructs in the light stimulated group were 
irradiated for 1 hour once every 24 hours. The appearances of in vitro wounds closure in 
stimulated and non-stimulated groups were obtained by SEM. After periods of 3 and 9 
days, the cell-scaffold constructs were fixed in 2.5% glutaraldehyde for 2 h. The scaffolds 
were further rinsed in DI water, dehydrated with increasing concentrations of ethanol 
(50%, 75% 95%, 100%) for 10 min each. Finally the cell-scaffold constructs were 
air-dried in fume hood overnight and observed under the SEM.  
6.2.7 Epidermal differentiation of ASCs on photosensitive scaffolds 
 
To study the potential of photosensitive nanofibrous scaffolds towards the epidermal 
differentiation of ASCs under light stimulation, illumination of ASCs on 
Gel/PLLCL/P3GF(cs) and Gel/PLLCL/GF(cs) was performed using the LED and light 
stimulation parameters as described in section 6.2.4. ASCs were seeded on the scaffolds 
at 5 ×10
3
 cells/well in 24-well plates using medium comprising of DMEM and Ham’s 
F12 medium (3:1) containing10% FBS, 100 IU ml
-1
 penicillin and 100 μg ml-1 
streptomycin. All samples were incubated under standard culture conditions and the 
culture medium was changed every 3 days.  
6.2.8 Immunostaining analysis of differentiated ASCs  
 
To confirm the differentiation of ASCs along the epidermal lineage, double 
immunostaining was performed. After 15 days, the cell-scaffold composites were washed 
with PBS, fixed with 2.5% paraformaldehyde. The ASCs on Gel/PLLCL/P3GF(cs) and 
Gel/PLLCL/GF(cs) were blocked for nonspecific staining using 2% BSA then 
immunostained with ASC-specific marker CD 105 for 2 h at room temperature. 
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Subsequently, the cell-scaffold composites were revealed with Alexa Fluor 594 (red) 
secondary antibody for 60 min at room temperature. After that, the samples were washed 
three times with PBS and treated with diluted Ker 10 (1:100) for 2 h at room temperature. 
Then, the secondary antibody Alexa Fluor 488 (green) was added for 60 min at room 
temperature. Finally, the samples were treated with DAPI after washing thrice with PBS 
and incubated for 30 min at room temperature. The stained samples were mounted on a 
glass slide and examined under confocal microscope (LSM 700, ZEISS).  
6.2.9 Statistical analysis 
 
All the experiments were repeated 3 times to calculate the mean ± standard deviation 
(SD). Statistical differences were determined by Student’s two-sample t-test. Differences 
were considered statistically significant at p ≤ 0.05.  
6.3 Results and discussion 
 
Over the last few decades innovations in biomaterials and medical technology have had a 
sustainable impact on the development of biomimetic scaffolds for regenerative medicine. 
To realize skin regeneration, researchers use stem cells, growth factors and smart 
bioactive materials to develop artificial extracellular matrix (ECM) (20). However, these 
tissue engineered composites still suffer certain drawbacks such as short shelf-life, high 
cost and the clinical performance of many of these scaffolds are poor due to low adhesion 
to lesion, difficulty in reproducing skin appendages and inability to replace the lost tissue, 
particularly the dermis, after severe burns [1, 297]. Hence, it was necessary to conquer 
wound healing directions via a different path such as the ‘photocurrent therapy’. 
Photocurrent is generated when photovoltaic device such as a photodiode gets irradiated 
with certain wavelength of light and absorbs energy from the light. While electrotherapy 
and phototherapy have shown promising results in skin regeneration, photocurrent 
therapy combines these two therapies and it could be more appropriate in regenerative 
medicine [134]. In order to improve the biocompatibility of the photosensitive P3HT, we 
electrospun core-shell structured nanofibers and encapsulated P3HT and EGF within the 
core and studied the ability of the core-shell nanofibers in promoting cell proliferation, in 
vitro wound healing and further utilized the scaffolds to study their potential for 
Chapter 6 
 113 
epidermal differentiation of stem cells.  
6.3.1 Morphology, chemical and mechanical characterization of electrospun nanofibers 
 
Nanofibers of Gel/PLLCL/P3GF(cs), Gel/PLLCL/GF(cs), Gel/PLLCL and PLLCL were 
fabricated by electrospinning under the optimized spinning conditions. SEM images (Fig. 
6.1) shows beadless, nano-scaled fibrous structures with interconnected pores.  
 
 
Fig. 6.1 Characterizations of electrospun nanofibers. a. SEM morphology of 
Gel/PLLCL/P3GF(cs), Gel/PLLCL/GF(cs) , Gel/PLLCL and PLLCL nanofibers. b. TEM 
morphology of core-shell nanofibers. c. FTIR spectra of Gel/PLLCL/P3GF(cs), 
Gel/PLLCL/GF(cs), Gel/PLLCL and PLLCL nanofibers. d. Water contact angle of 
electrospun nanofibers.  
 
Uniform nanofibers of Gel/PLLCL/P3GF(cs), Gel/PLLCL/GF(cs), Gel/PLLCL and 
PLLCL with fiber diameters of 804 ± 264, 751 ± 171, 702 ± 105, 392 ± 47 nm were 
respectively, obtained. The TEM images (Fig. 6.1b) demonstrate the core-shell structure 
of Gel/PLLCL/P3GF(cs) and Gel/PLLCL/GF(cs) scaffolds. The dark gray colored P3HT 
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was clearly distinguishable from the shell (light gray) due to the high electron density of 
P3HT molecules. On the other hand, the TEM image of Gel/PLLCL/GF(cs) shows a 
reverse color distribution with light grey in the core and dark grey in the shell. Fourier 
transform infrared spectroscopy was applied to analyze functional groups present in 
nanofibers (Fig. 6.1c). Ester absorption peak at 1760 cm
-1
 was observed as the 
characteristic peak of PLLCL. Meanwhile peaks at 1097, 1133 and 1187 cm
-1
 were 
observed as the C-O-C stretching vibrations of PLLCL. Characteristic bands of gelatin 
were observed in Gel/PLLCL/P3GF(cs), Gel/PLLCL/GF(cs) and Gel/PLLCL scaffolds. 
Bands of amide group are present in the spectra of gelatin containing nanofibrous 
scaffolds. In addition to the characteristic peaks of PLLCL, carbonyl stretch and N–H 
bend coupled with a C–N stretch were observed at 1650 cm-1 and 1550 cm-1, respectively. 
The water contact angle of pure PLLCL nanofibers was 136 ± 30, which reveals the 
highly hydrophobic property of PLLCL. However, the hydrophilicity of the 
Gel/PLLCL/P3GF(cs), Gel/PLLCL/GF(cs) and Gel/PLLCL nanofibers was greatly 
improved with incorporation of gelatin. The contact angle of Gel/PLLCL/P3GF(cs), 
Gel/PLLCL/GF(cs) and Gel/PLLCL was 43 ± 40, 45 ± 60 and 40 ± 20, respectively. 
 
The stress-strain curves of the fibers are shown in Fig. 6.2. A linear segment up to the 
proportionality limit was observed for all scaffolds, followed by a non-linear curve. The 
changes of fiber arrangement in the mat under loaded stress were mainly attributed to this 
feature. It was demonstrated that fibers tend to align in the direction of applied force 
before getting thinner and finally the breaking occurred [223]. The elastic modulus of 
Gel/PLLCL/P3GF(cs), Gel/PLLCL/GF(cs), Gel/PLLCL and PLLCL nanofibers was 
70.71 ± 2.62, 87.14 ± 3.37, 93.57 ± 5.28 and 29.75 ± 3.42 MPa, respectively. Table 6.1 
summarizes the tensile properties of different electrospun nanofibers. Comparing the 
stress-strain curves of gelatin containing nanofibrous scaffolds with those of the 
stress-strain curve of PLLCL, we found that the incorporation of gelatin to PLLCL led to 






Fig. 6.2 Stress-strain curve of electrospun Gel/PLLCL/P3GF(cs), Gel/PLLCL/GF(cs), 
Gel/PLLCL and PLLCL nanofibers. 
 
Table 6.1 Tensile properties of the electrospun nanofibers 
Property Gel/PLLCL/P3GF(cs)  Gel/PLLCL/GF(cs)  Gel/PLLCL PLLCL 
Elastic Modulus 
(MPa) 
70.71 ± 2.62 87.14 ± 3.37 93.57 ± 5.28 29.75 ± 3.42 
Tensile Stress 
(MPa) 
2.33 ± 0.02 2.52 ± 0.03 3.40 ± 0.12 4.23 ± 0.03 
Strain at break 
(%) 
76.05 ± 8.78 46.14 ± 6.94 37.70 ± 3.07 149.13 ± 1.84 
 
This is due to the influence of gelatin, introducing crystallinity to the gelatin containing 
scaffolds and the crystallinity of the electrospun nanofibers was found to strongly 
influence the mechanical properties of scaffolds [220-222]. Fibers with higher 
crystallinity are more likely to have higher molecular orientation which will result in 
higher resistance to axial tensile force [222] and hence the gelatin containing nanofibers 
had higher elastic modulus with low ductility. Among the gelatin containing scaffolds, 
Gel/PLLCL showed the highest ultimate tensile stress (followed by Gel/PLLCL/GF(cs) 
and Gel/PLLCL/P3GF(cs)). Wong et al. studied the effect of fiber diameter towards the 
tensile properties of electrospun fibers and they found that fiber diameter mainly affect 
tensile strength when the fiber diameter is less than ~700 nm [259]. Similarly our 
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Gel/PLLCL scaffold with the smallest diameter had the highest ultimate tensile stress. 
The elastic modulus of Gel/PLLCL/P3GF(cs) scaffold (70.71 ± 2.62 MPa) is comparable 
to the elastic modulus of human skin (15-150 MPa) (28). The tensile modules of 
Gel/PLLCL/P3GF(cs) provides the scaffold with good resilience and compliance as a 
skin graft, especially for flexible skin movement.  
6.3.2 Light stimulative effect  
 
Previously we have demonstrated that the photosensitive PCL/P3HT nanofibers 
promoted the proliferation of HDFs after light irradiation. The cell proliferation was 
greatly improved by the combination of light stimulation with assistance of 
photosensitive P3HT containing scaffolds [296]. However, due to the toxicity of P3HT, 
the proliferation of HDF on PCL/P3HT was extremely limited. In the current study, we 
encapsulated P3HT and EGF together within the Gel/PLLCL/P3GF(cs) core-shell 
nanofibers and studied the extend of cell proliferation under light stimulation and the 
results are given in Fig. 6.3. On day 6, the proliferation of HDFs on Gel/PLLCL/P3GF(cs) 
and Gel/PLLCL/GF(cs) was significantly higher compared to the cell proliferation on 
Gel/PLLCL and PLLCL nanofibrous scaffolds (under both light stimulated and dark 
conditions). This is because of the sustained release of EGF from core-shell nanofiber 
[298] and the released EGF helped to promote the proliferation of HDFs. EGF is known 
to promote the proliferation of various cell types and it has also been applied to skin 
wounds [299-301]. Matsumoto and Kuroyanagi designed a spongy sheet of hyaluronic 
acid containing EGF and evaluated its potential application in wound healing. They 
found that EGF in the wound dressing were sufficient to facilitate fibroblast proliferation 
and promote wound healing by inducing moderate inflammation [302]. At the same time, 
the proliferation of HDFs on stimulated Gel/PLLCL/P3GF(cs) was 1.6% higher 
compared to HDF proliferation on stimulated Gel/PLLCL/GF(cs). This higher amount of 
proliferation on stimulated Gel/PLLCL/P3GF(cs) is caused by the stimulative 
photosensitive effect of P3HT within the core of the fibers. Using Gel/PLLCL/P3GF(cs) 
as the substrate, we found higher proliferation (13.7%) of HDFs (p ≤ 0.05) under 
stimulated conditions compared to cell proliferation in non-stimulated (NS) conditions 
after 9 days. Moreover, the proliferation of fibroblasts on Gel/PLLCL/P3GF(cs) was 
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found 3.4%, 28.2% and 51.8% (p ≤ 0.05) higher than the cell growth on 
Gel/PLLCL/GF(cs), Gel/PLLCL and PLLCL, respectively under light stimulated 
conditions, (Fig. 6.3). From the obtained results, it was clear that the EGF mainly 
contributed towards the proliferation of HDFs and additionally the photosensitive P3HT 
under light radiation enhanced the ability of Gel/PLLCL/P3GF(cs) to promote the cell 
proliferation even better.  
 
 
Fig. 6.3 HDF proliferation on electrospun Gel/PLLCL/P3GF(cs), Gel/PLLCL/GF(cs), 
Gel/PLLCL and PLLCL nanofibrous scaffolds stimulated (S) compared to HDF 
proliferation on electrospun Gel/PLLCL/P3GF(cs), Gel/PLLCL/GF(cs), Gel/PLLCL and 
PLLCL nanofibrous scaffolds non-stimulated (NS) by MTS assay. *Significant against 
cell proliferation on PLLCL (NS) at p ≤ 0.05. ΔSignificant against cell proliferation on 
Gel/PLLCL/P3GF(cs) (NS) and Gel/PLLCL/GF(cs) (NS) at p ≤ 0.05. #Significant against 
cell proliferation on Gel/PLLCL/P3GF(cs) (NS) at p ≤ 0.05.
◆
Significant against cell 
proliferation on Gel/PLLCL/GF(cs) (S) at p ≤ 0.05. 
 
6.3.3 In vitro wound healing 
 
The potential application of Gel/PLLCL/P3GF(cs) nanofibrous scaffold for wound 
healing was evaluated using an in vitro wound model. As shown in Fig. 6.4, fibroblasts 
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under light stimulation migrated from the boundary of the wound towards the centre of 
the wound after 3 days and a few cells also showed elongated morphology towards 
wound. However, the migration of fibroblasts in the dark condition was limited and few 
cells showed elongated morphology, while most of the fibroblasts remained at the wound 
boundary. Cells could cover the entire surface of the stimulated Gel/PLLCL/P3GF(cs) 
nanofibrous scaffold in 9 days. In contrast, a void was observed after the same period of 
time for non-stimulated scaffold (red arrows).  
 
 
Fig. 6.4 In vitro wound healing on stimulated and non-stimulated Gel/PLLCL/P3GF(cs) 
nanofibrous scaffold for 9 days. 
 
The faster wound healing on Gel/PLLCL/P3GF(cs) under light stimulation could be due 
to the higher cell proliferation on this scaffold under light irradiation as obvious from the 
results of the cell proliferation study. Higher number of fibroblasts on the stimulated 
Gel/PLLCL/P3GF(cs) improves the efficacy of cell communication. Moreover, the shell 
portion of the nanofibers (Gelatin/PLLCL) provided hydrophilicity to the scaffolds, and it 
could assist in cell communication via promoting the circulation of bioactive molecules, 
thereby enabling faster wound closure. When light irradiated on the wound site of 
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Gel/PLLCL/P3GF(cs) fibers, electrons were generated by the core P3HT polymer 
molecules and when the electrons flow in the same direction, an electrical current was 
generated [134, 296]. Meanwhile, an electrical field gets created which guide the 
fibroblasts in migrating towards the wound site. Studies performed by Zhao and 
Nishimura et al. utilizing keratinocytes and corneal epithelial cells, were also found to 
migrate directionally towards the cathode in an electrical field as low as ∼25 mV/mm 
[121, 303]. Our in vitro wound healing result suggests that Gel/PLLCL/P3GF(cs) 
nanofibers could be applied as a wound healing graft for preclinical studies.  
6.3.4 Epidermal differentiation of ASCs on photosensitive core-shell nanofibers 
 
With the success of using the EGF and P3HT containing scaffolds for HDF proliferation, 
the epidermal differentiation capacity of ASCs was performed on electrospun 
Gel/PLLCL/P3GF(cs) and Gel/PLLCL/GF(cs) nanofibrous scaffolds for a period of 15 
days (Fig. 6.5). ASCs are a heterogeneous group of multipotent progenitor cells that can 
be readily derived from adipose tissue of adult humans in very large quantities by 
lipoaspiration [304] and the isolation of ASCs yields higher amount of stem cells, that are 
required for most of the stem cell-based therapies or accompanied tissue regeneration 
[262]. ASCs are multipotent stem cells and can differentiate into adipogenic, osteogenic, 
chondrogenic and myogenic cell lineages [160, 305]. Here we studied the plasticity of 
ASCs towards epidermal cell lineages on electrospun nanofibers. The epidermal 
differentiation capacity of ASCs on EGF incorporated Gel/PLLCL/P3GF(cs) and 
Gel/PLLCL/GF(cs) core-shell nanofibrous scaffolds were studied under light stimulation 
after 15 days and analyzed by immunostaining studies. Cells were stained for 
ASC-specific marker CD 105 and early epidermal differentiation marker Ker 10. The 
distinguishable phenotypical features of keratinocyte-like cells were observed on 
Gel/PLLCL/P3GF (cs) under light stimulation (highlighted with red boundary in Fig. 6.5). 
However, ASCs on Gel/PLLCL/GF(cs) nanofibers and non-stimulated Gel/PLLCL/P3GF 




Fig. 6.5 Dual immunocytochemical analysis for the expression of Ker 10, CD 105 and 
merged image showing the dual expression of both CD 105 and Ker 10 on stimulated 
Gel/PLLCL/P3GF(cs), Gel/PLLCL/GF(cs) nanofibers and non-stimulated 
Gel/PLLCL/P3GF(cs), Gel/PLLCL/GF(cs) nanofibers at 20 × magnification.  
 
Adamskaya and colleagues [116] found that blue light significantly influenced wound 
healing based on rat animal models. The keratin-10 mRNA level of the rats irradiated 
with blue (470 nm) and red (629 nm) LED was significantly elevated compared to control. 
Meanwhile, Liebmann et al. found that blue LED up to 453 nm induced differentiation of 
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primary keratinocytes [39]. Keratinocytes are produced in the deepest layer of the 
epidermis (basal layer) during cell division and they are carried towards the skin surface. 
In the meantime, they undergo a complex series of morphological and biochemical 
changes known as keratinocyte differentiation [53]. Results of their study demonstrated 
that the irradiated primary keratinocytes significantly increased the mRNA levels of 
involucrin by up to threefold relative to the non-irradiated control. Involucrin is 
increasingly expressed by differentiating keratinocytes and it is a marker of keratinocyte 
terminal differentiation [306]. Recently, Arai and colleagues investigated the keratinocyte 
differentiation under mono-directional pulsed electric stimulation. Cultured keratinocytes 
were exposed to an electric field of 3 V (ca. 100 mV/mm) or 5 V (ca. 166 mV/mm) at a 
frequency of 4,800 Hz for 5 min a day for a period of 5 days. They found that the 
expression of mRNAs encoding keratinocyte differentiation markers such as keratin 10, 
involucrin, transglutaminase 1, and filaggrin was significantly increased in response to 
the 5 V stimulation [307]. Both light and electrical stimulation were shown to promote 
the differentiation of keratinocyte. Similarly the epidermal differentiation of ASCs on the 
stimulated Gel/PLLCL/P3GF(cs) might have been induced by the sustained release of 
EGF and photosensitive ability of Gel/PLLCL/P3GF(cs) nanofibrous scaffold. Our 
immunocytochemical results proved that the electrospun Gel/PLLCL/P3GF(cs) under 
light stimulation could act as a suitable substrate for epidermal differentiation of ASCs. 
The studies open up new opportunities for transplantation of wound healing mediators 
containing nanofibrous scaffold as skin graft for skin tissue engineering. 
6.4 Conclusion  
 
EGF incorporated Gel/PLLCL nanofibers were prepared by core-shell spinning, either 
alone or with additional incorporation of a photosensitive polymer P3HT, within 
Gel/PLLCL nanofibers by coaxial electrospinning. Fibroblast proliferation was 
significantly improved with incorporation of EGF; while P3HT assist the proliferation of 
fibroblast on Gel/PLLCL/P3GF(cs) nanofibers under light stimulation. Moreover, the 
stimulated Gel/PLLCL/P3GF(cs) was found to accelerate the in vitro wound healing. The 
effect of the photosensitive Gel/PLLCL/P3GF(cs) on epidermal differentiation of ASCs 
was further explored and keratinocyte-like cells were only found on the stimulated 
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Gel/PLLCL/P3GF(cs) scaffolds. We propose here that the biomimetic and photosensitive 
Gel/PLLCL/P3GF(cs) nanofibers could be a novel scaffold that could be applied in 










Conclusions and Recommendations 
 
The scope of this research encompasses the fabrication of cost-effective NFS for in vivo 
wound healing, and the in vitro differentiation of human ASCs into epidermal lineage 
under an artificial skin-specific environment constructed by multiple EIF encapsulated 
core-shell NFS. In addition, the potential application of photosensitive P3HT containing 
NFS for skin tissue engineering was study. The final product is a biomimetic and 
photosensitve core-shell NSF/ASCs composite for skin graft application. This product 
has shown superior effects on promoting cell proliferation, differentiation and in vitro 
wound healing.  
7.1 Main conclusions 
 
 The epidermal differentiation potential of stem cells was confirmed and achieved 
by manipulating the biochemical cues combined with the environmental and 
physical factors of culture substrate (NFS). We found that the regional 
differentiation was greatly reduced by using electrospun NFS as a substrate 
instead of such differentiations on TCP.  
 
 The electrospun Gel/PLLCL(60) nanofibers which had sufficient mechanical 
properties in both dry and wet conditions, along with the highest cell proliferation 
was the optimized NFS for skin tissue engineering. The capability of 
Gel/PLLCL(60) in promoting wound healing was confirmed in a mouse model. In 
vivo wounds treated with NFS complete closure within 14 dyas and 4 days earlier 
than the control groups.  
 
 The core-shell structured NFS, which encapsulated multiple EIF, achieved 
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sustained release without burst release. The expression of early and intermediate 
epidermal differentiation markers was observed by performing the differentiation 
of ASCs to epidermal lineages on the core-shell NFS. With sustained release of 
EIF from core-shell NFS, the percentage of epidermally differentiated ASCs on 
core-shell nanofibers was significantly higher (62%) than that on EIF blended 
NFS (43%).  
 
 Photosensitive P3HT containing nanofibrous scaffolds were fabricated by 
electrospinning. Fibroblast proliferation on PCL, PCL/P3HT(2), PCL/P3HT(10) 
and PCL/P3HT(20) nanofibrous scaffolds under light stimulation was studied and 
the results of our study suggest that fibroblasts cultured on PCL/P3HT(10) after 
light stimulation had better proliferation and morphology than fibroblasts cultured 
on electrospun PCL, PCL/P3HT(2) and PCL/P3HT(20) nanofibers. Electrospun 
PCL/P3HT(10) nanofibrous scaffold was capable of supporting cell proliferation 
and favoring cell ECM secretion. 
 
 The feasibility of EGF and P3HT encapsulated core-shell NFS as skin graft was 
confirmed. Fibroblast proliferation was significantly improved with incorporation 
of EGF; while P3HT assist the proliferation of fibroblast on Gel/PLLCL/P3GF(cs) 
nanofibers under light stimulation. Moreover, the stimulated Gel/PLLCL/P3GF(cs) 
was found to accelerate the in vitro wound healing. The effect of the 
photosensitive Gel/PLLCL/P3GF(cs) on epidermal differentiation of ASCs was 
further explored and keratinocyte-like cells were only found on the stimulated 
Gel/PLLCL/P3GF(cs) scaffolds.  
7.2 Recommendations for future work 
 
The biomimetic and photosensitive core-shell NFS described herein has showed 
promising results in promoting ASCs epidermal differentiation and in vitro wound 
healing. Further study on the capability of NFS/ASCs composite in vivo wound healing is 
needed to be evaluated in anmal model. Moreover, investigations are required to 
understand the growth factor and gene expression profiles of ASCs under in vivo 
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wounding environment as well as to identify the functions of differentiated ASCs within 
wounding milieu and the underlying molecular mechanisms of ASCs transdifferentiation. 
 
Uniaxially aligned arrays of nanofibers can be electrospun under certain conditions such 
as use of an air-gap collector or a mandrel rotating at a high speed [308, 309]. Aligned 
core-shell NFS which includes growth factors and photosensitive polymer could be more 
efficient in promoting cell proliferation and migration compared to the random NFS. The 
photocurrent generated in aligned nanofibers is uniaxial and this uniaxial photocurrent 
will promoted cell migration along the direction of the electrical field to accelerate 
wound healing [121]. Furthermore, radially aligned nanofibers can be electrospun by 
utilizing a collector composed of a central point electrode and a peripheral ring electrode 
[310]. The photosensitive core-shell NFS constructed with radially aligned nanofibers 
could promote cell migration from the surrounding tissue to the center of a defect and 
shorten the time for healing and regeneration of wound.  
 
 
Fig. 7.1 Photograph of a scaffold of radically aligned nanofibers directly deposited on the 
ring collector [310]. 
 
The main advantage of the electrospun fibrous scaffold is the ability to mimic the native 
ECM of human skin, due to its fibrous structure, suitable mechanical properties and the 
ability in incorporating bioactive factors (e.g., growth factors). Moreover, the flexibility 
of the scaffold makes it can easily integrate with the skin wound. However, the high cost, 
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short-term shelf-time and complexity in using still impede the wide applications as tissue 
engineered scaffold. As a result, more studies are expected to address these issues of 
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